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1. p38 MAPKs 
1.1. GENERALITIES 
p38 MAPKs belong to the superfamily of MAPKs. MAPK pathways are 
evolutionarily conserved kinase modules that link extracellular signals to the 
machinery that controls fundamental cellular processes such as growth, 
proliferation, differentiation, migration and apoptosis (Dhillon et al. 2007). 
MAPKs are activated upon dual phosphorylation of tyrosine and 
threonine residues in a conserved Thr-X-Try motif (where X is any amino acid) by 
a MAP kinase kinase (MKK), which in turn is activated when phosphorilated by a 
MAPK kinase kinase (MKKK) (Fig. 1). MAPK phosphatases reverse the 
phosphorylation and 
return the MAPK to 
their inactive state 
(Chang and Karin 
2001;Dhillon et al. 
2007). 
In mammals, 
there are more than a 
dozen MAPK genes 
codifying for different 
MAPKs. The best 
known subfamilies of 
MAPKs are ERKs 
(Extracellular signal-
regulated kinases: ERK-
1 and ERK-2), mainly 
activated by growth 
factors, and the stress 
MAPKs, JNKs (c-Jun N-
terminal kinases: JNK-
1, JNK-2 and JNK-3) 
Figure 1: Schematic overview of MAPK pathway: 
Ilustration of the three-tiered MAPK cascades for ERK, JNK 
and p38 family members (Rose et al. 2010)  
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and p38 MAPKs, mainly activated by stress. Other MAPKs are ERK3, ERK5 and 
ERK7, which belong to the non-classical subfamily and have distinct regulation 
and functions (Raman et al. 2007). 
There are four p38 MAPKs isoforms in mammals: , ,  and , which are 
60% identical in their amino acid sequence. The four p38 MAPKs are encoded by 
different genes and have different tissue expression patterns. Furthermore, p38 
MAPK isoforms also differ in their sensibility to the inhibitors SB203580, 
SB202190 and BIRB796, and in their substrate specificity (Cuadrado and Nebreda 
2010; Nebreda and Porras 2000).  
The first member of the p38 MAPK family was independently identified 
by four groups. p38 was initially identified as a 38 KDa protein that was rapidly 
phosphorylated on tyrosine in response to LPS (lipopolysaccharide) stimulation 
(Han et al. 1994). In parallel, two other groups independently identified p38 as a 
kinase activated by stress (Rouse et al. 1994) and by IL-1 (Freshney et al. 
1994;Kim et al. 2012a). Later on that year, another identification of p38 was 
reported as a polypeptide receptor for a class of pyridinyl imidazole anti-
inflammatory drugs (CSAIDs) (Lee et al. 1994). A few years after the identification 
of p38, three additional isoforms were described: p38 (Jiang et al. 1996), p38 
(Li et al. 1996) and p38 (Goedert et al. 1997; Jiang et al. 1997).  
Although all p38 isoforms are widely expressed, p38 is the best 
characterized and ubiquitously expressed at significant levels. p38 is also 
ubiquitous, but it is expressed at lower levels. p38 is most significantly expressed 
in skeletal muscle and p38 is mainly found in testi, pancreas, kidney and small 
intestine (Cuenda and Rousseau 2007). 
The canonical activation of p38 MAPKs occurs via dual phosphorylation of 
their Thr-Gly-Tyr motif by three dual-specificity MKKs. MKK6 can phosphorylate 
the four p38 MAPK isoforms, whereas MKK3 activates p38, p38 and p38, but 
not p38. In addition, p38 can be also phosphorylated by MKK4, an activator of 
JNKs (Cuadrado and Nebreda 2010) (Fig. 2).  
Moreover, three non-canonical mechanisms of p38 (and probably p38) 
activation have also been described. One, apparently specific to antigen receptor 
TCR (T-cell receptor)-stimulated T-lymphocytes, involves p38 phosphorylation 
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on a non-canonical activating residue, Tyr323 (Salvador et al. 2005). A second 
mechanism of activation is mediated by the interaction of TAB-1 (Transforming 
growth factor--activated protein 1 (TAK1)-binding protein 1) with p38, which 
induces p38α auto-phosphorylation (Ge et al. 2002;Li et al. 2005). Finally, down-
regulation of the protein kinase Cdc7 induces an abortive S-phase leading to 
p38α-mediated apoptosis in HeLa cells (Im and Lee 2008). 
The magnitude and duration of p38 MAPK signal are critical determinants 
of its biological effects. Activation of p38 MAPK occurs within minutes in response 
to most stimuli and is transient, being down-regulated by dephosphorylation. 
Many dual-specificity phosphatases, grouped as the MAPK phosphatase family 
(MKP), can efficiently dephosphorylate p38 and p38 (but not p38 and p38). 
In addition, other protein phosphatases, as PP2C (Ser/Thr phosphatase) and PTP 
(Tyr phosphatase), can inactivate all p38 MAPK isoforms (Cuenda and Rousseau 
2007; Zarubin and Han 2005). 
The in vivo functional redundancy of p38 isoforms, mainly p38α and 
p38β, has made the elucidation of their physiological functions a complicated 
process. The main tools used to identify p38 MAPKs physiological roles have been 
the chemical inhibitors and the knock-out mice. The inhibitors, SB203580 and 
SB202190 are selective for p38 and p38, while BIRB796 can inhibit the four 
isoforms although at different doses (Kuma et al. 2005). p38 knock-out mouse 
was the first generated, but it is embryonic lethal, dying at midgestation due a 
placental defect (Adams et al. 2000;Mudgett et al. 2000). Tissue-specific p38α 
knock-outs have implicated this isoform in cardiomyocyte proliferation and 
survival (Engel et al. 2005). p38β knock-out mice are viable (Beardmore et al. 
2005) and only show a reduced bone mass phenotype (Greenblatt et al. 2010). 
Mice with combined deletion of p38α and p38β display diverse developmental 
defects at midgestation, including major cardiovascular and liver abnormalities 
(del Barco Barrantes et al. 2011). p38 and p38 and double p38/p38 knock-out 
mice have also been generated, which are viable and fertile and have no obvious 
health problems (Sabio et al. 2005).  
Although p38 MAPKs have overlapping substrate specificity, some 
substrates appear to be preferentially phosphorylated by one or more isoforms 
(Zarubin and Han 2005). The best known p38 and p38 substrates are some 
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transcription factors (ATF-1/2, CHOP or p53), protein kinases (MNK1, PRAK or 
MSK), cytoskeletal proteins, translational machinery components and other 
proteins such as metabolic enzymes, glycogen synthase or cytosolic 
phospholipase A2. p38 and p38 MAPK isoforms can phosphorylate typical p38 
MAPK substrates such as the transcription factors ATF2, Elk-1 or SAP-1, but they 
have specific ones such as α1-syntrophin, SAP90/PSD95 and SAP97/Hd1g in the 
case of p38γ, and stathmin, tau and eEF2 (eukaryotic elongation factor 2) kinase 
in the case of p38δ (Fig. 2) (Cuadrado and Nebreda 2010; Cuenda and Rousseau 
2007). 
 
 
 
Figure 2: The p38 MAPK pathway. Different stimuli such as growth factors, inflammatory cytokines 
or environmental stresses can activate p38 MAPKs. A number of representative downstream 
targets, including protein kinases, cytosolic substrates, transcription factors and chromatin 
remodelers are shown (Cuadrado and Nebreda 2010). 
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1.2. p38 MAPKs FUNCTIONS 
p38 MAPKs are important regulators of the cellular response to 
extracellular stimuli and therefore, they are implicated in a wide range of 
biological functions such as:  
1. Inflammation: p38α plays essential roles in pro-inflammatory cytokines 
production such as IL-1, TNF-α and IL-6 (Kumar et al. 2003) and induction of 
the pro-inflammatory mediator COX-2 (Cyclooxygenase-2) (Xu and Shu 2007). 
p38γ and p38δ are also crucial regulators of inflammation in collagen-induced 
arthritis (Criado et al. 2014) and colitis-associated colon cancer (Del Reino et 
al. 2014). By contrast, p38β does not seem to be required for acute or chronic 
inflammatory response (O'Keefe et al. 2007).  
2. Differentiation: p38/ have been implicated in various cell differentiation 
processes, such as adipocytic differentiation of 3T3-L1 fibroblasts, neuronal 
differentiation of PC12 cells or erythroid differentiation of SKT6 cells 
(Nebreda and Porras 2000). In this line, p38α promote skeletal muscle 
differentiation at different levels (Perdiguero et al. 2007), whereas p38γ 
blocks the premature differentiation of satellite cells (Gillespie et al. 2009).  
3. Development: p38 MAPKs are involved in the regulation of wing 
morphogenesis and the correct asymmetric egg development in Drosophila 
(Nebreda and Porras 2000). In addition, p38 is essential for embryonic 
development. p38α Knock-out mice display embryonic lethality due to 
placental defects (Adams et al. 2000; Mudgett et al. 2000), whereas p38β, 
p38γ and p38δ knock-out animals are fully viable and fertile (Beardmore et al. 
2005; Sabio et al. 2005).  
4. Cell cycle/proliferation: Depending on the cell type and stimulus, p38 MAPKs 
can have either a positive or a negative role in cell proliferation (Nebreda and 
Porras 2000). p38α can negatively regulate cell cycle progression both at the 
G1/S and the G2/M transitions by several mechanisms (Ambrosino and 
Nebreda 2001; Thornton and Rincon 2009). p38 and p38 play also a role in 
proliferation. p38γ and p38δ-deficient MEFs have a slightly more rapid 
growth rate than wt cells (Cerezo-Guisado et al. 2011). In contrast, it has 
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been suggested an in vivo role for p38δ promoting cell proliferation 
(Schindler et al. 2009).  
5. Cell death: p38 can play a dual role as a regulator of cell death, so it can 
either mediate cell survival or cell death through different mechanisms 
(Nebreda and Porras 2000; Wagner and Nebreda 2009), as it would be 
further explained.  
6. Migration/Invasion: p38α mediates cell migration and invasion of several cell 
types, including tumour cells (Cuenda and Rousseau 2007; Wagner and 
Nebreda 2009), as it would be later explained. 
7.  Adhesion: p38α can negatively regulate cell adhesion as shown by the 
enhanced adhesion observed in p38α-deficient ES cells (Guo and Yang 2006) 
or in embryonic cardiomyocytes derived cell lines (Zuluaga et al. 2007b). 
However, in chronic myeloid leukemia (CML) cells, p38α despite inhibiting the 
expression and/or phosphorylation of some focal adhesion (FA) proteins, it 
increases cell adhesion (Maia et al. 2013). 
8. Senescence: p38 MAPKs have been described to play a role in senescence 
induction (Bihani et al. 2004; Haq et al. 2002; McMullen et al. 2005). For 
example, in response to telomere shortening (Bihani et al. 2004; Haq et al. 
2002) and in oncogene induced senescence (OIS) (Bulavin et al. 2003; Kwong 
et al. 2013; Kwong et al. 2009). 
9. Cancer: p38α MAPK can function both, as a promoter of tumour growth and 
as a tumour suppressor. In the initial stages, p38 can act as a tumour 
suppressor. For example, in MEFs transformed by oncogenic H-Ras p38α 
promotes apoptosis, which in turn leads to tumour suppression (Dolado et al. 
2007). According to this, p38α conditional deletion in adult mice favours 
unscheduled proliferation of progenitor cells and K-rasG12V -induced 
tumourigenesis (Ventura et al. 2007). Similarly, p38 liver-specific deletion  
enhances tumour development through up-regulation of the JNK-c-Jun 
pathway (Hui et al. 2007). However, in colitis associated colon-cancer p38 
MAPK plays a dual role, suppressing tumour initiation, while contributing to 
cell proliferation and survival later on (Gupta et al. 2014). In addition, it also 
favours colon cancer metastasis to the lung (Urosevic et al. 2014). 
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Furthermore, in head and neck cancer, p38α induces tumour dormancy, 
which favours survival of disseminated tumour cells (Aguirre-Ghiso 
2007;Bragado et al. 2013). In addition, p38δ has also been shown to play an 
important role in skin carcinogenesis (Schindler et al. 2009) and p38γ/δ in 
colitis-associated colon cancer formation (Del et al. 2014). In contrast, 
another study revealed a tumour suppressor role for p38γ and p38δ  (Cerezo-
Guisado et al. 2011).  
 
1.3. p38 MAPK CROSS-TALK WITH OTHER SIGNALING PATHWAYS 
The cross-talk between different signaling pathways is a common theme 
in cell regulation. It usually depends on the cell context and plays an important 
role in fine-tuning biological responses (Cuadrado and Nebreda 2010). There are 
many examples of cross-talk between p38 MAPKs and other proteins. For 
example, p38 MAPK negatively regulates the activity of the ERKs pathway 
(Porras et al. 2004) likely through PP2A stimulation (Junttila et al. 2008). 
The interplay between the JNK and p38 MAPK pathways has been broadly 
documented. Although multiple stimuli can simultaneously activate both 
pathways, their activation have antagonistic effects in many cases. p38 MAPKs 
can negatively regulate JNK activity at the level of MAP3Ks, either by 
phosphorylating MLK3 or the TAK1 regulatory subunit TAB1 (Cuadrado and 
Nebreda 2010). Moreover, p38α controls myoblast proliferation by antagonizing 
the proliferation-promoting function of JNK (Perdiguero et al. 2007). 
The interaction between p38 MAPK and Akt pathways at different levels 
is remarkable. Akt can inhibit the activation of p38α MAPK through 
phosphorylation of the upstream regulator, ASK1, on Ser83 (Yuan et al. 2003). On 
the other hand, p38α negatively modulates Akt activity through activation of 
PP2A in caveolae by regulating the interaction between caveolin-1 and PP2A 
(Zuluaga et al. 2007a). There are additional connections between the PI3K/Akt 
pathway and p38 MAPK. Thus, p38 MAPK was identified as an upstream regulator 
of mTORC1 activity in Drosophila melanogaster and in a transformed human cell 
line in response to stresses, amino acids and growth factors (Cully et al. 2010). 
Introduction 
10 
 
Moreover, in quiescent tumour cells, activation of ATF6 via p38α up-regulates 
mTORC1 and induces survival (Schewe and Aguirre-Ghiso 2008).  
A link between the p38 MAPK and Wnt/β-catenin pathway has also been 
proposed. p38α MAPK inactivates GSK3β by phosphorylation, leading to β-
catenin accumulation (Thornton et al. 2008).  
The existence of a functional cross-talk between Rac and p38 MAPK has 
been largely reported in relation with different cellular functions. p38 can act 
either as an effector or an activator of Rac, as well as an inhibitor. In embryonic 
cardiomyocytes derived cell lines, p38α acts as either a positive or a negative 
regulator of Rac1 depending on the presence of growth factors (Zuluaga et al. 
2007b). On the other hand, active Rac induces p38 activation in some cellular 
systems (Nobes and Hall 1995).  
Some data from the literature point out to a regulation of p38 MAPK by 
Rap-1, which could be either positive or negative. Thus, Rap-1 can inhibit Ras-
induced p38 MAPK activation in a thymoma cell line (Palsson et al. 2000;Stork 
and Dillon 2005), while FGF2 induced p38 MAPK activation in endothelial cells is 
mediated by Rap-1 (McDermott and O'Neill 2002). In addition, Rap-1 induces 
p38α activation in MEFs stimulated with H2O2 (Gutierrez-Uzquiza et al. 2010) and 
the combined function of p38 MAPK and Rap-1 is required for LPS 
(lipopolysaccharide)-induced chemotaxis breakdown (Yi et al. 2012).  
Moreover, we have recently identified a new functional interaction 
between C3G, a GEF of Rap-1, and p38α MAPK involved in the regulation of 
apoptosis and cell adhesion. This cross-talk operates in MEFs (non-tumoural cells) 
(Gutierrez-Uzquiza et al. 2010) and in the K562 chronic myeloid leukemia cell line 
(Maia et al. 2009) and it would be later explained in detail in the group 
background section.  
p38 MAPKs have been also linked with the expression and/or activity of 
some extracellular matrix proteins (Ivaska et al. 1999;Reddy et al. 2002). For 
instance, p38α/β inhibition has been demonstrated to inhibit TGF-β1 induced 
collagen expression in fibroblasts (Sato et al. 2002) and hepatic cells (Varela-Rey 
et al. 2002).  
In summary, p38 MAPKs cross-talk with other signaling pathways is a 
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complex network that contributes to explain their involvement in several 
biological functions and their different context-dependent effects (Cuadrado and 
Nebreda 2010).  
 
1.4. ROLE of p38 MAPKs IN CELL SURVIVAL/CELL DEATH 
p38 MAPKs can play a dual role in the control of cell death, so it can 
either mediate cell survival or cell death through different mechanisms. The 
specific function of p38 MAPKs in apoptosis/survival depend on the cell type, the 
stimuli and/or the isoform (Nebreda and Porras 2000; Wagner and Nebreda 
2009). 
p38 is a mediator of apoptosis in response to a number of cellular 
stresses and other stimuli acting through transcriptional and post-transcriptional 
mechanisms in order to regulate apoptotic and/or survival pathways (Wagner 
and Nebreda 2009). For example, p38 sensitizes cardiomyocytes derived cell 
lines to apoptosis induced by different stimuli through both, up-regulation of the 
pro-apoptotic proteins Fas and Bax and down-regulation of the activity of ERKs 
and Akt survival pathways (Porras et al. 2004; Zuluaga et al. 2007). p38 is also a 
negative regulator of survival in embryonic stem (ES) cells (Guo and Yang, 2006) 
and contributes to mammary acinar morphogenesis by inducing anoikis of 
epithelial cells (Wen et al. 2011). The antitumoural effects of a number of 
chemotherapeutical drugs are also based on the activation of apoptosis through 
p38α. For example, it is essential for cisplatin-induced apoptosis in the colon 
carcinoma derived cell line, HCT116 (Bragado et al. 2007). However, in some 
tumours p38α is involved in chemotherapeutical resistance. Studies in head and 
neck cancer has shown that p38α/β upregulates the endoplasmic reticulum (ER) 
chaperone BiP/Grp78, which inhibits Bax activation and renders dormant HEp3 
cells highly resistant to chemotherapy (Ranganathan et al. 2006).  
On the other hand, p38 and  can have pro-survival roles (Cuenda and 
Rousseau 2007;Nebreda and Porras 2000;Wagner and Nebreda 2009). Anti-
apoptotic roles of p38 MAPKs have been described in DNA-damaged fibroblasts 
(Heron-Milhavet and LeRoith 2002), differentiating neurons (Okamoto et al., 
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2000) and activated macrophages (Park et al. 2002). In some cases, p38 has 
been identified as the isoform responsible for this survival effect. For example, in 
pulmonary arterial endothelial cells exposed to anoxia-reoxygenation during 
ischemia-reperfusion, carbon monoxide (CO) protects from apoptosis through 
p38 activation (Zhang et al. 2003;Zhang et al. 2005). In addition, in some tumour 
cells p38 has a pro-survival effect mediated by the up-regulation of the 
transcription factor ATF6, which favours survival of dormant tumour cells through 
activation of Rheb/mTOR pathway (Schewe and Aguirre-Ghiso 2008). In addition, 
p38 can also induce cell survival of colorectal cancer cells through inhibition of 
autophagy (Comes et al. 2007). 
p38 MAPKs play also an important role in the coordination of cellular 
stress responses to reactive oxygen species (ROS), mediating cell death or 
survival, as it would be further explained. 
However, the precise mechanisms by which p38 signaling achieves cell 
survival are poorly understood. 
 
2. REACTIVE OXYGEN SPECIES  
2.1. GENERALITIES 
Oxidative stress is defined as a disturbance in the equilibrium between 
free radicals, reactive oxygen species (ROS) and endogenous antioxidant 
defenses. Therefore, each cell maintains a condition of homeostasis between the 
oxidant and antioxidant species (Dayem et al. 2010). 
ROS is a collective term that describes the chemical species that are 
formed upon incomplete reduction of oxygen and includes the superoxide anion 
(O2-), hydrogen peroxide (H2O2) or hydroxyl radical (OH.) (D'Autreaux and 
Toledano 2007).  
There are numerous sources of ROS within the cell (Fig. 3). The majority 
of intracellular ROS production is derived from the mitochondria, where 
mitochondrial oxidants are formed predominantly at complex I (Kushnareva et al. 
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2002) or complex III (Chen et al. 2003) of the respiratory chain, when electrons 
derived from NADH or FADH2 react with oxygen to produce superoxide anions. 
Peroxisomes are also known to produce H2O2 under physiologic conditions (Valko 
et al. 2004). Other important generators of intracellular ROS are the NADPH 
oxidases (NOX), which primary function is ROS production in the membrane 
(Bedard and Krause 2007). In addition, other intracellular enzymes such as 
xanthine oxidase, cyclooxygenases, cytochrome p450 and lipoxygenases produce 
ROS as part of their normal enzymatic function. ROS are also generated by 
exogenous substances, such as γ-ray or ultraviolet light irradiation (Kamata and 
Hirata 1999). 
 
2.2. ROS FUNCTIONS  
The intracellular redox state is tightly regulated because it is essential for 
the control of cell fate. Oxidative stress has been traditionally considered as a 
toxic by-product of cellular metabolism, but during the last years it has been 
established that ROS are actively involved in the regulation of signal-transduction 
pathways (Hancock et al. 2001). 
Cells are capable of generating endogenously and constitutively ROS, 
which are necessary for many biochemical processes such as proliferation, 
differentiation, cell death, migration or inflammatory response (Finkel 2000; 
Valko et al. 2007a). Most cell types generate low concentrations of ROS in 
response to several cytokines, growth factors and hormones. Then, ROS can 
function as secondary messengers, reacting with transcription factors (AP-1, NF-
kB or HIF-1) and proteins (protein tyrosine kinases or phosphatases) (Kamata and 
Hirata 1999; Valko et al. 2007a). 
In contrast, high doses and/or inadequate removal of ROS can damage 
cellular constituents including proteins, lipids and DNA. Excessive generation of 
ROS has been linked to aging, neurodegenerative diseases such as Alzheimer, 
epilepsy and Parkinson, and vascular disease (Valko et al. 2007a). ROS and 
oxidative damage have been implicated in the induction of apoptosis or other 
types of cell death. Moderate levels of oxidative stress usually induce apoptotic 
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cell death, whereas a higher dose of ROS leads to necrosis (Kamata and Hirata 
1999). For example, H2O2 at a low concentration is able to induce apoptosis 
(Pierce et al. 1991) and some extracellular signals, such as TNF-	 can also induce 
apoptosis through a mechanism dependent on ROS generation (Talley et al. 
1995).  
Different signaling pathways have been involved in mediating cell death 
induced by ROS such as p38 MAPKs, JNK and Akt. For instance, ASK-1 activates 
JNK and p38 MAPK in response to ROS, inducing apoptosis (Tobiume et al. 2001). 
Moreover, ROS generated by oncogenic H-Ras induces apoptosis through p38 
activation, inhibiting tumour initiation (Dolado et al. 2007), whereas p38α 
inhibition results in ROS up-regulation, which in turn activates the JNK pathway 
sensitizing human tumour cells to cisplatin-induced apoptosis (Pereira et al. 
2013). Although Akt generally inhibits apoptosis induced by multiple apoptotic 
stimuli, it has been shown that Akt activation can mediate ROS-induced 
apoptosis. Hence, Akt would elevate ROS levels by two mechanisms: (i) increasing 
oxygen consumption, (ii) and impairing ROS scavenging through inhibition of 
FoxO transcription factors (Nogueira et al. 2008). Additionally, the PI3K/Akt 
signaling pathway would play important roles in NOX activation (Nakanishi et al. 
2014). 
ROS can cooperate with oncogenic signaling in cellular transformation 
and cancer. The carcinogenic effects of ROS accumulation have been proposed to 
operate at different levels, including changes in gene expression (Allen and 
Tresini 2000), increased proliferation and DNA-mutation, as well as generation of 
genomic instability (Woo and Poon 2004). Furthermore, high levels of ROS have 
been detected in several human cancer cell lines (Szatrowski and Nathan 1991), 
as well as in human tumours from different tissues (Toyokuni et al. 1995). 
According to this, the levels of ROS scavenger enzymes, such as superoxide 
dismutase (SOD), glutathione peroxidase and peroxiredoxin, have been shown to 
be significantly decreased in cancer cells (Dayem et al. 2010).  
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Figure 3: ROS sources and antioxidant defenses. There are numerous sources of ROS within the 
cell: Mitochondria, peroxisomes, NADPH oxidases (NOX), xanthine oxidase, cyclooxygenases, 
cytochrome p450 and lipoxygenases or exogenous molecules such as UV or γ-Ray. Cellular 
enzymatic antioxidant defenses include superoxide dismutases (SODs), catalase or glutathione 
peroxidases (GPx), among others. 
 
2.3. ANTIOXIDANT SYSTEMS 
To prevent excessive accumulation of ROS and the subsequent cell 
damage, aerobic organisms have developed efficient defense systems of 
enzymatic and non-enzymatic antioxidants (Kamata and Hirata 1999; Mates et al. 
1999; Valko et al. 2007b). Exposure to oxidative stress results in the up-regulation 
of the enzymatic activity of the antioxidant enzymes and/or their levels (Fig. 3).  
Cellular enzymatic antioxidant defenses include superoxide dismutases 
(SODs), catalase, glutathione peroxidases (GPx), glutathione-S-transferases 
(GSTs), glutathione reductase, heme oxigenase, peroxiredoxins (Prx), thioredoxin 
(Trx), thioredoxin reductases (TrxR) and the uncoupling proteins (UCPs), which 
participate in the prevention of ROS accumulation (Monsalve et al. 2007) (Fig. 3). 
The balance between ROS production and antioxidant defenses 
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determines the degree of oxidative stress. Regulation of these proteins plays a 
pivotal role in balancing the concentration of ROS. The Nrf2 transcription factor is 
a relevant regulator of the expression of host antioxidants and detoxifying genes 
through binding to promoter sequences containing a consensus antioxidant 
response element (Singh et al. 2010). 
The main antioxidant enzymes are: 

 Superoxide dismutases (SODs), which catalyze the dismutation of the 
superoxide anion into oxygen and hydrogen peroxide. In humans, there are 
three isoforms of SOD: cytosolic Cu/Zn-SOD (SOD1), mitochondrial Mn-SOD 
(SOD2) and extracellular SOD (EC-SOD). These isoforms elicit a similar 
function, but their protein structure characteristics, chromosome localization, 
metal cofactor requirements, gene distribution, and cellular 
compartmentalization are distinctly different (Kamata and Hirata 1999; Valko 
et al. 2006). They can be regulated at a transcriptional, post-transcriptional 
and post-translational (activity) level. Many transcriptional regulatory 
elements in the proximal promoter regions of the sod genes are binding sites 
for several transcription factors, such as NF-κB, AP-1, AP-2, Sp-1, FOXO3a or 
C/EBP. In addition, Sod-1 and sod-2 promoters have GC-rich regions, 
susceptible to methylation (Miao and St Clair 2009).  
Among the three SOD isoforms, MnSOD is the only SOD that is essential 
for the survival of aerobic organisms (Carlioz and Touati 1986). Thus, MnSOD 
knock-out mice showed dilated cardiomyopathy and neurodegeneration and 
die shortly after birth (Lebovitz et al. 1996;Li et al. 1995).  

 Catalase is a tetrameric hemoprotein containing Fe (III) at its active site. It is 
responsible for the degradation of the H2O2 into water and molecular oxygen. 
It is mainly localized in the peroxisomes (Kamata and Hirata 1999; Valko et al. 
2007b; Valko et al. 2006).  
Catalase can also be regulated at a transcriptional, post-transcriptional 
and post-translational (activity) level, as well as in a tissue-specific manner. A 
few transcription factors have been reported to directly bind to the human 
catalase promoter: Sp1 (Nenoi et al. 2001), PPARγ (Okuno et al. 2010), FoxM1 
(Park et al. 2009) or Oct-1 (Quan et al. 2011). NFκB and AP-1 have been 
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associated with catalase gene expression in mouse muscle cells (Zhou et al. 
2001). An increase in catalase mRNA stability has been also shown to up-
regulate catalase levels (Clerch et al. 1991; Sen et al. 2005). On the other 
hand, hypermethylation of a CpG island in the promoter leads to down-
regulation of catalase expression upon prolonged ROS exposure (Min et al. 
2010).  

 Glutathione peroxidases (GPx) catalyze the reduction of peroxides by using 
reduced glutathione (GSH). Their active sites contain selenium ions in the 
form of selenocysteine. There are five different isoforms, which present a 
differential tissue distribution and localization inside the cell (Kamata and 
Hirata 1999; Valko et al. 2006).  

 Non-enzymatic antioxidants are represented by GSH, ascorbic acid (vitamin 
C), α-tocopherol (vitamin E), carotenoids or flavonoids (Valko et al. 2006).  
 
2.4. p38α MAPK AND ROS 
p38 MAPKs play an important role in the coordination of cellular stress 
responses to reactive oxygen species (ROS), mediating cell death or survival.  
Years ago, it was described that ASK-1 is activated in response to ROS, 
activating JNK and p38 MAPK, which induces apoptosis (Tobiume et al. 2001). 
According to this, ROS-induced activation of p38α in the initial stages of tumour 
transformation promotes apoptosis and prevents ROS accumulation and their 
carcinogenic effects (Dolado et al. 2007). Moreover, p38α is necessary for 
cisplatin-induced apoptosis upon activation by p53-mediated ROS production 
(Bragado et al. 2007). Accordingly, highly tumourigenic cancer cell lines have 
developed mechanisms to uncouple p38α activation from ROS production, so that 
they can survive (Dolado et al. 2007). 
In contrast, a newly identified important function for the p38α pathway is 
to facilitate cell survival in response to stress (Gutierrez-Uzquiza et al. 2010; 
Thornton and Rincon 2009). For instance, p38 allows survival of cells exposed to 
osmotic shock or oxidative stress by inducing cell cycle arrest (Joaquin et al. 
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2012). According to this, p38α (and to a lesser extend p38β) inhibition results in 
ROS up-regulation, which in turn activates the JNK pathway sensitizing some 
human tumour cells to cisplatin-induced apoptosis (Pereira et al. 2013). 
Initially, stress signaling mechanisms are pro-survival systems as they 
tend to repair damage before committing cells to death or senescence. In this 
line, p38α has been proposed to be a positive regulator of antioxidant enzymes 
expression. p38α up-regulates catalase levels in response to low doses of H2O2 
through enhancement of mRNA stability (Sen et al. 2005) and heme oxygenase-1 
mRNA levels (Aggeli et al. 2006). 
 
3. C3G 
3.1. GENERALITIES 
C3G (Crk SH3-domain-binding guanine-nucleotide-releasing factor) is a 
guanine nucleotide exchange factor (GEF) for Rap-1 (Gotoh et al. 1995) and R-Ras 
(Gotoh et al. 1997), two members of the Ras family of small GTPases. In addition, 
C3G can activate other Ras family members, such as TC21 and the Rho family 
member TC10 (Ehrhardt et al. 2002). Nevertheless, C3G can also act through a 
GEF independent mechanism (Guerrero et al. 1998; Guerrero et al. 2004; 
Shivakrupa et al. 2003). Alternate names of C3G are Rap GEF1, GRF2 and DKFZ 
p781p1719. 
C3G was the first Rap GEF identified in 1994, originally isolated as an 
interacting partner of Crk (Tanaka et al. 1994). The nucleotide sequence of the 
4.1 kb C3G c-DNA contains a 3.2 kb open reading frame encoding a 121 kDa 
protein, and antibodies against C3G have been shown to detect a protein of 130-
140 kDa (Tanaka et al. 1994). The human C3G gene comprises 24 exons spanning 
163kb on chromosome 9q34.3 (Takai et al. 1994).  
Although C3G is ubiquitously expressed, some tissue-specific differences 
in expression levels have been seen. C3G transcripts are subject to alternative 
splicing and variant isoforms have been cloned from different species. In humans, 
C3G levels are higher in adult skeletal muscle, placenta, fetal heart and brain than 
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in other tissues such as liver (Tanaka et al. 1994). In mouse, C3G expression is 
high in brain, heart, liver and muscle and low in adipose tissue, kidney and spleen.  
Sequence comparison revealed 88% nucleotide sequence identity 
between mouse and human C3G c-DNA (Zhai et al. 2001). Human C3G has two 
predominant isoforms, a and b, which arise from alternative splicing and differ in 
their N-terminus, where three amino acids of isoform a are replaced by 21 amino 
acids in isoform b (Radha et al. 2011). A truncated C3G isoform (lacking N-
terminal 305 resiudes), named p87C3G, is abundantly expressed in chronic 
myeloid leukemia (CML) cells and in primary cells from CML patients. p87C3G 
showed differences in expression levels depending on disease remission during 
treatment, suggesting a role for C3G in CML (Gutierrez-Berzal et al. 2006). In 
mice, two transcripts with or without a 114 bp insertion in the N-terminal are 
expressed in most tissues (Zhai et al. 2001). C3G is built up with three modular 
domains clearly differentiated, both structurally and functionally (Fig. 4). The C-
terminal C3G catalytic domain is homologous to CDC25 and, together with the 
REM (Ras-Exchange-Motif) domain, are responsible for its GEF activity. The 
central region contains five proline-rich sequences that bind to SH3 domains of 
Crk, p130Cas, Grb2, c-Abl and Hck (Radha et al. 2011). In the N-terminal region 
(from amino acids 144 to 230) there is a binding site for the cytoplasmic domain 
of E-cadherin (Hogan et al. 2004). The N-terminal region negatively regulates its 
GEF activity, since deletion of the amino terminus results in constitutive catalytic 
activity (Ichiba et al. 1999).  
 
Figure 4: Schematic diagram showing the domain organization of C3G protein as well as its 
interaction with other proteins.  
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Currently, very little information is available on regulation of C3G 
expression and activation. It is known that a variety of stimuli such as T cell 
receptor stimulation (Reedquist et al. 1996), hepatocyte growth factor (Sakkab et 
al. 2000), growth hormone (Ling et al. 2003), platelet-derived growth factor 
(PDGF) (Yokote et al. 1998), nerve growth factor (NGF) (York et al. 1998), 
interferon-γ (Alsayed et al. 2000), integrins (Buensuceso and O'Toole 2000) or 
interleukin-3 (Arai et al. 2001) engage C3G-mediated signaling.  
The major C3G activating mechanism in response to these stimuli is the 
multimolecular complex formation. It primarily occurs through membrane 
recruitment of Crk-C3G complex, which facilitates its interaction with the 
substrate Rap-1 (Gotoh et al. 1995; van den Berghe et al. 1997). The SH2 domain 
in Crk enables translocation of the Crk-C3G complex to tyrosine-phosphorylated 
molecules (Ichiba et al. 1997), such as receptor tyrosine kinases (Yokote et al. 
1998). Moreover, C3G activation has been shown to be regulated by tyrosine 
phosphorylation at Y504 and membrane targeting, enabled by its interaction with 
Crk (Ichiba et al. 1999; Radha et al. 2004). c-Src, Hck, Fyn and c-Abl are kinases 
known to phosphorylate C3G at Y504. In addition to Y504, C3G is phosphorylated 
in other tyrosine residues, but its contribution to C3G regulation remains 
unknown (Radha et al. 2011). Recently, it has been also described a C3G serine-
phosphorylation (Utreras et al. 2013). 
 
3.2. C3G FUNCTIONS 
Over the last 15 years, several studies have thrown light on the 
involvement of C3G in multiple signaling pathways and its role in the regulation of 
diverse cellular functions (summarized in Fig. 5). In addition, it is important to 
highlight that C3G actions are not always dependent on its GEF activity and it can 
also be mediated by protein-protein interactions (Guerrero et al. 1998; 
Shivakrupa et al. 2003).  
C3G-/- homozygous mice died before embryonic day 7.5 due to its 
function in integrin-mediated cellular adhesion and migration. Moreover, C3G-
dependent activation of Rap1 is required for adhesion and spreading of 
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embryonic fibroblasts derived from C3G knock-out mice (Ohba et al. 2001). 
C3G inhibits cell proliferation in some cell types such as neuroblastoma 
cells (Radha et al. 2008). In agreement with this, C3G-deficient neuroepithelial 
cells show an over-proliferation of the cortical neuroepithelium (Voss et al. 2006).  
Vesicle traffic is also regulated by C3G. Insulin-stimulated GLUT4 (glucose 
transporter type 4) translocation in muscle and adipose tissue is dependent on 
C3G mediated TC10 activation (Chiang et al. 2001).  
 C3G has also been shown to play a role in cell death regulation. It can 
induce apoptosis though Hck (Shivakrupa et al. 2003) or c-Abl (Radha et al. 2008), 
2008). Moreover, C3G through the negative regulation of p38α activity mediates 
cell survival or death depending on the stimulus and cell type (Gutierrez-Uzquiza 
et al. 2010;Maia et al. 2009). 
C3G also plays a relevant role as a mediator of cell adhesion, spreading, 
migration and cell-cell junction assembly and disassembly (Radha et al. 2011), as 
it would be explained later on. 
The function of C3G in human cancer is controversial. C3G can act as a 
tumour suppressor gene, preventing malignant transformation induced by 
several oncogenes (Guerrero et al. 1998;Guerrero et al. 2004;Martin-Encabo et 
al. 2007). According to this, C3G expression was shown to be reduced in cervical 
squamous cell carcinoma (Okino et al. 2006). In contrast, an increase in C3G 
expression was observed in human non-small-cell lung cancers (Hirata et al. 
2004), which is in agreement with the involvement of the Crk-C3G-Rap1 pathway, 
downstream RET, in the process of transformation produced in papillary thyroid 
carcinoma (De Falco et al. 2007). The expression of p87C3G isoform in CML cells 
is also associated with the development of this type of cancer (Gutierrez-Berzal et 
al. 2006).  
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Figure 5: Interacting partners of C3G and their involvement in pathways leading to specific 
functions (Radha et al. 2011). C3G acting through a wide range of effectors regulates several 
cellular functions and biological processes, such as embryogenesis, cell adhesion, migration, 
apoptosis or leukemia development.  
 
4. CELL MIGRATION AND INVASION  
4.1. GENERALITIES 
Cell migration is a complex biological process playing a key role in 
physiological and pathological processes. During embryogenesis, complex 
patterns of cell migration are essential for proper tissue formation (Franz et al. 
2002). In the process of renewal of skin and intestine, new epithelial cells migrate 
from the basal layer or the crypts, respectively, to the top layer. Migration is also 
a prominent component of tissue repair and immune response, in which 
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leukocytes from the circulation migrate into the surrounding tissue to destroy 
invading microorganisms and infected cells (Ridley et al. 2003). On the other 
hand, migration also contributes to several important pathological processes, 
including vascular disease, osteoporosis, chronic inflammatory diseases or cancer 
(Ridley et al. 2003). In metastasis, tumour cells migrate from the initial tumour 
mass into the circulatory system and finally, to a new site, where they form a 
secondary tumour (van Zijl et al. 2011). 
There are different types of cell migration. Cells can migrate as individual 
cells, referred to as “individual cell” migration or expand in solid cell strand, 
sheets, files or clusters, called “collective” migration (Friedl and Wolf 2003; Rorth 
2009). 
Cell migration through the tissues results from a continuous cycle of 
coordinated and interdependent steps that involve the cytoskeletal machinery 
(Friedl and Brocker 2000). Cell motility is a complex and highly coordinated 
process, and it is likely that changes in the expression of several genes are 
required for the cell to become motile (Ridley et al. 2003).  
Several studies have demonstrated that stromal cells play a role in the 
control of tumour cells migration and invasion (Sameni et al. 2003). For example, 
fibroblasts and macrophages produce matrix-metalloproteases (MMPs) in many 
tumours, which allows extracellular matrix (ECM) degradation, promoting cancer 
cell motility and invasion (Wels et al. 2008). 
4.2. MATRIX METALLOPROTEASES (MMPs) 
The extracellular matrix (ECM) is the non-cellular component present 
within all tissues and organs, and provides not only essential physical scaffolding 
for the cellular constituents, but also initiates crucial biochemical and 
biomechanical cues that are required for tissue morphogenesis, differentiation 
and homeostasis (Frantz et al. 2010). It is composed of a large collection of 
biochemically distinct components including collagens, laminins, fibronectin, 
elastin, fibrillins, tenascin, nidogen, entactin, fibulins, fibrinogen or 
thrombospondins (Halper and Kjaer 2014).  
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During cell migration and invasion, ECM is degraded preparing the path 
for cells to migrate, invade and spread to distant areas. Matrix 
metalloproteinases (MMPs) play a crucial role in this process. MMPs belong to a 
family of zinc-dependent endopeptidases (Bourboulia and Stetler-Stevenson 
2010). There are 23 human MMPs (24 in mouse) which differ from each other in 
their structural domain architecture, in the substrate specificity, and their 
temporal and tissue specific expression patterns (Radisky and Radisky 2010). 
Originally, they were divided based on their cellular localization (17 soluble, 
secreted enzymes and 6 membrane-associated enzymes), or according to their 
substrate specificity: collagenases (MMP-1, -8 and -13), gelatinases (MMP-2 and -
9), and MMPs that degrade a broad spectrum of ECM proteins called stromelysins 
(MMP-3, -10 and -11) or matrilysins (MMP-7). Nowadays, as the MMP family 
grew, a numbering system was adopted and MMPs are now grouped according to 
their domain structure (Radisky and Radisky 2010;Tallant et al. 2010). 
MMPs are constituted by a modular combination of inserts and domains 
(Fig. 6). This includes, from N- to C-terminus: a signal peptide for secretion, a 
zymogenic pro-peptide, a zinc- and calcium-dependent catalytic domain, a linker 
region and a hemopexin-like domain for collagen binding, pro-MMP activation 
and dimerization. Additional domains are unique for a number of MMP members 
(Kessenbrock et al. 2011; Tallant et al. 2010).  
 
Figure 6: MMP domain structure: The various domain organizations of human MMPs. S, signal 
peptide; Pro, propeptide; CAT, catalytic domain; F, fibronectin repeats; PEX, hemopexin domain; 
TM, transmembrane domain; GPI, glycophosphatidylinositol membrane anchor;C, cytoplasmic 
domain; CA, cysteine array; Ig, immunoglobulin-like domain (Radisky and Radisky 2010). 
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MMPs are mainly regulated via modulation of gene expression, 
compartmentalization and inhibition of its activity by endogenous inhibitors, 
named tissue inhibitor of metalloproteinases (TIMPs). There are four TIMP family 
members (TIMP-1, -2,-3 and -4) that can inhibit all active MMPs, however, not 
with the same efficacy (Bourboulia and Stetler-Stevenson 2010). 
Most MMPs are not constitutively transcribed, but are expressed after 
external induction by cytokines and growth factors (Tallant et al. 2010). MMPs 
are initially expressed in an enzymatically inactive state (pro-enzymes) due to the 
interaction of a cysteine residue of the pro-domain with the zinc ion of the 
catalytic site. Only after disruption of this interaction by a mechanism called 
cysteine switch, the enzymes become proteolytically active (Sternlicht and Werb 
2001). 
MMPs are implicated in a variety of physiological processes, including 
wound healing, uterine involution and organogenesis, as well as in pathological 
conditions, such as inflammatory, vascular and auto-immune disorders and 
carcinogenesis (Gialeli et al. 2011). 
During tumour progression, cancer cells participate in several interactions 
with the microenvironment involving extracellular matrix (ECM), growth factors 
and cytokines, as well as surrounding cells. The proteolytic activity of MMPs is 
required for a cancer cells to degrade physical barriers during local expansion and 
for intravasation at nearby blood vessels, extravasation and invasion at a distant 
location (Gialeli et al. 2011). Cancer cells stimulate host cells, such as fibroblast 
that constitute an important source of MMPs (Wels et al. 2008). 
Increased MMP2 and MMP9 expression and activity has been described 
in hundreds of publications related to malignant diseases ranging from breast, 
urogenital, brain, lung, skin, colorectal and many more (Klein and Bischoff 2011).  
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4.3. ROLE of p38 MAPKs IN MIGRATION/INVASION AND IN THE GENERATION OF 
METASTASIS 
p38 MAPKs also play a role in different aspects of cell migration, invasion 
and metastasis, favouring tumour progression (del Barco Barrantes and Nebreda 
2012). p38 MAPK can mediate cell migration in HeLa cells and MEFs through the 
regulation of the actin cytoskeleton by MK2 (del, I and Nebreda 2012;Rousseau et 
al. 2006). In addition, in HGF/Met-triggered cortical neurons, Rac1/p38 cascade is 
important for migration (del, I and Nebreda 2012;Segarra et al. 2006). The 
activation of p38α can also induce cell migration and cytoskeletal remodeling in 
tumour cells by increasing the phosphorylation of Hsp27 (heat-shock protein 27) 
(Laferriere et al. 2001). 
p38 MAPKs are also relevant for invasion. For example, in melanoma cells 
(Estrada et al. 2009) or ovarian cancer cells, where EGF, HGF and p38 MAPK 
promote cell migration and invasion through regulation of MMP-9 (Zhou et al. 
2007). In addition, p38α induces the expression of MMP-1, MMP-2, MMP-9 and 
MMP-13 in bladder, breast, liver, skin, keratinocytes and prostate cancer (del 
Barco Barrantes and Nebreda 2012). A role for p38α mediating invasion of 
tumour cell has been observed in hepatocellular carcinoma, head and neck 
squamous carcinoma, pancreatic o glioma cell lines (del Barco Barrantes and 
Nebreda 2012; Wagner and Nebreda 2009).  
p38α also plays a central role in the regulation of disseminated tumour 
cells (DTCs) fate at secondary organs (Bragado et al. 2013), where p38α would be 
activated, leading to tumour cell dormancy. This allows DTCs to keep in a 
quiescent state until the microenvironment is favourable for proliferation (Sosa et 
al. 2014).  
In addition to p38, p38 and p38 also regulate these processes. p38δ 
isoform increases head and neck squamous cell carcinoma invasion, which 
correlates with an increase of MMP-1 and MMP-13 expression (Junttila et al. 
2007). p38γ also regulates invasion and metastasis acting as an activator and a 
cofactor for c-Jun-induced MMP-9 expression (Loesch et al. 2010). 
In summary, p38 MAPKs contribute to the different steps (epithelial-
mesenchymal transition (EMT), migration/invasion, anoikis resistance, 
Introduction 
27 
 
extravasation, tumour dormancy, etc) required for cancer cells to form metastatic 
tumours (Fig. 7) (del Barco Barrantes and Nebreda 2012). 
 
 
 
Figure 7: Roles of p38 MAPKs in tumour progression: The activation of p38 MAPKs has been 
reported to contribute to the EMT of cells from the primary tumour, acquisition of invasion and 
migrating capabilities resistance to anoikis, extravasation of migrating cells, pre-metastatic niche 
formation and tumour cell dormancy (del Barco Barrantes and Nebreda, 2012). 
 
4.4. ROLE OF C3G IN ADHESION AND MIGRATION 
C3G plays a relevant role as a mediator of cell adhesion and spreading 
activated by integrins. Hence, C3G deficient MEFs shows impaired cell adhesion, 
delayed cell spreading and accelerated cell migration (Ohba et al. 2001; Voss et 
al. 2003). This function of C3G is, at least, partially mediated by its main target, 
Rap-1 (Huang et al. 2008; Ohba et al. 2001; Pannekoek et al. 2009), although 
Introduction 
28 
 
overexpression of C3G can also promote c-Abl-induced filopodia formation during 
cell spreading through mechanisms independent of its catalytic activity (Radha et 
al. 2007). C3G and/or Rap-1, as well as other proteins such as Crk or p130Cas, are 
involved in the multiprotein complex formation during integrin-linked focal 
adhesions (Bos 2005).  
In addition, Dr. Guerrero´s group in collaboration with our group has 
recently shown that C3G and p38α are acting through a common pathway 
promoting cell adhesion in K562 chronic myeloid leukemia cell line, where both 
proteins interact forming a complex (Maia et al. 2013). However, despite they 
positively regulate cell adhesion, they display antagonistic roles in the regulation 
of the levels of focal adhesion proteins. Thus, whereas C3G silencing inhibits their 
expression, p38α knock-down leads to an increase of some of these proteins 
(Maia et al. 2013). 
The role of C3G in cell migration has not been well characterized, although 
a number of studies indicate that it can play specific roles in different contexts. 
On one side, C3G deficient MEFs present an enhanced migration (Ohba et al. 
2001), while sympathetic preganglionic neurons migrate abnormally in a C3G 
mutant mouse (Yip et al. 2012). On the other side, C3G overexpression results in 
opposite outcomes in different cell types: increase cell migration in 
glomerulonephritis (Rufanova et al. 2009) or decrease cell migration in highly 
invasive breast carcinoma cells (Dayma and Radha 2011). 
C3G also regulates cell-cell interactions (Kooistra et al. 2007; Pannekoek et 
al. 2009), where E-cadherin plays a key role (Pannekoek et al. 2009). 
Mechanistically, C3G binds intracellular E-cadherin to activate Rap-1 and induces 
E-cadherin translocation (Pannekoek et al. 2009). Moreover, as C3G competes 
with β-catenin in the binding to E-cadherin (Kooistra et al. 2007), β-catenin and E-
cadherin functions can be additionally modulated by C3G. All this is relevant for 
cell migration. 
Introduction 
29 
 
5. FIBULINS 
5.1. GENERALITIES 
 
Fibulins are a family of ECM secreted glycoproteins in the 50-200 KDa 
range. In 1989, Argraves described fibulin-1 (Argraves et al. 1989) as an ECM 
protein (Argraves et al. 1990). Since then, six more members have been identified 
in mammals (de Vega et al. 2009).  
As shown in figure 8, structurally, fibulins are organized in three domains. 
All fibulins share a globular C-terminal domain referred to as “fibulin-like” or “FC 
domain” (domain III). Functionally, these fibulin-like modules have been 
implicated in mediating a number of protein-protein interactions. Domain II 
represents the central portion and contains a variable number of EGF-like 
modules in a tandem array. Most of the EGF-like modules contain a consensus 
sequence for calcium binding and are known as calcium-binding EGF (cbEGF)-like 
modules. Domain I represents the N-terminus and varies among the family 
members (Obaya et al. 2012).  
The members of the fibulin family have been classified into two 
subgroups according to their domain architectures. The first subgroup includes 
fibulin-1 (100kDa) and fibulin-2 (195kDa), which are larger than the other 
members, as they have an extra domain with three anaphylatoxin (AT) modules 
in domain I and more EGF-like modules in the central portion. The second 
subgroup contains the rest of the members, from fibulin-3 to fibulin-7. They are 
smaller proteins of around 50-60 kDa, except fibulin-6 or hemicentin-1, which is 
the largest member of the family (615kDa) due to the presence of 44 tandem of 
immunoglobulin C-2 and 6 thrombospondins type-I modules within their domain 
I. Fibulin-7 has a unique N-terminal domain I, containing a sushi domain, also 
known as complement control protein (CCP) domain (de Vega et al. 2009).  
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Figure 8: Schematic representation of Fibulin family members (Obaya et al. 2012).  
 
The different fibulins have a distinct tissue distribution, although some of 
them are expressed in the same places.  
The functional relevance of fibulins is reinforzed when performing the 
phenotypic characterization of mouse models deficient in a specific fibulin gene. 
Mice lacking Fibulin 1 do not survive long after birth, as they undergo severe 
bleeding in muscle, skin and perineural tissue (Kostka et al. 2001). In contrast, 
mice deficient in Fibulin 2 are viable, fertile and show no apparent defects (Sicot 
et al. 2008). Fibulin 3 deficient mice evidence alterations associated with 
premature aging and reduced lifespan, reproductive difficulties, loss of body mass 
and generalized atrophy in tissues such as fat or muscle (McLaughlin et al. 2007). 
Fibulin 4 knock-out mice die perinatally and exhibit lung and vascular disorders 
(McLaughlin et al. 2006). Finally, mice lacking Fibulin 5 survive to adulthood, but 
display highly disorganized elastic fibers (Yanagisawa et al. 2002).  
Fibulins exhibit an extensive array of protein-protein interactions, 
particularly, with other extracellular matrix proteins. Indeed, it is thought that 
fibulins act as intramolecular bridges within the ECM, connecting various 
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supramolecular structures, and mediate certain cell signaling events (Gallagher et 
al. 2005). Fibulins have been shown to modulate cell morphology, growth, 
adhesion and motility. The dysregulation of certain fibulins occurs in a range of 
human disorders, including cancer. So far, different studies conclude that both 
tumour suppressive functions and oncogenic activities can be elicited by fibulins 
(Obaya et al. 2012). 
 
5.2. FIBULIN 3 
Fibulin 3, also known as S1-5 or EFEMP-1, was isolated by subtractive 
screening of a c-DNA library derived from mRNA of senescent human diploid 
fibroblasts (HDF) established from a patient with Werner syndrome of premature 
aging (Lecka-Czernik et al. 1995). Fibulin 3 was overexpressed in Werner 
syndrome and senescent normal HDFs. It is induced by growth arrest of young 
normal cells, but significantly decreases by high serum (Lecka-Czernik et al. 1995).  
Fibulin 3 is detected in bone and cartilage structures during the 
development and is also highly expressed in retina, as well as in epithelial and 
endothelial cells throughout the body (de Vega et al. 2009). The R345W mutation 
in fibulin-3 causes age-related macular degeneration and is associated with 
Malattia Leventinese (Marmorstein et al. 2007; Stone et al. 1999).  
Fibulin 3 exhibits both antitumour and oncogenic activities towards 
human cancers. Fibulin 3 is simultaneously overexpressed with MMP-2, MMP-9 
and ADAMTS-5 in glioma cells promoting tumour invasion and survival (Hu et al. 
2009). A pro-angiogenic role for Fibulin 3 in gliomas through the activation of 
Notch signaling has also been described (Nandhu et al. 2014). Moreover, Fibulin 3 
has been associated with progression of pancreatic adenocarcinomas through 
interaction with epithelial growth factor (EGF) receptor, which triggers Akt 
pathway activation (Camaj et al. 2009).  
However, there are also a considerable number of studies that support 
that Fibulin 3 behaves as an anti-tumour protein. In particular, in non-small cell 
lung cancer, Fibulin 3 down-regulates MMP-2 and MMP-7 and consequently, 
decreases the invasiveness of these cells (Kim et al. 2012a). Furthermore, Fibulin 
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3 suppresses both EMT and self-renewal of the lung cancer stem cells by 
modulating the IGF1R/PI3K/Akt/GSK3β pathway (Kim et al. 2014). Down-
regulation of Fibulin 3 also contributes to lung cancer invasion and metastasis by 
activating Wnt/β-catenin signaling (Chen et al. 2014). Moreover, Fibulin 3 is 
down-regulated in nasopharyngeal carcinomas and it has the ability to suppress 
cell migration and invasion by decreasing Akt activity (Hwang et al. 2010). This 
Fibulin 3 down-regulation is mostly correlated with epigenetic silencing through 
promoter methylation in different types of cancer, including lung cancer (Kim et 
al. 2012a), hepatocellular carcinoma (Nomoto et al. 2010), colorectal carcinoma 
(Tong et al. 2011) and prostate cancer (Kim et al. 2011). 
 
 
6. EPIGENETIC REGULATION AND DNA-METHYLASES 
6.1. EPIGENETICS. DNA METHYLATION 
The term epigenetics has been defined as the inheritance of changes in 
gene function without any change in the DNA nucleotide sequence (Fraga and 
Esteller 2007).The epigenome refers to the overall state of the cell. Epigenetic 
modifications can be grouped into three main categories: DNA methylations, 
post-translational histone modifications and chromatin remodeling (Portela and 
Esteller 2010).  
The most widely studied epigenetic modification in human is cytosine 
methylation. DNA methylation occurs in the 5 position of the pyrimidine ring of 
cytosines in the context of the dinucleotide sequence CpG (Portela and Esteller 
2010). DNA methylation is essential for proper mammalian development, crucial 
for imprinting and plays a role in maintaining genomic stability, as well as in 
dosage compensation. DNA methylation patterns are susceptible to change in 
response to environmental factors such as diet, inflammation, aging or toxins. 
Aberrant DNA methylation changes have been detected in several diseases, 
particularly in cancer (Tost 2010).  
Several studies have led to the generalization that DNA methylation 
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functions to silence promoter activity and is associated with repressed chromatin 
structure (Bird and Wolffe 1999; Esteller 2002). There are two general 
mechanisms by which DNA methylation inhibits gene expression. First, 
modification of cytosine bases can inhibit the association of some transcription 
factors and second, methyl-binding domain proteins (MBDs) directly recognize 
methylated DNA and recruit repressive chromatin-modifying complexes (Fig. 9) 
(Portela and Esteller 2010).  
 
 
Figure 9: DNA methylation. CpG island at promoters of genes are normally unmethylated, allowing 
transcription. Aberrant hypermethylation leads to transcriptional inactivation (Portela and Esteller 
2010).  
 
6.2. DNA METHYLTRANSFERASES (DNMTs) 
DNA methylation results from the activity of a family of DNA methyl 
transferases (DNMTs) that catalyze the addition of a methyl group to cytosine 
residues at CpG (Robertson 2001).  
In mammals, five members of the DNMTs have been identified, but only 
three of them have been shown to possess methyltransferase activity. DNMT1 
has a preference toward hemimethylated DNA and is responsible for maintaining 
the methylation patterns following DNA replication. DNMT3 functions as a novo 
methyltransferase (equal preference for unmethylated and hemimethylated 
DNA) and consists of two related proteins encoded by distinct genes, dnmt3a and 
dnmt3b. DNMT2 and DNMT3L, do not show methyltransferase activity (Newell-
Price et al. 2000;Subramaniam et al. 2014). 
The DNMTs are comprised of two regions: a C-terminal catalytic domain 
and a N-terminal region with a large multi-domain of variable size, which encodes 
regulatory functions (Subramaniam et al. 2014). 
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Moreover, DNMT3 (a and b) levels can be regulated, being of relevance 
its post-transcriptional regulation (Denis et al. 2011). In particular, binding of HuR 
protein (an RNA-binding protein that stabilizes and/or modulates the translation 
of target mRNAs) to the 3´UTR of DNMT3B mRNA enhances its stability and 
increases its protein levels in colorectal RKO cells (Lopez de Silanes et al. 2009).  
The levels of DNMTs, especially those of DNMT3A and DNMT3B, are often 
increased in various cancer tissues and cell lines, including colon, prostate, breast, 
liver and in leukemia (Subramaniam et al. 2014).  
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1. ROLE OF p38α MAPK IN THE CONTROL OF CELL DEATH. CROSS-TALK 
WITH C3G. 
p38 MAPKs regulate several cellular functions, including cell death. 
Initially, a number of studies indicated that p38 MAPKs promoted cell death and a 
few suggested that they could also mediate cell survival depending on the cell 
type, stimulus and p38 isoform (Nebreda and Porras 2000). However, the role 
played by the p38isoformwas unclear. Thus, our group focused their studies on 
the characterization of the function of p38α MAPK pathway in the regulation of 
cell death and its interactions with other routes. To do it, cardiomyocytes and 
MEFs-derived cell lines deficient in p38α were used. Additionally, some studies 
were also carried out in some tumour cell lines, where p38α was permanently 
knocked-down. Data from those studies demonstrated that p38α plays an 
important role as a mediator of apoptosis in response to different stimuli through 
both, the up-regulation of the pro-apoptotic proteins, Bax and Fas (Porras et al. 
2004) and the down-regulation of the activity of the survival pathways, ERKs 
(Porras et al. 2004) and Akt (Zuluaga et al. 2007a). In addition, p38α was shown 
to be relevant for the cisplatin-induced apoptosis in colon carcinoma HCT116 
cells, where the p53/ROS/p38α MAPK cascade mediated this process (Bragado et 
al. 2007).  
During the last years, in collaboration with Dr. Carmen Guerrero’s group 
(Centro del Cáncer de Salamanca), we have found a new functional relationship 
between C3G and p38α MAPK that regulates apoptosis. This cross-talk operates 
in MEFs (Gutierrez-Uzquiza et al. 2010) and in the K562 chronic myeloid leukemia 
(CML) cell line (Maia et al. 2009). In both cell types exposed to apoptotic stimuli, 
C3G regulated cell death through down-regulation of p38α activity. In K562 CML 
cells, C3G silencing enhanced STI-571-induced apoptosis through the up-
regulation of p38α activity mediated by the decrease in Rap-1 activation (Maia et 
al. 2009). In MEFs, C3G knock-down also through the up-regulation of p38α 
activity either promoted cell survival in response to oxidative stress or cell death 
upon serum-deprivation, but through a Rap-1 independent mechanism (Fig. 10) 
(Gutierrez-Uzquiza et al. 2010). Therefore, in MEFs lacking p38α treated with a 
moderate dose of H2O2, C3G silencing reduced survival. 
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Figure 10: Regulation of apoptosis by C3G and Rap-1 through p38α MAPK. Model showing the 
regulation of p38α by C3G and Rap-1 in MEFs and their effects on the balance between apoptosis 
and cell survival., A) Upon serum deprivation C3G through the negative regulation of p38α activity 
mediates cell survival, while activation of Rap-1 by other GEFs would lead to p38α activation 
inducing apoptosis. B) Upon treatment with H2O2, C3G mediates apoptosis through inhibition of 
p38α activity and Rap-1 induces cell survival through p38α activation (Gutierrez-Uzquiza et al. 
2010). 
 
This prompted us to investigate this pro-survival role of p38α under mild 
levels of oxidative stress. First, it was confirmed by p38α reconstitution in p38α-/- 
cells that p38 rescue increased cell viability in response to H2O2 up to the levels 
observed in wt cells (Fig. 11) 
             
Figure 11: p38 protects from H2O2-induced cell death. MEFs (wt and p38-/-) maintained in the 
presence of serum were treated with 1 mM H2O2 for 6h when indicated. p38 expression increases 
cell viability in cells treated with  H2O2. p38 reconstitution in p38 -/- cells (Rec) rescues cells from 
cell death upon treatment with H2O2. Data correspond to cell viability expressed as percentage, and 
p38 expression determined by Western-blot and normalized with tubulin. ((Gutierrez-Uzquiza et 
al. 2010) and A. Gutierrez´s Thesis). 
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As Akt activity is up-regulated in p38α-/- cells (Zuluaga et al. 2007a)  and 
it could play a role sensitizing cells to oxidative stress (Nogueira et al. 2008), the 
activation of the Akt/mTORC1/p70S6K pathway was analyzed in response to H-
2O2. It was observed that H2O2-induced Akt activation in p38α-deficient MEFs was 
higher than in wt cells, but p70S6K was not activated (Fig. 12: A. Gutierrez´s 
Thesis). Additionally, preliminary data from the group (A. Gutiérrez´s Thesis) 
suggested that the mTORC1 pathway was not relevant in this process of cell 
death.   
 
 
Figure 12: p38 MAPK positively regulates p70S6K through an Akt independent mechanism.  
MEFs (wt and p38 -/-) maintained in the presence of serum were treated with H2O2 (0.1-1mM in A) 
for 20min when indicated. Western-blot analysis of the levels of P-Thr389-p70S6K, P-Ser939-TSC-2, 
P-Ser473- Akt, as well as total levels of p70S6K, Akt and p38 normalized with tubulin.  
 
Therefore, a more detail study was required: (i) to fully characterize the 
role played by this Akt/mTORC1/p70S6K pathway and (ii) to identify other 
potential mechanisms involved in this pro-survival role of p38α in response to 
oxidative stress. In this way, we could understand how p38α regulates cell death 
in this context. 
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2. FUNCTION OF p38α MAPK IN CELL ADHESION AND MIGRATION. NEW 
TARGETS OF p38 
p38 MAPKs play also a relevant role regulating cell adhesion and 
migration. Our group has previously shown that p38 was a negative regulator of 
cell adhesion in embryonic cardiomyocytes derived cell lines through a 
mechanism involving down-regulation of Rac-1 activity (Zuluaga et al. 2007b). 
Additionally, in collaboration with Dr. Carmen Guerrero’s group, we found that 
C3G/p38α pathway also regulated cell adhesion in the K562 chronic myeloid 
leukemia (CML) cell line (Maia et al. 2013). Both proteins promoted K562 cells 
adhesion, acting through a common regulatory pathway. However, C3G and p38α 
displayed antagonistic roles in the regulation of focal adhesion complex 
formation in K562 cells, where p38α regulated C3G expression and both proteins 
interacted forming a complex (Maia et al. 2013).  
To uncover novel mechanisms of action of p38 MAPKs in cell adhesion 
and migration/invasion, DNA microarray analyses were performed using wt and 
p38α knock-out MEFs (A. Gutiérrez´s Thesis). Changes in the pattern of 
expression of different genes were found. Some of these genes encoded proteins 
involved in the regulation of cell adhesion and/or migration, including the fibulin 
family. Among them, fibulin 3 was highly up-regulated in p38 knock-out MEFs. 
Therefore, we decided to focus our research on the study of fibulin 3 as a target 
of p38α. Thus, these results were validated by RT-PCR and RT-qPCR and it was 
confirmed that p38α negatively regulated fibulin 3 expression, but not that of 
other fibulins (Fig. 13). Therefore, a more detail study was required: (i) to 
characterize how p38α MAPK regulates Fibulin 3 expression and (ii) the 
implication of this p38/Fibulin 3 pathway in the regulation of cell migration and 
invasion.  
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Figure 13: Preliminary results showing fibulins mRNA expression in MEFs. Total RNA was isolated 
from MEFs (wt and p38α-/-) maintained in 10% FBS. A) Fibulin 1, 2, 3, 4 and 5 mRNA levels 
determined by RT-qPCR. B) Fibulin 3 levels were determined by RT-PCR.  
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General Aim:  
The main objective of this research project is to further characterize the 
role played by p38α MAPK in different cellular processes and its functional 
interaction with C3G pathway. In particular, we aim to investigate how p38α 
MAPK controls cell survival and migration/invasion and to identify new targets 
and regulators.  
 
Specific Aims: 
1. To characterize the pro-survival function of p38α MAPK in response to 
oxidative stress and the potential implication of the Akt/mTORC1/p70S6K 
pathway. 
 
2. To identify the mechanisms involved in the regulation of fibulin 3 expression 
by p38α MAPK and a potential role for fibulin 3 as a mediator of p38 
effects on cell migration and invasion.  
 
3. To investigate whether C3G and p38α MAPK act in a common pathway to 
regulate cell migration and invasion.  
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1. CELL CULTURE 
1.1. Cell lines 
The cell lines used for our studies are mouse embryonic fibroblasts 
(MEFs) derived from wt and p38 knock-out E10.5 embryos, which were 
immortalized by passages in our laboratory. Then, they were additionally 
modified to knock-down C3G gene (using a shRNA)or to express a dominant 
negative Rap-1 (DNRap-1) construct permanently (Gutierrez-Uzquiza et al. 2010) 
(Table 1). p38γ, p38δ and p38γ/δ knock-out MEFs (from E13.5 embryos) (Cerezo-
Guisado et al. 2011) were obtained from Dr. A. Cuenda’s lab (CNB, Madrid).  
Table1: Cell lines 
Type of cell line Organism Genotype Genetic modification using shRNAs 
Mouse embryonic 
fibroblasts (MEFs) 
immortalized by 
passages 
Mus musculus 
E10.5 
wt +/- pRS 
shC3G pRS shC3G 
DNRap-1 pCEP4 DNRap-1 
p38 +/- pRS 
p38 shC3G pRS shC3G 
p38
DNRap-1 
pCEP4 DNRap-1 
Mus musculus 
E13.5 
p38γ  
p38δ  
p38γδ  
1.1.1. Gene silencing by shRNA and siRNA 
Permanent Fibulin 3 knock-down (in wt and p38 Knock-out MEFs) was 
performed by infection with mouse Fibulin 3 shRNA Lentiviral Particles (Santa 
Cruz, sc-44625-V) which are a pool of transduction-ready viral particles containing 
3 target-specific constructs encoding 19-25 nt shRNAs. Cells were seeded in a 6-
well plate 4-6h prior to the viral infection at a density that guaranteed 50-60% 
confluence the next day. Then, the medium was replaced and 75.000 infectious 
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units of virus were added in the presence of 10 g/ml Polybrene (Santa Cruz; sc-
134220). Cells were incubated overnight and the medium was replaced. After 
48h, cells were trypsinized and splitted in a puromycin (1 g/ml)-containing 
medium to select clones expressing the shRNA. Different clones were picked, 
expanded and analyzed for Fibulin 3 expression.  
Transient ATF-2 knock-down was performed by transfection with a siRNA 
targeting mouse ATF-2 (Cell signaling, 6433) and a control scrambled siRNA 
(Ambion) diluted in media without serum at a final concentration of 50 nM using 
siPORT NeoFX Transfection reagent (Ambion) and following the manufacture 
instructions. Tripsinized cells were resuspended and overlaid onto the 
transfection complexes. After 24h, proteins or RNA were isolated or cell viability 
was quantified.  
1.1.2. p38α MAPK rescue 
To re-express p38 MAPK in p38-/- MEFs, a p38α construct containing 
human p38α c-DNA cloned into the EcoRI site of the pEFmlink expression vector 
(Porras et al. 2004) was transiently transfected using Metafectene-Pro (Biontex, 
T040), following the protocol supplied by the manufacturer. Cell assays were 
performed 48h after transfection.  
1.1.3. Expression of p70S6K wt and constitutive active 
To express wt and constitutive active p70S6K, transient transfections 
were performed using Metafectene-Pro and the following constructs containing: 
(i) wtp70 and (ii) p70Δ29-46 ΔCT104 (deletion of aminoacids 29-46 and C-
terminal tail, 422-525) active mutant cloned in PMT2 vector containing HA-tag 
(Addgene plasmid 1892) (Weng et al. 1995). The protocol supplied by the 
manufacturer was followed. Cell assays were performed 48h after transfection. 
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1.2. Cell culture conditions and cryopreservation 
1.2.1. Cell culture conditions 
All cell lines were grown in DMEM (4.5 g/l glucose) medium 
supplemented with 10% fetal bovine serum (FBS) (Gibco), 20 mM Hepes (pH 7.4) 
and antibiotics: penicillin (12 g/ml), streptomycin (10 g/ml), amphotericin B 
(0.25 g/ml) and MycoZap (Lonza). MEFs with permanent Fibulin 3 or C3G knock-
down were grown in the same medium, but in the presence of puromycin (1 
g/ml) and DNRap-1 in the presence of hygromycin (2 ug/ml), which was 
removed 48h before the experiments. Cells were maintained at 37ºC with 5% CO2 
in a humidified atmosphere.  
Cells were splitted when they reached 90% confluence by trypsinization 
with 0.25% Trypsin-0.02% EDTA, stopping trypsin action with 10% FBS 
supplemented medium.  
1.2.2. Freezing, cryopreservation and thawing of cells 
Cells were stored in 10% DMSO-FBS in liquid nitrogen (-170ºC). They were 
progressively frozen: -20ºC (for 20-30 min), -80ºC (for 12-16h) and liquid 
nitrogen.  
Thawing was performed quickly at 37ºC and cells were placed in culture 
medium.  
1.3. Cell treatments  
90% confluent cells were treated with the following compounds:  

 Stimuli:  
o H2O2: 0.1-1 mM H2O2 for 20 min for signaling experiments or for 6-
24h for cell death analysis. 
o Serum: 10% FBS for 10 min after serum-deprivation (24h) for 
signaling experiments.  
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 Inhibitors: 
o SB203580 (Calbiochem, 559389), at 5 M or 10 M for p38 and/or 
p38β. 
o Rapamycin (Sigma, R0395) at 1-10 M for mTORC1.  
o Actinomycin D (Sigma, A9415) at 5 μg/ml for transcription. 
o MG-132 (Sigma, M7449) at 1 μM for proteasome-dependent protein 
degradation. 
o 5-Aza-2´-deoxicytidine (Sigma, A3656) at 0.5 and 1 M for 48h for 
DNA methylation.  

 Anti-oxidants: (1h pre-treatment) 
o N-Acetyl-cysteine (Sigma, A-9165) at 2.5 mM. 
o 50 units/ml of catalase (Sigma, C-1345)  
 
2. PROTEIN ANALYSIS 
2.1. Cell extracts preparation 
Cells were washed twice with cold PBS and lysed with the following 
buffer: 
Table 2: Lysis buffer 
Tris pH 7.5 50 mM 
NaCl 150 mM 
NP40 1% 
EGTA 5 mM 
EDTA 50 mM 
PMSF 1 mM 
Aprotinin 10 g/ml 
Leupeptin 10 g/ml 
Na3VO4 1 mM 
NaF 20mM 
 
Cells were detached from the plate by scraping, collected in an eppendorf 
tube, and maintained on ice for 20 min. Every 5 min the tubes were shaken using 
a vortex. Then, cell lysates were centrifuged at 13000 rpm for 10 min at 4°C and 
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the supernatant (total protein extracts) was transferred to a new tube and stored 
at -80°C.  
For some experiments, the cell culture medium was also collected into 
tubes and stored at -80ºC until it was processed (to analyze the levels of Fibulin 3 
secreted to the medium).  
2.2. Protein quantification  
Protein quantification was performed using the method described by 
Bradford in 1976. 5min after the addition of Bradford reagent, the absorbance 
was measured at 595 nm. For each experiment, a standard curve with different 
known concentrations of BSA was prepared using (0 to 5 g/l).  
 
2.3. Western-blot analysis 
2.3.1. Protein electrophoresis 
Protein electrophoresis was performed using SDS-polyacrylamide gels 
(SDS-PAGE) (Table 3) and non-SDS-polyacrylamide gels (Anderson gels) (Table 4). 
The last ones allow a better separation of phosphorylated proteins with similar 
electrophoretic mobility. Acrylamide concentrations were different depending on 
the proteins size to be studied: for proteins of a relatively small molecular weight 
(25-80 KDa), we used higher percentages of separating gel (12-15 %) and for 
proteins of high molecular weight (more than 80 KDa), we used lower 
percentages of separating gel (7.5-10 %). 
 
 
 
Matherials and methods 
56 
 
SDS-PAGE gels composition: 
Table 3: SDS-PAGE gels composition (Vf=10ml) 
Composition 
Separating 
Gel 10% 
Separating 
Gel 12% 
Separating 
Gel 15% 
Stacking gel 
(Vf=5ml) 
30% Acrylamide/ 
Bisacrylamide 
3.3 ml 4 ml 5 ml 0.83 ml 
H2O 4 ml 3.3 ml 2.3 ml 3.4 ml 
1.5 M Tris pH 8.8 2.5 ml 2.5 ml 2.5 ml - 
Tris 1 M pH 6.8 - - - 0.63 ml 
10% SDS (w/v) 100 μl 100 μl 100 μl 50 μl 
10% Ammonium 
persulfate (APS) 
100 μl 100 μl 100 μl 50 μl 
TEMED 4 μl 4 μl 4 μl 5 μl 
 
Anderson gels composition:  
Table 4: Anderson gels composition (Vf=10 ml) 
Composition 
Separating 
Gel 7.5% 
Separating 
Gel 10% 
Separating 
Gel 15% 
Stacking gel 
(Vf=5 ml) 
30% Acrylamide  2.52 ml 3.36 ml 5.03 ml 0.833 ml 
1% Bis-acrylamide  1.95 ml 1.31 ml 0.87 ml 0.667 ml 
H2O 3.02 ml 2.82 ml 1.59 ml 2.875 ml 
1.5 M Tris pH 8.8 2.52 ml 2.52 ml 2.52 ml - 
1 M Tris pH 6.8 - - - 0.625 ml 
10% Ammonium 
persulfate (APS)  
50 μl 50 μl 50 μl 50 μl 
TEMED 5 μl 5 μl 5 μl 5 μl 
 
Laemmli buffer 4X (Tris-HCl pH 7.6; 10% (w/v) glycerol; 1% (w/v) SDS; 
0.002% (w/v) bromophenol blue; 2 mM –mercaptoethanol) was added to 
protein samples and then, they were heating at 95ºC and loaded into the gel, as 
well as the molecular weight markers. Electrophoresis was developed at a 
constant amperage of 20mA using the following running buffers: 
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 For SDS-PAGE gels: 25 mM Tris-HCl (pH 8.3), 200 mM Glycine and 
0.1% SDS. 

 For Anderson gels: 50 mM Tris-HCl (pH 8.3), 400 mM Glycine and 
0.1% SDS. 
 
 
2.3.2. Proteins transfer 
Proteins from the gels were transferred to a nitrocellulose membrane 
using a semi-dry equipment. The nitrocellulose membrane was activated by 
immersion into distilled water and it was assembled as follows from bottom to 
top: 3 Whatman papers, nitrocellulose membrane, acrylamide gel and 3 
Whatman papers, which were all previously soaked in transfer buffer (20% 
methanol, 50 mM Tris, 400 mM glycine and 0.1% SDS). Then, an electrical current 
of 15 V for 30-45 min (depending on the number/size of gels) was applied. 
Transfer was confirmed by staining the membrane with a Ponceau S solution 
(0.5% in 1% acetic acid).  
 
2.3.3. Proteins immunodetection  
Membranes were washed several times with distilled water, and twice 
with TTBS (10 mM Tris-HCl, 150 mM NaCl, pH 7.5 (TBS) with 0.05% Tween-20). 
Then, they were incubated in the blocking solution (either 5% non-fat dry milk or 
5% BSA in TTBS) for 1h at room temperature (RT). After this time, they were 
rinsed with TTBS and incubated with the primary antibody in 5% non-fat milk-
TTBS or BSA-TTBS (overnight at 4ºC for phospho-proteins or 1h at RT for non-
phosphorylated proteins) at the dilution indicated in Table 5. Then, membranes 
were washed 4 times with TTBS (5 min/each) and incubated with the secondary 
antibody at a dilution of 1:5000 in 1% milk TTBS for 1h at RT. Finally, they were 
washed 4 times with TTBS and incubated with a chemiluminescent solution (ECL 
from Amersham Boisciences) to visualize proteins in an X-ray film. 
 
Matherials and methods 
58 
 
 
Table 5: Antibodies 
Antibody Laboratory Reference 
-Actin Sigma-Aldrich A-5441 
Phospho-Ser473-Akt Cell-Signaling 9271 
Akt Cell-Signaling 9272 
Phospho-ATF2 Cell-Signaling 9221 
ATF-2 Cell-Signaling 9226 
Catalase Sigma-Aldrich C-0979 
C3G (H-300) Santa Cruz sc-15359 
DNMT3A Cell-Signaling 2160 
Phospho-ERK1/2 Cell-Signaling 9101 
Fibulin-3 Santa Cruz sc-99177 
GAPDH Cell-Signaling 2118 
Phospho-p38 Cell-Signaling 9211 
p38 Santa Cruz sc-535 
Phospho-Thr389-p70S6K Cell-Signaling 4376 
p70S6K Cell-Signaling 9202 
SOD-2 Upstate Biotech 06-984 
Tubulin Sigma-Aldrich T-5168 
 
 
3. ANALYSIS OF mRNA EXPRESSION 
3.1. Total RNA isolation 
Total RNA isolation was performed using RNeasy Mini Kit (Quiagen, 
74104) following manufacturer instructions. DNase (Quiagen, 79254) treatment 
was included to avoid possible genomic DNA contaminations. Finally, RNA was 
eluted with ultrapure water and stored at -80ºC until it was used. 
RNA concentration was determined spectrophotometry at 260 nm (1 unit 
of absorbance at 260 nm corresponds to 40 μg of RNA per ml (cuvette). To 
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estimate RNA purity, the ratio of absorbance at 260 and 280 nm was calculated. A 
ratio of A260/A280 of 1.8-2 is accepted for pure RNA.  
3.2. c-DNA synthesis  
Total RNA (1-3 g) was reverse-transcribed to generate the cDNA using 
the SuperScript III RT kit (Invitrogen 18080-040) following instructions from the 
manufacturer. Essentially, RNA, oligo (dT) (0.5 mM) and random primers (2.5 M) 
were incubated at 65 ºC for 5 min to ensure RNA denaturation and then, placed 
on ice for at least 1min. cDNA synthesis mix (5X RT buffer, 20 Units of RNase 
inhibitor, 5 mM DTT and 200 Units of SuperScript III) was added to each sample 
and incubated at 50ºC for 1h. The reaction was stopped by heating at 70ºC for 15 
min to inactivate the enzyme. C-DNA was stored at -20 ºC for its use for PCR or 
qPCR analysis. 
3.3. Semi-quantitative PCR 
RT-qPCR analysis was used to evaluate SOD-1 and SOD-2 mRNAs levels. 
PCR reactions were carried out using 0.4 μM specific primers (Table 6), dNTPs at 
200 μM each, 2 mM MgCl2 and 1 unit of Taq Polymerase (Biotools, 10-014). The 
amplified bands were normalized using GAPDH as a control. PCR conditions were: 
94°C, 45 sec; 55°C, 45 sec; and 72°C, 1 min for 30 cycles.  
 
The obtained PCR products were analyzed in 1% agarose gels containing 
Gel Red Nucleic Acid Stain (Biotium, 41003). 
Table 6: Primer sequences used in semi-quantitative PCR 
Gene Forward primer (5’-3’) Reverse primer (5’-3’) 
SOD-1 GATGAAGAGAGGCATGTTGG CCAATGATGCAATGGTCTCC 
SOD-2 TGGGGCTGGCTTGGCTTCAA GCGTGCTCCCACACGTCAAT 
GAPDH CATCAAGAAGGTGGTGAAGC CATCGAAGGTGGAAGAGTTGG 
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3.4. Quantitative PCR 
Real Time PCR or quantitative PCR (qPCR) was performed using specific 
primers (Table 7) and SYBR Green (Roche) to detect DNA in the 7900 Fast Real 
Time System (Life Technologies). PCR reactions were done in triplicate. GAPDH 
was used as the normalizing gene, as its expression was constant under the 
experimental conditions. 
 
Table 7: Primer sequences used in quantitative PCR 
Gene Forward primer (5’-3’) Reverse primer (5’-3’) 
Catalase GTCACCGGCACATGAATGGCT TGATGCCCTGGTCGGTCTTGT 
Fibulin 3 GAATGTGATGCCAGCAACC TCACAGTTGAGTCTGTCACTGC 
GAPDH CATCAAGAAGGTGGTGAAGC CATCGAAGGTGGAAGAGTTGG 
 
During the exponential phase of real-time PCR, a fluorescence signal 
threshold was determined, so that it was significantly greater than background 
fluorescence. The fractional number of PCR cycles required to reach this 
threshold is defined as the cycle threshold, or Ct. Based on this, quantification of 
RNA levels was performed through calculation of RQ (2-ΔΔCt). First, ΔCt value for 
each sample and primer is obtained as follows: Ct for a primer minus -Ct for 
GAPDH=ΔCt under a particular experimental condition and then, this is referred 
to wt ΔCt control values (sample ΔCt-wt ΔCt= ΔΔCt) to calculate the RQ value. We 
consider a significant difference when there is a minimum of two-fold change: RQ 
more than 2 or less than 0.5. 
4. CHROMATIN IMMUNOPRECIPITATION (ChIP) ASSAY  
Protein-DNA interactions were cross-linked with 1% formaldehyde 
solution (15 min incubation of cultured cells at RT). Cross-linking was stopped by 
incubation with 125 mM glycine for 5 min at RT. Cells were then washed, 
harvested in PBS (with protease and phosphatase inhibitors) and centrifuge at 
2000 rpm (5 min at 4ºC). Pelleted cells were lysed on ice (10 min) in a buffer 
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containing 1% SDS, 10 mM EDTA, 50 mM Tris-HCl at pH 8.1 and protease and 
phosphatase inhibitors. Lysates were sonicated 10 seconds, 6 times on ice. DNA 
was fragmented in a range of 200-600 bp. Then, samples were centrifuged and 
equal amounts of the chromatin solution were diluted in ChIP buffer (0.01% SDS, 
1.1% Triton-X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl pH 8.1, 167 mM NaCl) and 
incubated o/n at 4ºC with a P-ATF-2 antibody or a rabbit IgG (negative control), 
followed by 1h incubation with salmon Sperm DNA/protein A Agarose-beads. 
10% of the volume was retained as the input. To reduce non-specific background, 
the chromatin solution was previously pre-cleared by incubation with 50% 
protein A sepharose containing salmon sperm DNA (20 μg) and BSA (1 mg/ml) in 
TE (10 mM Tris-HCl, 1 mM EDTA, pH 8.0) for 30 min at 4ºC. Then, samples were 
centrifuged and protein A agarose-beads pellets were sequentially washed with 
the following buffers: a low salt buffer (0.1% SDS, 1% Triton-X-100, 2mM EDTA, 
20 mM Tris-HCl, pH 8.1, 150 mM NaCl); a high salt buffer (0.1 % SDS, 1% Triton-X-
100, 2 mM EDTA, 20 mM Tris-HCl pH 8.1, 500 mM NaCl); a LiCl wash buffer (0.25 
M LiCl, 1% NP40, 1 % deoxycholate, 1 mM EDTA, 10 mM Tris-HCl, pH 8.1) and TE. 
Protein-DNA complexes were eluted from the beads by incubation with elution 
buffer (1% SDS and 0.1 M NaHCO3) at RT by orbital mixing. Protein-DNA cross-
linking was reversed by incubation with 
200 mM NaCl for 4h at 65ºC and proteins 
were eliminated by incubation with 
proteinase K (20 g) in 40 mM Tris-HCl pH 
6.5 and 10 mM EDTA for 1h at 45ºC. DNA 
was then extracted with 
phenol/chloroform and precipitated. DNA 
fragments were amplified by PCR using 
primers for an AP-1 site (positions 844-
853) from mouse SOD-2 promoter: 
Forward: 5´-GCAAGCAGCAGAACTCGCAGC-
3´; and Reverse: 5´-
AGCACTCAGGAGGCAGAGGCA-3´. Inputs 
were also amplified by PCR (Fig. 14). 
Figure 14: Schematic ChIP protocol 
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5. ANALYSIS OF DNA METHYLATION THROUGH PYROSEQUENCING 
5.1. DNA isolation 
Genomic DNA was extracted from 24h serum-deprived wt and p38-/- 
MEFs. Once cells were washed twice with cold PBS solution 1 (10 mM Tris-HCl pH 
7.5, 10 mM EDTA, 0.15 M NaCl), proteinase K (10 mg/ml) was added. Then, they 
were scraped and 20% SDS was added and mixed. The homogenate was digested 
at 65ºC for 2-3h and Solution 2 (10 mM Tris-HCl pH 7.5, 10 mM EDTA, 0.65 M 
NaCl) was added to each tube. Then, DNA was purified by phenol-chloroform 
method and precipitated with ethanol (two volumes). Finally, samples were 
resuspended in ultrapure water. DNA was stored at -20ºC until it was processed. 
DNA concentration was determined spectrophotometrically at 260 nm. An 
absorbance of 1 unit at 260 nm corresponds to 50 μg of DNA per ml (A260 = 1 = 
50 μg/ml). 
5.2. Bisulphite modification 
To analyze DNA methylation, the DNA was treated with bisulphite to 
induce cytosine deamination leading to uracil, while leaving 5-methylcytosine 
intact. Thus, genomic DNA (1 g) was modified in this way using the BisulFlash 
DNA Modification Kit from Epigentek (P-1026) following manufacturer 
instructions.  
 
Figure 15: DNA bisulphite modification. Reaction between cytosine and bisulphite (step 1) leads to 
deamination (step 2) at acid pH. Afterward, desulphonation (step 3) at alkaline pH produces uracil 
(Adapted from (Darst et al. 2010)).  
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5.3. PCR amplification  
The specific region of interest, a fragment of the fibulin 3 (efemp 1) gene 
promoter with twelve CpG islands were amplified using the bisulfite modified 
DNA. The PyroMark PCR kit (Qiagen 978703) was used and the following primers: 
forward: 5´-CCTCCTGTGGCTGCTGCTGCAG-3´; reverse (biotinylated): 5´-
CACTTTGACATGTCTCTTCTACCTCCA-3´ (Figure 16: mi_EfempF and mi_EfempR). 
PCR cycles were as follows: 30 seg at 95 ºC, 30 seg at 52ºC and 30 seg at 72ºC (45 
cycles). PCR products were converted into single-stranded DNA (ssDNA) 
fragments and one strand was isolated using Streptavidine-sepharose beads in 
the PyroMark workstation for its use as a template in the Pyrosequencing 
reaction.  
 
5.4. Pyrosequencing 
The resulting PCR fragments were sequenced (by synthesis) using two 
different primers: 5´-GCTGCCCTCCCCTACGCACTCCTT-3´ (mi_Efemp1_S2) for the 
analysis of the methylation status of five CpG sites and 5´-
CCCGCAGGTAGGAGCCCAAAGC-3´ (mi_Efemp1_S3) for the analysis of seven 
additional CpG sites (Fig. 16). The degree of methylation of each CpG site was 
estimated by measuring the relative peak height of the cytosine (5-
methylcytosine in the original sequence) versus thymine (cytosine in the original 
sequence) profile. This was performed in the Unitat de Genètica Molecular, 
Institut de Biomedicina de València – CSIC. 
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Figure 16: Analyzed region of fibulin 3 gene. mi_EfempF and mi_EfempR (in green) are 
respectively, forward and reverse primers used for amplifying the region of interest. mi_Efemp1_S2 
and mi_Efemp1_S3 are the primers used for sequencing.  
 
 
6. ANALYSIS OF CELL VIABILITY AND APOPTOSIS 
6.1. Quantification of cell viability by Crystal Violet staining 
Cells were treated with the different stimuli or antioxidants. Then, the 
medium was removed, cells were washed twice with PBS and incubated with a 
Crystal Violet solution at 0.2% (w/v) (in 2% ethanol) for 20 min. Cells were then 
washed several times with distilled water until the excess staining was 
eliminated. The plate was air-dried and the stained cells were lysed in 1% SDS and 
absorbance at 595 nm was measured. Results are expressed as the percentage of 
viable cells as compared to control cells.  
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6.2. Analysis of nuclei morphology by fluorescent microscopy 
This method is based on the identification of apoptotic (condensed 
and/or fragmented) nuclei by fluorescence microscopy after fixation and staining 
with propidium iodide. Cells were washed twice with PBS and fixed by incubation 
with a methanol-acetic acid (3:1) solution for 30 min at room temperature. Then, 
cells were washed three times with PBS and stained with a solution containing: 5 
g/ml propidium iodide in PBS, 0.1% Triton X-100, 0.1 M EDTA, supplemented 
with 5 g/ml RNAse. After 30 min of incubation at 37ºC in the dark, cells were 
washed with PBS. Samples were assembled to visualize the nuclei by fluorescent 
microscopy. Apoptotic indices were calculated after counting 500-1.000 cells per 
treatment in an inverted fluorescence microscope (Eclipse TE300, Nikon). 
7. MEASUREMENT OF INTRACELLULAR ROS 
In order to measure the intracellular content of reactive oxygen species 
(ROS), a fluorimetric method was used. Cells were incubated with 5 μM DCFH2-DA 
(2',7'-dichlorfluorescein-diacetate; Sigma, 35845) in PBS for 30-60 min at 37ºC in 
the dark and were either treated with H2O2 (0.1-1 mM) for 15 min or maintained 
untreated (control). Then, cells were collected by trypsinization, centrifuged at 
2000 rpm for 5 min and washed twice with warmed PBS. Cells were then 
resuspended in PBS and propidium iodide was added at 1 g/ml, to distinguish 
between dead and alive cells. DCFH2-DA is incorporated into the cells and 
converted into 2’,7’-diclorodihidrofluorescein (DCFH2) by intracellular esterases. 
In turn, DCFH2 is converted into 2’,7’-diclorofluorescein (DCF) when oxidized by 
hydrogen peroxide, which is the fluorescent compound. The fluorescent intensity 
of DCF was detected by a FACScan Cytometer. Results were calculated as a 
percentage of fluorescence positive cells compared to the control.  
One extra dish from each condition was also treated with DCFH2-DA and 
analyzed in an inverted fluorescence microscope (Eclipse TE300, Nikon), taking 
representative pictures. 
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8. MIGRATION AND INVASION ASSAYS 
8.1. Wound healing  
To study cell migration, wound healing assays were carried out. Confluent 
cells were pre-treated with mitomycin C (25 μg/ml, Sigma M0503) for 30 min to 
inhibit cell growth. Then, they were washed twice with PBS to eliminate 
mitomycin C and a straight scratch was performed with a pipette tip. Cells were 
washed again with PBS and fresh medium without serum was added. Cells were 
maintained for 24h at 37ºC in a humidified atmosphere and 5% CO2 to allow 
migration. Migration was followed by phase-contrast microscopy (Eclipse TE300 
Nikon microscope coupled to a digital sight DS-U2 camera) at different time 
points (0, 4, 8, 12 and 24h) up to wound healing closure. Photographs were taken 
to quantify (using TScratch program) the percentage of wound healing closure at 
the different time points. 
8.2. Invasion through matrigel 
To study cell invasion capacity, cells were 
allowed to migrate through matrigel using 
transwells inserts (8 μm filter, BD 353097) 
coated with matrigel (444 g/cm2) (BD 
Biosciences, 356234). 
Cells (50.000) were seeded in the 
upper chamber in a serum-free medium with 
or without additional treatments (SB203580 
for p38/ inhibition or marimastat for MMPs inhibition). In the lower chamber, 
a medium supplemented with 10% FBS was added to act as a chemoattractant 
and cells were left in the incubator for 24h at 37ºC and 5% CO2 (Fig. 17). Then, 
the medium and the matrigel from the upper chamber were removed with 
cotton-tipped swabs. Cells present in the lower chamber were fixed in 4% 
paraformaldehyde, washed twice with PBS and stained with crystal violet 0.2% 
w/v (Sigma Ref C-0775). Finally, inserts were washed with distilled water and 
Figure 17: Schematic protocol of 
invasion assay through matrigel  
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dried at room temperature and cells were counted using a phase-contrast 
microscope. 
9. CUANTIFICATION OF SOD-2 PROMOTER ACTIVITY 
To asses SOD-2 promoter activity in wt and p38-/- MEFs upon H2O2 
treatment, cells were cotransfected with a construct containing the SOD-2 
promoter coupled to a luciferase reporter (kindly provided by Daret St Clair, 
Kentucky University) and a plasmid-encoding Renilla luciferase (Clontech) (100–
500 ng). Then, cells were treated with H2O2 (0.5 mM for 4 and 8h) and lysed using 
the passive lysis buffer from Promega. Luciferase activity was detected by a 
luminometer (Molecular Devices Spectramax M5E) using the Dual Luciferase 
Reporter Kit from Promega following the manufacturer’s instructions. Luciferase 
activity was normalized to Renilla luciferase activity.  
10. ENZYMATIC ASSAYS 
10.1. Catalase activity assay 
Catalase activity was measured by quantification of H2O2 decomposition 
in a 50 mM phosphate buffer at pH 7 containing 3 mM H2O2. To do it, the sample 
was added to the cuvette, mixed well and H2O2 decomposition was monitored 
spectrophotometrically at 240 nm for 1min. Catalase specific activity was 
calculated by the formula: mU CAT/ mg prot = (380 x log Abs t0/Abs t60)/mg 
prot/ml).  
10.2. SOD activity assay 
SOD activity from cell extracts was quantified using a Kit (BioVision, K335-
100), where WST-1 (2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2, 4-disulfo-phenyl)-2H 
tetrazolium, monosodium salt) is the substrate. WST-1 produces a water-soluble 
formazan dye upon its reduction with the superoxide anion, which can be 
monitored spectrophotometrically at 450nm (Fig. 18). This rate of reduction is 
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linearly related to the xanthine oxidase activity and inhibited by SOD, so the IC50 
of SOD is determined as a measure of SOD activity.  
Treated cells were lysed in a buffer containing 0.1 M Tris-HCl pH 7.4, 0.5% 
Triton X-100, 5 mM -mercaptoethanol and 0.1 mg/ml PMSF on ice. After 
centrifugation at 14000 rpm (5 min at 4ºC), supernatant fractions (that contains 
total SOD activity from cytosol 
and mitochondria) were 
collected. Then, SOD activity was 
measured following the 
manufacture instructions by 
incubating the WST-1 working 
solution and the sample at 37ºC 
for 20min. Finally, the absorbance 
was read at 450 nm and SOD 
activity was calculated.  
10.3. Quantification of MMP2 and MMP9 activities by zymography 
MMP2 (Gelatinase A) and MMP9 (Gelatinase B) activity was determined 
using conditioned medium from serum-deprived cells. Total protein levels in cell 
extracts were measured to establish the amount of medium used. Samples were 
prepared under non-reducing conditions (absence of heating and reducing 
agent), mixing the medium with a non-reducing loading buffer 4X (250 mM Tris-
HCl pH 6.8, 25% glycerol, 2.5% SDS and 1 mg/ml Bromophenol blue) and loaded 
in a 8% SDS-PAGE gel polymerized in the presence of 0.1% gelatin. The 
electrophoresis was carried out at constant voltage of 80 V for 3-4h. Then, SDS 
was removed from the gel by incubation with 2.5% Triton X-100 for 30min. The 
gel was then rinsed with the substrate buffer (0.2 M NaCl, 5 mM CaCl2, 1% Triton 
X-100, 0.02% NaN3, 50 mM Tris pH 7.5) and incubated in this substrate buffer at 
37ºC overnight to allow protein renaturation and MMP activation. Next day, to 
visualize gelatin digestion areas (MMP2/9 activity) as clear bands, the gel 
(zymogram) was stained with Coomassie Brilliant Blue (BioRad, 161-0400). 
Figure 18: Schematic reaction of superoxide 
dismutase activity assay 
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11. TUMOURIGENESIS STUDIES  
11.1. Focus formation assay  
To measure anchorage dependent growth, 300 cells (MEFs) were seeded 
in a 10 cm dish. After 10-13 days, the medium was removed and cells foci were 
fixed and stained with a 0.2% crystal violet solution (in 2% ethanol). The total 
number of foci was quantified using Image J program and their size using 
OpenCFU program. 
11.2. Growth in soft-agar 
To measure anchorage-independent growth in soft agar, cells were 
cultured in 24-well dishes containing two agar layers. Cells (3x103) were 
resuspended in 0.7 % granulated agar (BD, 214530) diluted in complete medium 
(2X) and poured onto a 0.5 % layer of agar (diluted in complete medium). Fresh 
medium was added to the top layer every 3 days to prevent gel drying. After 2 
weeks, colonies were stained with MTT and counted.  
11.3. Xenografts assays 
For xenograft experiments, MEFs cells (1.5x106 cells/100 l DMEM) were 
resuspended in DMEM and injected subcutaneously into the flank of eight-week 
old male nude mice (Harlam Laboratories). Tumour growth was monitored twice 
a week for 6 weeks. All animal experiments were carried out in compliance with 
the institutions guidelines. 
12. STATISTICAL ANALYSIS 
Data have been represented as the mean value of 3-10 independent 
experiments and ±SEM. The comparisons were made between two experimental 
groups. An unpaired Student's t-test was used and alternatively, ANOVA test was 
carried out for comparisons of more than two experimental groups. 
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1. p38 MAPK MEDIATES CELL SURVIVAL IN RESPONSE TO OXIDATIVE 
STRESS VIA INDUCTION OF ANTIOXIDANT GENES IN MEFs 
p38 MAPKs play an important role in the coordination of cellular stress 
responses to signals such as ROS, mediating cell death or survival. Interestingly, 
previous results from our group indicated that p38α MAPK induced cell survival in 
response to relatively low levels of H2O2 (Gutierrez-Uzquiza et al. 2010). However, 
the precise mechanisms by which p38α MAPK signaling achieves cell survival 
were poorly understood. In addition, in this context of moderate oxidative stress, 
the Akt/mTORC1/p70S6K pathway was differentially regulated by p38α MAPK. 
Although Akt phosphorylation was enhanced in p38α-/- MEFs treated with H2O2, 
p70S6K activation was very low and the potential relevance of this pathway in the 
control of this process of cell death was unclear. Therefore, we decided to fully 
characterize this pro-survival role of p38 MAPK in response to these moderate 
levels of oxidative stress and the potential implication of the 
Akt/mTORC1/p70S6K pathway.  
 
1.1. Loss of p38 sensitizes cells to H2O2-induced cell death  
As explained in the group background section, wt MEFs exhibited a higher 
resistance to a level of oxidative stress, able to generate damage but not massive 
toxicity (0.1-0.5 mM H2O2), than p38-deficient MEFs (Fig 11 background). This 
suggests that p38α allows cells to survive under mild levels of oxidative stress. 
This was confirmed by p38α reconstitution in p38α-/- cells (Fig 11 background).  
We have now analyzed nuclei morphology and found a significantly 
higher number of condensed and/or fragmented nuclei in p38α-deficient MEFs 
than in wt cells upon H2O2 treatment (Fig. 19), which suggests that cells would be 
dying by a process of apoptosis. All these data demonstrate that p38α protects 
from low levels of H2O2-induced cell death. 
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Figure 19: Loss of p38 increases the number of apoptotic nuclei in MEFs treated with H2O2. MEFs 
(wt and p38-/-) maintained in the presence of serum were treated with 0.5 mM H2O2 for 3h. 
Apoptotic (condensed and/or fragmented) nuclei were counted in an inverted fluorescence 
microscope after fixation and staining with propidium iodide. The histogram shows the mean values 
± S.E.M (n=3). ***p<0.001, p38-/- versus wt MEFs upon treatment with H2O2. 
 
1.2. Loss of p38 MAPK impairs mTORC1/p70S6K activation in response to H2O2 
through Akt independent mechanisms 
Our previous results indicated that Akt activity is negatively regulated by 
p38α, so that Akt is hyperactivated in p38α-/- cells, leading to increased survival 
in response to serum-deprivation (Zuluaga et al. 2007a). However, whether this 
had any effect on ROS sensitivity remained unknown. Results from Nogueira et 
al., showed that Akt activation sensitized cells to oxidative stress through down-
regulation of ROS scavengers, which increased intracellular ROS (Nogueira et al. 
2008). This led us to hypothesize that p38α, through inhibition of Akt, might allow 
a proper expression of anti-oxidant genes. 
As previously mentioned (group background section), under mild levels of 
oxidative stress, Akt activation was uncoupled from mTORC1-mediated p70S6K 
phosphorylation in p38-deficient cells. (Fig. 12 background). Thus, we next 
confirmed this result by p38α reconstitution in p38α-/- cells, which rescued the 
levels of p70S6K activation (Fig. 20), reaching a level comparable to that of wt 
cells treated with H2O2. In the absence of p38α, although Akt phosphorylation 
was enhanced in response to H2O2 treatment, p70S6K activation was very low.  
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Figure 20: p38 MAPK positively regulates p70S6K through an Akt independent mechanism. MEFs 
(wt, p38-/- and p38-/- with reconstitution of p38 (Rec)) maintained in the presence of serum 
were treated with H2O2 (1 mM) for 20 min. Western-blot analysis of the levels of P-Thr389-p70S6K, 
P-Ser473-Akt, P-p38, as well as total levels of p70S6K, Akt, and p38 normalized with tubulin. P-
p70/tubulin represents the relative value resulting from the densitometric analysis of P-Thr389-
p70S6K versus tubulin levels multiplied by 10.  
 
We next considered the possibility that the higher mTORC1/p70S6K 
activation in cells expressing p38α could be responsible for the increased survival 
in response to H2O2. Thus, we inhibited this pathway with rapamycin to evaluate 
it. However, rapamycin did not sensitize wt cells to ROS-induced cell death (Fig. 
21A). Therefore, the higher activation of mTORC1/p70S6K appears not to be 
responsible for the p38-mediated increased survival. According to this, 
transfection of either an active p70S6K (p70Δ29-46 ΔCT104 mutant) or a wt 
p70S6K construct did not increase cell viability of p38-deficient MEFs treated 
with H2O2 (Fig. 21B). In contrast, basal viability was slightly reduced upon 
expression of these p70S6K constructs. 
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Figure 21: mTORC1/p70S6K does not mediate p38-dependent survival in response to H2O2. MEFs 
(wt and p38-/-) maintained in the presence of serum were treated with H2O2 (0.1, 0.5 or 1 mM). A) 
Effect of rapamycin on H2O2-induced cell death. Cells were pretreated for 1h with rapamycin (5 and 
10 M). Results show the mean values ± S.E.M (n=3) of the percentage of viable cells determined by 
crystal violet staining. *p<0.05, p38-/- versus wt MEFs treated with H2O2. B) Left panel, effect of 
the expression of transfected p70S6Kwt (p70wt) and p70Δ29-46ΔCT104 active mutant on cell 
viability. *p<0.05, p38-/- versus wt MEFs treated with H2O2. Right panel, western-blot analysis 
showing HA expression in cells transfected with p70S6Kwt and p70Δ29-46ΔCT104 active mutant. 
Arrows indicate the migration of 80 and 50 KDa molecular weight markers. 
 
On the other side, Akt inhibition with the selective chemical inhibitor, 
A443354, had no effect on H2O2-induced cell death, either in wt or p38-/- MEFs 
(Fig. 22), which suggests that the Akt pathway does not play a major role in p38-
mediated survival. 
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Figure 22: Inhibition of Akt activity has no effect on H2O2-induced cell death. MEFs (wt and p38-
/-) maintained in the presence of serum were treated with 1 mM H2O2 for 3h. When indicated, cells 
were pretreated for 1h with A443354 (0.5 μM). Results show the percentage of viable cells 
determined by crystal violet staining and are the mean values ±S.E.M (n=3). **p<0.01, p38-/- 
versus wt MEFs treated with H2O2. 
 
All these data indicate that either the higher activation of 
mTORC1/p70S6K or the lower Akt activation is responsible for the p38-
mediated increased survival. Therefore, we decided to explore alternative 
mechanisms by which p38α might protect cells from ROS damage, allowing cell 
survival in response to oxidative stress. 
 
1.3. Activation of p38 prevents the accumulation of ROS  
Although p38α MAPK is known to mediate cell death in response to 
oxidative stress (Dolado et al. 2007;Tobiume et al. 2001;Wada and Penninger 
2004), p38 has also been shown to induce the expression of antioxidant enzymes 
(Aggeli et al. 2006;Sen et al. 2005). This led us to hypothesize that p38α through 
the regulation of the anti-oxidant response might maintain low ROS intracellular 
levels, leading to cell survival.  
As shown in figure 23, the percentage of cells with detectable levels of 
ROS (positive for DCFH) was slightly higher in untreated p38-deficient cells 
compared with wt cells, and was highly increased upon treatment with H2O2 in a 
dose dependent manner. This suggests that p38α-/- cells are unable to efficiently 
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scavange ROS in response to H2O2, leading to a high and progressive 
accumulation of ROS (Fig. 23).  
 
 
 
Figure 23: ROS accumulation upon H2O2 treatment is higher in cells lacking p38. MEFs (wt and 
p38-/-) were incubated with DCFH and treated with H2O2 (1 mM for A and 0.1 and 1 mM for B) for 
15 min. Analysis of DCFH-positive cells using an inverted fluorescence microscope. A) 
Representative images of DCFH-positive cells in green. B) Percentage of DCFH-positive cells. Results 
are the mean values ±S.E.M (n=3). ** p<0.01, p38-/- versus wt MEFs treated with the same dose 
of H2O2.  
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1.4. The presence of p38 increases basal and H2O2-induced expression of the 
antioxidant enzymes 
This high ROS accumulation in p38α-deficient cells could be a 
consequence of a deficiency in the activation of the anti-oxidant mechanisms. In 
agreement with this potential role of p38 as a positive regulator of antioxidant 
enzymes expression, it was previously reported that p38 MAPK up-regulated 
catalase (Sen et al. 2005) and heme oxygenase-1 mRNAs (Aggeli et al. 2006) in 
response to H2O2. For this reason, we decided to analyze the effect of p38 in the 
expression of relevant antioxidant enzymes such as superoxide-dismutases (SOD-
1 and SOD-2) and catalase.  
We first analyzed the protein levels of SOD-2 and catalase under basal 
conditions and after H2O2 treatment. As shown in figure 24A, p38α-/- cells 
expressed lower protein levels of SOD-2 and catalase than wt cells under basal 
conditions. Moreover, upon treatment with H2O2 these cells were either unable 
to efficiently induce the expression of these enzymes, as observed for SOD-2, or 
had a delay and a reduced induction, as happens for catalase (Fig. 24A). These 
results suggest that impaired or delayed induction of antioxidant enzymes in 
p38α-/- MEFs could be responsible for its higher sensitivity to H2O2-induced cell 
death.  
To demonstrate that the absence of p38 was responsible for the lower 
catalase protein levels, we re-introduced p38α in p38-deficient cells. Results 
presented in Fig.24B indicate that p38 reconstitution in p38-/- cells led to an 
increase in catalase protein levels after 2h of treatment with H2O2. 
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Figure 24: Loss of p38 reduces de expression of antioxidant enzymes. MEFs (wt, p38-/- 
reconstituted with p38 (Rec) and p38-/-) maintained in the presence of serum were treated with 
0.5 mM H2O2 for 2 (A and B) and 4h (A). A) Catalase and SOD-2 protein levels determined by 
western-blot analysis and normalized with tubulin. B) Rescue of catalase protein expression by 
p38 reconstitution in p38-/- cells (Rec) treated with H2O2. p38 MAPK was transiently re-
expressed in p38-/- MEFs. Western-blot analysis of catalase and p38 normalized with tubulin.  
 
In addition, basal and H2O2-induced catalase and SOD activities were 
significantly higher in wt than in p38α-/- MEFs (Fig. 25A and R25B, respectively). 
Therefore, all these data indicate that the presence of p38 highly increases the 
anti-oxidant activity of cells. 
 
 
Figure 25: Loss of p38 reduces the activity of catalase and SOD-2. MEFs (wt and p38-/-) 
maintained in the presence of serum were treated with 0.5 mM H2O2 for 20 min. Catalase and SOD-
2 activity are shown as a fold increase of that of wt untreated cells (9.35 mU/mg protein for 
catalase and 7.32 mU/mg protein for SOD-2) and are the mean values ±S.E.M (n=3) *p<0.05, 
**p<0.01 or ***p<0.001, compared as indicated.  
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 These results led us to conclude that p38 was increasing the antioxidant 
capacity in this moderate oxidative stress context.  
To get further insight into the role of p38 as a regulator of antioxidant 
enzymes expression, we measured SOD-1 and SOD-2 mRNA levels by RT-PCR. 
They were significantly lower in p38α-/- cells under basal conditions and H2O2 
only induced an increase in SOD-1 mRNA after 20-60 min, while SOD-2 mRNA 
remained unchanged (Fig. 26). 
 
 
Figure 26: Loss of p38 reduces the expression of SOD-1 and SOD-2. MEFs (wt and p38-/-) 
maintained in the presence of serum were treated with 0.5 mM H2O2 for 20 and 60 min. RT-PCR 
analysis of the expression of SOD-1 and SOD-2 mRNAs normalized with GAPDH.  
 
 
1.5. p38 through ATF-2 regulation induces SOD-2 expression and resistance to 
H2O2 treatment  
To better understand the regulation of SOD-2 expression by p38 in 
response to H2O2, we started analyzing SOD-2 promoter activity using luciferase 
as a reporter (colaboration with Dr. P. Bragado and Dr. J. A. Aguirre-Ghiso (Mount 
Sinai Hospital, New York, USA)). 
As shown in figure 27, H2O2 treatment induced a significant increase in 
SOD-2 reporter activity in wt cells after 8h, but not in p38-/- MEFs.  
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Figure 27: H2O2 treatment induced an increase in SOD-2 reporter activity in wt cells, but not in 
p38-/- MEFs. MEFs (wt and p38-/-) maintained in the presence of serum were treated with 0.5 
mM H2O2 for 4 and 8h. SOD-2 reporter activity using luciferase as reporter. Results are expressed as 
arbitrary units and are the mean values ±S.E.M (n=3). *p<0.05, ***p<0.001 compared as indicated.  
 
 In an effort to define possible substrates of p38 that helped us to 
understand the link between p38 and SOD-2, we found that ATF-2, a p38 MAPK 
substrate, was more phosphorylated in wt than in p38-deficient cells in 
response to H2O2 (Fig. 28). Therefore, the lack of activation of SOD-2 promoter in 
the absence of p38 could be a consequence of the lower activation of the 
transcription factor ATF-2. 
 
 
 Figure 28: H2O2 induced a higher ATF-2 phosphorylation in wt cells than in p38-/- MEFs. MEFs 
(wt and p38-/-) maintained in the presence of serum were treated with H2O2 (0.1 and 0.5 mM) for 
20 min. Western-blot analysis of P-ATF-2 levels normalized with -actin. 
 
To address this issue, ATF-2 knock-down experiments were performed 
using an ATF-2 siRNA, which markedly reduced ATF-2 protein levels in wt MEFs 
(Fig. 29A). A high decrease in SOD-2 mRNA levels was observed in wt cells upon 
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ATF-2 knock-down, either when they are maintained untreated or treated with 
H2O2 (Fig. 29). This suggests that ATF-2 is a mediator of p38-induced SOD-2 
expression and it would bind SOD-2 promoter to exert its action.  
 
 
Figure 29: ATF-2 is an important mediator of p38 in the induction of SOD-2 mRNA expression 
upon H2O2 treatment. Effect of ATF-2 siRNA on SOD-2 mRNA levels. A negative control (siRNA neg) 
was also used. A) Western-blot analysis of ATF-2 levels normalized with GAPDH. B) Histogram shows 
the mean values ±S.E.M. (n=3) of SOD-2 mRNA levels of wt, siATF-2-wt and p38-/- MEFs untreated 
or treated with 0.5 mM H2O2 for 1 or 2h. (*p<0.05), (***p<0.001), compared as indicated. 
 
To demonstrate that ATF-2 was able to bind to SOD-2 promoter under 
these conditions, we next performed chromatin immunoprecipitation (CHiP) 
assays. As shown in figure 30, CHiP assays revealed a significant binding of P-ATF-
2 to SOD-2 promoter in wt MEFs treated with H2O2, while in p38-/- cells it was 
no detectable binding.  
 
Figure 30: P-ATF-2 binds to SOD-2 promoter in wt MEFs, but not in p38-/- MEFs. CHIP analysis of 
P-ATF-2 binding to SOD-2 promoter. PCR analysis of DNA inmunoprecipitated by a P-ATF-2 antibody 
and of input DNA.  
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In parallel to these studies, and to know whether p38 was mediating cell 
survival through the up-regulation of ATF-2 and consequently SOD-2, viability 
assays were performed using wt, ATF-2 knock-down and p38 knock-out cells. 
Results presented in figure 31 show that ATF-2 siRNA significantly decreased cell 
viability of wt MEFs treated with H2O2. Therefore, these results indicate that p38α 
through ATF-2 regulation induces SOD-2 expression and resistance to H2O2 
treatment.  
 
 
Figure 31: ATF-2 activation is required for p38-mediated cell survival upon H2O2. Effect of ATF-2 
siRNA on cell viability upon treatment of MEFs (wt, ATF-2 knock-down and p38 knock-out) with 
0.5 mM H2O2 for 24h. A negative control (siRNAneg) was also used. Results are expressed as the 
percentage of viable cells, showing the mean values ±S.E.M. (n=3). **p<0.01, ATF-2 knock-down (wt 
siRNA ATF-2) as compared with wt cells treated with H2O2.  
 
1.6. p38 positively regulates catalase through mechanisms involving protein 
stabilization and mRNA expression and/or stabilization 
We have demonstrated that catalase levels and activity were significantly 
lower in p38-/- than in wt MEFs. Next, we wanted to explore the mechanisms 
involved in the regulation of catalase expression by p38.  
As shown in figure 32A, catalase mRNA levels were increased by H2O2 
progressively at 2h and 4h in both, wt and p38-deficient cells, but to a higher 
extent in wt cells at 4h. However, after 8h of treatment, catalase mRNA highly 
decreased to the level of control in p38-/- cells, while in wt cells these levels 
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remained above control values. Inhibition of transcription by actinomycin D 
abolished the increase in catalase mRNA levels observed at 2h and 8h, regardless 
of the presence of p38. However, at 4h it was just a partial decrease in catalase 
mRNA upon actinomycin D treatment, specially, in wt cells. This would suggest 
that increases in catalase mRNA levels are only partially dependent on 
transcription and p38 might stabilize catalase mRNA at 4-8h of treatment. In 
addition, the evaluation of the effect of the proteasome inhibitor MG-132 
revealed that p38α could also regulate catalase protein stability. As shown in 
figure 32B, MG-132 increased catalase protein levels only in p38-deficient cells, 
which strongly suggests that catalase protein would be also stabilized by p38. 
 
Figure 32: p38 positively regulate catalase through mRNA and protein stability. MEFs (wt and 
p38-/-) maintained in the presence of serum were treated with H2O2 (0.5 mM) in the presence or 
absence of actinomycin D or MG-132 for the indicated time periods. A) Analysis of catalase mRNA 
levels by RT-qPCR in the presence or absence of actinomycin D. Catalase mRNA expression was 
normalized using GAPDH. Histograms show mean values ±S.E.M (n=3). *p<0.05, +p<0.05, **p<0.01, 
compared as indicated. B) Effect of the proteasome inhibitor, MG-132, on catalase protein 
expression. Western-blot analysis of catalase protein levels normalized with tubulin. 
Catalase/tubulin represents the relative value resulting from the densitometric analysis of catalase 
versus tubulin levels multiplied by 10.  
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Hence, based on these results, p38 might be a positive regulator of 
catalase through protein stabilization and mRNA expression and/or stabilization. 
 
 
1.7. Antioxidants protect p38α-deficient MEFs from ROS-induced cell death 
Our data indicate that p38α activation in MEFs can protect from H2O2-
induced cell death through a mechanism that reduces ROS accumulation via 
induction of antioxidant enzymes. Thus, we next studied the effect of the 
antioxidant N-acetyl cysteine (NAC) on H2O2-induced cell death.  
As shown in figure 33A, NAC significantly decreased the number of 
apoptotic nuclei induced by H2O2 in p38-/- cells. Moreover, NAC not only 
protected from cell death, but also induced an increase in phosphoThr389-
p70S6K levels, which was particularly strong in p38-deficient cells, reaching a 
similar level to that found in wt cells (Fig. 33B). In contrast, Akt and p38 
phosphorylation decreased in NAC treated cells. 
All these results suggest that H2O2-induced cell death would be a 
consequence of the damage induced by ROS accumulation, which is higher in 
p38-/-MEFs. Hence, because catalase levels were lower in these cells, we added 
exogenous catalase to mimic wt cells situation. As shown in figure 33A, 
exogenous catalase highly decreased the number of apoptotic nuclei in p38α-
deficient MEFs treated with H2O2. In addition, a parallel increase in P-Thr389-
p70S6K levels was observed (Fig. 33C). 
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Figure 33: N-acetyl cysteine or catalase protects from ROS-induced apoptosis and allows H2O2-
induced activation of p70S6K by mTOR in p38-/- MEFs. MEFs (wt and p38-/-) maintained in the 
presence of serum were treated with H2O2 (1 mM) for 20 min (B and C) or 3h (A). When indicated, 
cells were pretreated for 1h with N-acetyl cysteine (NAC) (2.5 mM) or catalase (50 units/ml). A) 
Results show the percentage of apoptotic nuclei. ***p<0.001, p38-/- versus wt MEFs upon 
treatment with H2O2 and 
++p<0.01, compared to p38-/- MEFs treated with H2O2 plus NAC or 
catalase, as indicated. B) and C) Western-blot analysis of the levels of P-Thr389-p70S6K and P-
Ser473-Akt normalized with tubulin. P-p70/tubulin represents the relative value resulting from the 
densitometric analysis of P-Thr389-p70S6K versus tubulin levels multiplied by 10.  
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Moreover, in agreement with the idea that a high accumulation of ROS 
impairs p70S6K activation, we observed that treatment of wt MEFs with a very 
high dose of H2O2 (5 mM) impaired p70S6K activation in wt cells (Fig. 34), which 
indicates that a very high accumulation of ROS, either prevents activation or 
inactivates mTORC1/p70S6K pathway.  
 
 
Figure 34: A high dose of H2O2 impairs p70S6K activation, even in MEFs expressing p38. MEFs (wt 
and p38-/-) maintained in the presence of serum were treated with H2O2 (5 mM) for 20 min. 
Western-blot analysis of P-Thr389-p70S6K and P-Ser473-Akt normalized with tubulin. 
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2. p38 MAPK DOWN-REGULATES FIBULIN 3 EXPRESSION THROUGH 
HYPERMETHYLATION OF GENE REGULATORY SEQUENCES, PROMOTING 
MIGRATION AND INVASION 
As described in the group background section, affymetrix microarrays 
analyses revealed that fibulin 3 mRNA was highly up-regulated in p38α-/- MEFs. 
Fibulin 3 is an extracellular matrix protein, which is involved in the regulation of 
migration and invasion in some tumour cell lines (Chen et al. 2014;Hu et al. 
2009;Kim et al. 2012a). p38α also regulates these cellular functions (del, I and 
Nebreda 2012;Wagner and Nebreda 2009). This prompted us to deeply 
characterize the role played by p38α in the regulation of Fibulin 3 expression, as 
well as to investigate if p38α could act through Fibulin 3 to regulate migration 
and invasion. Additionally, we wanted to test the involvement of the others p38 
MAPK isoforms in the regulation of Fibulin 3.  
 
2.1. p38 MAPKs down-regulate fibulin-3 expression  
Based on our data derived from Affymetrix microarrays showing that 
fibulin 3 was down-regulated by p38α and taking into account that there were so 
far no studies linking fibulin 3 expression and p38 MAPKs, we decided to 
characterize the regulation of fibulin 3 expression by p38 MAPKs. First, we 
validated data from microarrays assays and quantified fibulin 3 expression by RT-
qPCR using wt and p38 knock-out MEFs. As shown in figure 35A, fibulin 3 mRNA 
levels were significantly higher in p38 knock-out than in wt MEFs. Moreover, 
western-blot analysis using total cell extracts or mediums (to analyze Fibulin 3 
secretion) showed an increase in the levels of the secreted and intracellular 
Fibulin 3 protein in p38 deficient MEFs (Fig. 35C). To further demonstrate that 
these changes in fibulin 3 expression were dependent on p38 MAPK, the effect 
of the selective p38/ inhibitor SB203580 was determined. As shown in figure 
35B, treatment of wt MEFs with SB203580 led to an up-regulation of fibulin 3 
mRNA, while it had no effect on p38-/- cells, even when using a higher 
SB203580 concentration (data not shown). According to mRNA data, treatment of 
wt MEFs with SB203580 led also to the up-regulation of secreted Fibulin 3 protein 
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levels (Fig. 35D).These results confirmed that p38 is a negative regulator of 
Fibulin 3 expression. As SB203580 had no effect on p38-/- MEFs, it is very likely 
that p38β is not a relevant regulator of fibulin3 expression as compared to p38α.  
 
 
Figure 35: p38, p38 and p38 are negative regulators of fibulin 3 mRNA expression. MEFs (wt, 
p38-/-, p38-/-, p38-/- and p38/-/-) were maintained in the absence of serum and in the 
presence or absence of SB203580 (5 M) for 24h and then, total RNA or proteins were isolated. A) 
and B) Analysis by RT-qPCR of fibulin 3 mRNA levels. Results represent the means ± S.E.M. of RQ 
values (n=3-8). ***p<0.001, as compared with wt cells. B) Effect of SB203580 (5 μM) in wt and 
p38α-/- MEFs. C) and D) Western-blot analysis of Fibulin 3 protein levels in the culture medium 
(secreted) or in cell extracts, as indicated. β-actin was used to normalize cell extracts and p38α as a 
control of its expression. D) Effect of SB203580 (5 μM) in wt and p38α-/- MEFs. Histograms show 
the mean values ± S.E.M. of the densitometric analyses of the blots normalized with β-actin. 
*p<0.05, **p<0.01, ***p<0.001 compared as indicated.  
 
As explained in the introduction section, four p38 MAPK isoforms (p38α, 
p38β, p38γ and p38δ) have been identified so far, which have either overlapping 
Results 
91 
 
or specific functions according to the cellular context (Nebreda and Porras 2000). 
Thus, we analyzed whether p38 and p38 isoforms could also regulate fibulin 3 
expression. In order to perform this study, we used p38-/-, p38-/- and p38/-/- 
MEFs and analyzed fibulin 3 mRNA levels by RT-qPCR. Results from figure 35A 
show increased levels of fibulin 3 mRNA in MEFs lacking p38, p38 or both, as 
compared to wt cells, although at a lower extent than in p38-/- MEFs.  
All these data indicate that p38, p38 and p38 are all capable to down-
regulate fibulin 3 expression, although p38 elicits the strongest effect. 
Therefore, we decided to focus our studies on the analysis of the function of 
p38 in the regulation of Fibulin 3 expression. 
 
2.2. p38 MAPK induces methylation of regulatory sequences of fibulin 3 gene 
Data from the literature indicated that Fibulin 3 expression was mainly 
regulated at the transcriptional level. According to this, in 2003, it was described 
in mammalian retina the relevance of different regulatory sequences present at 
the 5´end of the fibulin 3 gene controlling its transcription (Blackburn et al. 2003). 
Moreover, in some tumours, Fibulin 3 expression has been found to be down-
regulated as a consequence of promoter methylation (Kim et al. 2011;Tong et al. 
2011). 
Based on all this, we wondered whether p38 might down-regulate 
Fibulin 3 expression through promoter methylation and consequently, might be 
responsible for its low expression in wt MEFs.  
To examine the potential involvement of DNA methylation in the down-
regulation of Fibulin 3 in wt MEFs, we first determined whether the expression of 
Fibulin 3 could be restored in wt cells upon treatment with the DNA methylation 
inhibitor, 5-aza-2´-deoxicytidine (5A2dC). As shown in figure 36A, fibulin 3 mRNA 
levels highly increased in wt MEFs treated with 5A2dC, both at 0.5 and 1 M, 
while they remained unchanged in p38-/- MEFs. Accordingly, 5A2dC treatment 
induced an increase in the levels of the secreted Fibulin 3 protein in wt MEFs, 
while it had no effect in p38 knock-out MEFs (Fig. 36B).  
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Figure 36: 5-Aza-2´-deoxicytidine treatment leads to an up-regulation of Fibulin 3 expression in wt 
MEFs. wt and p38-/- MEFs were maintained with 5-Aza-2´-Deoxicytidine (5A2dC) (0.5 M or 1 M) 
for 48h (24h pretreatment in the presence of serum plus 24h treatment in the absence of serum) 
and then, total RNA or proteins were isolated. A) RT-qPCR analysis of fibulin 3 mRNA levels. Results 
represent the mean ± S.E.M. of RQ values. *p<0.05, compared as indicated. B) Western-blot 
analysis of Fibulin 3 protein levels secreted to the culture medium. Densitometric analysis of the 
blots normalized with total intracellular protein levels are shown. 
 
These results suggest that p38 might down-regulate fibulin 3 expression 
through a mechanism dependent on DNA hypermethylation. Nevertheless, 
5A2dC is a general inhibitor of DNA methylation that helps us to know 
qualitatively if the regulatory sequences of a gene are methylated or not. 
However, it does not give us an accurate information about the methylation 
status of the different CpG islands.  
To demonstrate and quantitatively evaluate the effect of p38 on the 
methylation levels of fibulin 3 regulatory sequences, we analyzed methylation 
status of fibulin 3 gene regulatory sequences in wt and p38 knock-out MEFs. In 
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particular, methylation levels of twelve CpG islands sites present in the 
5´untranslated region (UTR) of fibulin 3 gene (1210bp upstream of the ATG 
translation start site) were determined by pyrosequencing in wt and p38-/- cells 
(Fig. 37).  
 
 
Figure 37: Fibulin 3 regulatory sequences analyzed by pyrosequencing (red box). The sequences 
labeled in green correspond to the primers used to amplify the region; those labeled in blue 
correspond to the primers used for the PCRs in the pyrosequencing process; the twelve analyzed 
CpG islands are in red. 
 
Figure 38A shows the pyrosequencing diagram of the twelve CpG islands 
analyzed in the DNA from wt and p38-deficient MEFs. The average methylation 
percentage of 10 out of 12 CpG sites was higher in wt as compared to p38-/- 
MEFs (Fig. 38B). 
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Figure 38: p38 leads to hypermethylation of fibulin 3 gene regulatory sequences. Percentages of 
methylation of CpG sites from fibulin 3 gene regulatory sequences (5´UTR region) in wt and p38-/- 
MEFs. A) Representative pyrosequencing diagrams showing the methylation status of the 12 CpG 
sites. B) Graphic showing the percentages of methylation of the 12 analyzed CpG sites. 
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These results strongly indicate that p38 represses fibulin 3 expression 
through hypermethylation of 5´UTR regulatory sequences.  
 
2.3. DNMT3A protein levels are down-regulated in p38 MAPK knock-out MEFs 
DNA methylation results from the activity of DNA methyltransferases 
(DNMTs), leading to gene regulation (Denis et al. 2011). Among the different 
DNMTs present in mammals, DNMT3A/3B are thought to function as de novo 
DNA methyltransferases (Miremadi et al. 2007). Their levels can be regulated, 
being of relevance its post-transcriptional regulation (Denis et al. 2011). In 
particular, binding of HuR protein (an RNA-binding protein that stabilizes and/or 
modulates the translation of target mRNAs) to the 3´UTR of DNMT3B mRNA 
enhances its stability and increases its protein levels in colorectal RKO cells 
(Lopez, I et al. 2009). p38 MAPK can phosphorylate HuR, which enhances its 
binding to certain mRNAs such as p21mRNA, increasing its protein levels (Lafarga 
et al. 2009). This raised the possibility that p38 MAPK could be regulating 
DNMT3A/3B protein levels through a HuR-dependent mechanism. Thus, we 
initially analyzed DNMT3A protein levels in wt and p38-/- MEFs and we found a 
significant decrease in DNMT3A protein levels in p38-/- MEFs as compared to wt 
cells (Fig. 39).  
 
Figure 39: p38 positively regulates DNMT3A protein levels. wt and p38-/- MEFs were 
maintained in the absence of serum for 24h. DNMT3A protein levels were determined in cell 
extracts by western-blot analysis using -actin to normalize and p38 as a control of its expression 
in wt cells. 
 
These results indicate that p38 MAPK positively regulates DNMT3A 
protein levels. Thus, DNMT3A could lead to the p38-induced hypermethylation 
of fibulin 3 gene regulatory sequences detected by pyrosequencing. Therefore, it 
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is likely that DNMT3A might be a mediator of the p38α-induced 
hypermethylation of fibulin 3 regulatory sequences, although we cannot exclude 
the possibility of the participation of other DNA methyltransferases.  
 
2.4. Fibulin 3 knock-down promotes migration and invasion of MEFs  
p38 is a mediator of cell migration and invasion (Nebreda and Porras 
2000;Wagner and Nebreda 2009). Fibulin 3 is an extracellular matrix (ECM) 
protein that can regulate migration and invasion properties of distinct tumour 
cells, either promoting or inhibiting cell invasiveness depending on the tumour 
type (Hu et al. 2009;Kim et al. 2012a). Therefore, we next wondered whether 
p38, through down-regulation of Fibulin 3, could favour cell migration and 
invasion.  
To perform these studies, Fibulin 3 was permanently knocked-down in wt 
and p38-/- MEFs using a mouse Fibulin 3 shRNA. Different Fibulin 3 knock-down 
clones were generated, which showed a similar behaviour. As shown in figure 40, 
secreted Fibulin 3 protein levels were decreased in both, wt and p38-/- MEFs by 
this shRNA, but not by a control shRNA (data not shown).  
 
 
Figure 40: Fibulin 3 knock-down in wt and p38-/- MEFs. Western-blot analysis of Fibulin 3 protein 
levels secreted to the culture medium by MEFs (wt and p38-/-, with (shFib3) or without fibulin 3 
knock-down) maintained in the absence of serum for the last 24h. p38 was used as a control. 
Fibulin 3 quantification referred to total protein levels is shown. 
  
To study the migratory capacity of these cells, wound healing assays were 
carried out. As expected, a faster migration of wt MEFs as compared with p38-/- 
cells was observed. Fibulin 3 knock-down highly increased migration of p38-/- 
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MEFs up to the levels of wt cells, while no significant changes were observed in 
wt MEFs (Fig. 41). 
    
 
Figure 41: Fibulin 3 knock-down enhances migration of MEFs. Wound healing assay. MEFs (wt and 
p38-/-, with (shFib3) or without fibulin 3 knock-down) were pre-treated with mitomycin C for 30 
min in serum free medium and, then, a straight scratch was performed. Cells were maintained in 
the absence of serum and allowed to migrate. A) Representative images from phase contrast 
microscope at 0 and 12h. B) Histograms show the mean value ± S.E.M. of the percentage of wound 
closure at 8 and 12h. *p<0.05, **p<0.01, compared as indicated.  
 
Based on these results, the effect of Fibulin 3 knock-down in the invasive 
capacity of MEFs was also evaluated. Fibulin 3 knock-down promoted invasion 
through matrigel of p38α knock-out MEFs, so the number of invading cells was 
similar to the one found in wt MEFs (Fig. 42). Although wound healing assays did 
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not reveal any significant change in cell migration in wt MEFs upon fibulin 3 
knock-down, invasion through matrigel was increased (Fig. 42).  
 
 
Figure 42: Fibulin 3 knock-down enhances invasion of MEFs. MEFs (wt and p38-/-, with (shFib3) 
or without fibulin 3 knock-down) were seeded in the upper transwell chamber covered with 
matrigel in serum-free medium. Medium with FBS (10%), to act as a chemoattractant, or without 
FBS (0%) was placed in the lower chamber. Cells were allowed to pass through the matrigel for 24h. 
A) Representative images of invading cells after staining with crystal violet (phase contrast 
microscope). B) Histograms show the mean values ± S.E.M. of the number of invading cells (n=3). 
*p<0.05,**p<0.01, compared as indicated. 
 
Accordingly with other data from the literature, these results support a 
role for p38 as a mediator of cell migration and invasion. Moreover, Fibulin 3 
acts as an inhibitor of cell migration and invasion in MEFs as it happens in certain 
tumours, such as non-small lung carcinoma (Kim et al. 2012a). Additionally, we 
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have found that the p38 pro-migratory/invasive effect might be, at least in part, 
mediated by fibulin 3 down-regulation in MEFs. 
 
2.5. Mechanisms involved in the regulation of cell migration and invasion by 
Fibulin 3 in MEFs. Role of p38α/β.  
As MMPs are relevant for extracellular matrix degradation during cell 
migration/invasion (Bourboulia and Stetler-Stevenson 2010;Kessenbrock et al. 
2011), we evaluated whether the increased invasion observed in fibulin 3 knock-
down MEFs was due to changes in MMPs levels and/or in their activities. We did 
not find significant changes in the levels of MMP2, 7, 9, 10, 11 and 13 mRNAs that 
could explain invasion results (data not shown). Thus, we next evaluated MMP2 
and MMP9 activities. As observed in figure 43A and XB, MMP2 and 9 activities 
were lower in p38α-/- than in wt MEFs and MMP9 activity increased in p38α 
Knock-out MEFs upon fibulin 3 knock-down, which could be responsible for their 
enhanced invasion. However, MMP2/9 activities were decreased in fibulin 3 
knock-down wt MEFs (Fig. 43A and 43B), which did not correlate with its 
enhanced invasive capacity. Therefore, we determined the effect on cell invasion 
of a broad spectrum MMP inhibitor, marimastat. We found that it impaired 
invasion in all cell lines (Fig. 43C and 43D). This suggests that other MMPs, 
different from MMP2 and 9, could be responsible for the increased invasion of 
fibulin 3 knock-down wt MEFs. Overall, these results indicate that MMPs are 
involved in the fibulin 3 knock-down-induced cell invasion in MEFs.  
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Figure 43: Role of MMPs in Fibulin 3 knock-down induced invasion: MEFs (wt and p38-/-, with 
(shFib3) or without fibulin 3 knock-down) were maintained in absence of serum for 24h. A) and B) 
MMP2/9 activities analysis by zymography. FBS was used as a positive control. A) Representative 
zymogram. B) Histograms show the mean values ± S.E.M. of the densitometric analyses of 
gelatinase areas expressed as fold increase of the control value (n=6). *p<0.05, ***p<0.001, 
compared as indicated. C) and D) Effect of MMPs inhibition on invasion. The MMPs inhibitor, 
marimastat was added to the cells 24h prior to the invasion assay through matrigel. FBS (10%) was 
used as a chemoattractant. C) Representative images of invading cells after staining with crystal 
violet (phase contrast microscope). D) Histograms show the mean ± S.E.M. of the number of 
invading cells (n=3). *p<0.05,**p<0.01, compared as indicated.  
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We also evaluated the impact of fibulin 3 knock-down in some of the 
signaling pathways regulating cell migration and invasion such as p38 MAPKs, 
PI3K/Akt and ERKs. As shown in figure 44, an increase in P-ERKs and P-p38 MAPKs 
levels was induced by fibulin 3 knock-down, mainly in cells stimulated with 
serum. Moreover, upon fibulin 3 knock-down p38α MAPK phosphorylation was 
enhanced in wt MEFs, while in p38α-/- cells there was a strong increase in the 
phosphorylation of another p38 MAPK isoform (potentially, p38β) with a lower 
mobility (Fig. 44).    
 
 
Figure 44: Fibulin 3 knock-down up-regulates the levels of p38 phosphorylation. MEFs (wt and 
p38-/-, with (shFib3) or without fibulin 3 knock-down) were serum deprived for 24h and then, 
treated with 10% FBS for 10 min. Western-blot analysis of P-Akt, P-ERKs and P-p38 levels 
normalized with -actin. p38 was used as a control. P-p38/-actin ratio derived from the 
densitometric analysis is shown (arbitrary units). 
  
To determine the relevance of the hyper-activation of these p38 MAPKs, 
we evaluated the effect of the treatment with SB203580 on migration and 
invasion. As shown in figure 45, inhibition of p38α/β impaired migration of fibulin 
3 knock-down cells and wt MEFs.  
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Figure 45: Analysis of the function of p38/ in migration of fibulin 3 knock-down MEFs. Wound 
healing assay. Cells (wt and p38-/-, with (shFib3) or without fibulin 3 knock-down) were pre-
treated for 24h with 10 M SB203580 before performing the scratch. Then, cells were allowed to 
migrate in the absence of serum (with or without SB203580). A) Representative images from phase 
contrast microscope after 0 and 8h of migration. B) Histograms show the mean value ± S.E.M. of the 
percentage of wound closure at 8h. **p<0.01, *** p<0.001, compared as indicated.  
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According to these results, p38/ inhibitor also impaired cell invasion 
through matrigel of fibulin 3 knock-down cells and wt MEFs (Fig. 46). All these 
data indicate that the enhanced activation of p38α in wt and of p38β in p38α-/- 
cells induced by fibulin 3 knock-down is necessary for migration and invasion of 
these cells.  
  
 
 
Figure 46: Inhibition of p38/ impairs cell invasion. MEFs (wt and p38-/-, with (shFib3) or 
without fibulin 3 knock-down) were pretreated with 10 M SB203580 for 24h prior to the invasion 
assay through matrigel. FBS (10%) was used as a chemoattractant. A) Representative images of 
invading cells after staining with crystal violet (phase contrast microscope). B) Histograms show the 
mean values ± S.E.M. of the number of invading cells (n=3). *p<0.05,**p<0.01, compared as 
indicated. 
 
The observed effect of p38α/β inhibition with SB203580 on cell migration 
and invasion partially correlates with the decrease in MMP9 activity upon 
treatment with SB203580 (Fig. 47). Therefore, MMP9 would contribute to 
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mediate p38α/β actions on migration/migration in MEFs, including those where 
fibulin 3 was knocked-down. 
 
 
Figure 47: Effect of p38/ inhibition onMMP9 activity. MEFs (wt and p38-/-, with (shFib3) or 
without fibulin 3 knock-down) were maintained in absence of serum and in the absence or presence 
of 10 M SB203580 for 24h. FBS was used as a positive control. A) Representative zymogram. B) 
Histograms show the mean values ± S.E.M. of the densitometric analyses of gelatinase areas 
expressed as fold increase of the control value (n=6). *p<0.05, ** p<0.01, ***p<0.001, compared as 
indicated. 
 
2.6. Role of Fibulin 3 in cell transformation 
As fibulin 3 knock-down had an impact on the invasive capacity of MEFs, 
mainly in p38-/- cells, we further analyzed the behavior of fibulin 3 knock-down 
MEFs. They grew faster than wt and p38-/- MEFs (data not shown). In addition, 
anchorage-dependent growth assays revealed an enhanced foci formation upon 
fibulin 3 knock-down (in wt and p38-/- MEFs) (Fig. 48A and 48B). In contrast, 
Results
105 
 
foci size was only increased in p38 knock-out cells, mainly in those where fibulin 
3 has not been knocked-down (Fig. 48C).  
 
 
Figure 48: Fibulin 3 knock-down enhances focus formation. A) Representative images of anchorage 
dependent growth of MEFs (wt and p38-/-, with (shFib3) or without fibulin 3 knock-down) after 13 
days. B) and C) Number and size of foci, respectively. Histograms show the mean values ± S.E.M. of 
foci number (B) and the percentage of those with a size ≥60 pixels, respectively. **p<0.01, shFib3 
MEFs as compared with non-silenced cells; *p<0.05, compared as indicated. 
  
All this indicates that contact inhibition is lost in fibulin 3 knock-down 
cells. This suggests that these cells could have suffered a process of 
transformation as impaired contact inhibition is considered a hallmark of cell 
transformation (Hanahan and Weinberg 2000). To further characterize the 
potential role of fibulin 3 in cell transformation, we also determined the ability of 
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these cells to grow in soft-agar, which is in vitro assay to determine in vivo 
tumourigenesis. However, fibulin 3 knock-down MEFs were unable to grow in soft 
agar (data not shown). Accordingly, in vivo xenograft assays revealed that fibulin 
3 knock-down MEFs were unable to induce tumours in nude mice (Fig. 49).  
 
 
Figure 49: Fibulin 3 knock-down MEFs does not induce tumours in vivo. Xenograft assay. MEFs (wt 
and p38-/-, with (shFib3) or without fibulin 3 knock-down) (1.5x106 cells) were injected in both 
flanks of nude mice. Representative image of two mice 6 weeks after injection of the cells.  
 
Results shown here suggest that fibulin 3 knock-down is not sufficient to 
induce transformation, but it may collaborate with other genes to induce it. 
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3. C3G INHIBITS CELL MIGRATION AND INVASION THROUGH DOWN-
REGULATION OF p38α MAPK ACTIVITY  
As explained in the group background section, we have previously 
described a functional relationship between C3G and p38α MAPK in the 
regulation of apoptosis in CML and in MEFs (Gutierrez-Uzquiza et al. 2010;Maia et 
al. 2009) as well as in the regulation of cell adhesion in CML (Maia et al. 2013). 
Moreover, both p38α MAPK and C3G, play important roles in the regulation of 
cell adhesion (Guo and Yang 2006;Ohba et al. 2001;Pannekoek et al. 2009;Voss et 
al. 2003;Zuluaga et al. 2007b) and migration (Cuenda and Rousseau 2007;Dayma 
and Radha 2011;Ohba et al. 2001;Rufanova et al. 2009;Wagner and Nebreda 
2009). However, the function of C3G in cell migration and invasion has not been 
fully characterized. Based on all this, we hypothesized that C3G could act though 
p38 to control cell migration and invasion. We aim to study whether C3G and 
p38α MAPK can act in a common regulatory pathway to modulate cell migration 
and invasion in MEFs and if Rap-1 is a mediator of C3G.  
 
3.1. C3G knock-down promotes cell migration through p38 by a mechanism 
not mediated by Rap-1  
To study the cross-talk between C3G and p38α, MEFs (wt and p38-/-) 
with permanent C3G knock-down (Fig. 50) (Gutierrez-Uzquiza et al. 2010) were 
used.  
 
Figure 50: Decrease in C3G expression upon C3G silencing. MEFs (wt and p38-/-, with (shC3G) or 
without C3G knock-down) were maintained in the presence of serum and proteins were isolated. 
Western blot analysis of C3G and p38 levels normalized with -actin. 
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To determine whether C3G regulates cell migration through a mechanism 
dependent on p38α, wound healing assays were carried out. As shown in results 
section 2 (Fig. 41), wt cells migrate faster than p38-/- cells. C3G knock-down 
highly enhanced cell migration in wt cells, but not in p38-/- MEFs, which 
presented even a lower migration than p38-/- cells (Fig. 51). 
 
Figure 51: C3G knock-down enhances migration of MEFs expressing p38. Wound healing assay. 
MEFs (wt and p38-/-, with (shC3G) or without C3G knock-down were pre-treated with mitomycin 
C for 30 min in serum free medium. Then, a straight scratch was performed and cells were allowed 
to migrate in a serum free medium. A) Representative images from phase contrast microscope at 0 
and 8h of migration. B) Histograms show the mean value ± S.E.M. of the percentage of wound 
closure at 8h. *p<0.05, ***p<0.001, compared as indicated. 
 
According to other data from the literature (Ohba et al. 2001), C3G 
inhibits cell migration. Additionally, our data suggest that C3G regulates 
migration through a p38α dependent mechanism. To confirm this hypothesis, we 
evaluated the effect of the selective p38/ inhibitor, SB203580. As shown in 
figure 52, treatment with SB203580 decreased migration of wt cells, with or 
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without C3G knock-down, while it had not effect in p38-/- cells. These results 
confirm that C3G knock-down increases cell migration through the up-regulation 
of p38 activity in MEFs. 
 
 
Figure 52: C3G knock-down enhances cell migration through p38. Wound healing assay. MEFs (wt 
and p38-/-, with (shC3G) or without C3G knock-down) were pre-treated for 12h with 5M 
SB203580 before performing the scratch. Then, cells were pre-treated with mitomycin C for 30 min 
in serum free medium. Then, a straight scratch was performed and cells maintained in the absence 
of serum (with or without SB203580) were allowed to migrate. A) Representative images from 
phase contrast microscope after 0 and 8h of migration. B) Histograms show the mean value ± S.E.M. 
of the percentage of wound closure at 8h. *p<0.05, **p<0.01, compared as indicated. 
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Next, we wanted to know if C3G was acting through its main target, Rap-
1. Thus, we used MEFs with permanent expression of a dominant negative Rap-1 
(DNRap-1) construct (Gutierrez-Uzquiza et al. 2010) to perform migration assays. 
As shown in figure 53, the effect of DNRap-1 expression and C3G knock-down on 
cell migration was opposite. While C3G knock-down increased migration of wt 
MEFs, the expression of the DNRap-1 impaired this process. Moreover, in p38-/- 
cells, C3G knock-down slightly decreased cell migration, whereas the expression 
of a Rap-1 dominant negative induced a small increase in cell migration.  
 
 
Figure 53: Rap-1 does not mediate C3G effects on cell migration. Wound healing assay. MEFs (wt 
and p38-/-, with (shC3G) or without C3G knock-down, or expressing a dominant negative Rap-1 
mutant (DNRap-1)) were pre-treated with mitomycin C for 30 min in serum free medium. Then, a 
straight scratch was performed and cells were allowed to migrate in serum free medium. A) 
Representative images from phase contrast microscope at 0 and 8h of migration. B) Histograms 
show the mean value ± S.E.M. of the percentage of wound closure at 8h. +++ p<0.001 versus wt, 
**p<0.01, ***p<0.001, compared as indicated. 
 
Therefore, all these data are in favour of a model where C3G would 
inhibit cell migration through the negative regulation of p38α activation, while 
Rap-1 would play an opposite role.  
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3.2. C3G knock-down increases cell invasion through p38 by a mechanism not 
mediated by Rap-1  
We next examined the invasiveness of these cells. According to the 
results derived from the migration assays, the effect of C3G knock-down and 
DNRap-1 expression on cell invasion was opposite in wt MEFs. While C3G knock-
down enhanced invasion through matrigel, the expression of the DNRap-1 
impaired this process. In p38-/- MEFs invasion through matrigel was very low as 
compared to wt cells, and there was no additional effect of C3G knock-down, or 
even a reduction upon DNRap-1 expression (Fig. 54).  
 
Figure 54: C3G knock-down enhances invasion of MEFs expressing p38	while the expression of a 
DNRap-1 impaired cell invasion. MEFs (wt and p38-/-, with (shC3G) or without C3G knock-down, 
or expressing a dominant negative Rap-1 mutant (DNRap-1)) were seeded in the upper transwell 
chamber covered with matrigel in serum-free medium. Medium with 10% FBS (10%), to act as a 
chemoattractant, or without FBS (0%), was placed in the lower chamber. Cells were allowed to pass 
through matrigel for 24h. A) Representative images of invading cells after staining with crystal violet 
(phase contrast microscope). B) Histograms show the mean value ± S.E.M. of the number of 
invading cells (n=3). +++ p<0.001, ++ p<0.01 versus wt; ***p<0.001, *p<0.05, compared as 
indicated. 
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These results suggest that C3G would inhibit cell invasion through the 
negative regulation of p38α activation, while Rap-1 would promote this process 
through a mechanism independent of C3G GEF-activity.  
 
3.3. Role of MMP2 and MMP9 as mediators of C3G/p38 effects on cell 
invasion  
In order to further understand the role of C3G/p38 pathway in cell 
invasion and the potential implication of MMPs, the effect of C3G knock-down on 
MMP2 and 9 activities was determined in wt and p38-/- MEFs (Fig. 55). As 
previously shown, MMP2/9 activities were lower in p38-/- than in wt MEFs (Fig. 
43A and 43B). Consistent with the enhanced invasive capacity, in C3G knock-
down MEFs, MMP2 and MMP9 activities increased as compared to wt cells, while 
they decreased in p38α-/- MEFs. The expression of the DNRap-1 significantly 
reduced MMP2/9 activities in wt MEFs, which is in agreement with the lower 
invasion observed in these cells. However, the expression of the DNRap-1 in 
p38α-/- cells increased MMP9 activity.  
Therefore, all these results indicate that MMP2/9 activities are up-
regulated by p38α, mainly that of MMP9. In contrast, C3G through down-
regulation of p38α activity would decrease MMP2/9 activities, which correlates 
with its effect on cell invasion in wt MEFs. Curiously, C3G, in the absence of p38α, 
would be a positive regulator of MMP2 activity. In contrast, Rap-1 would be a 
negative regulator of MMP9 in p38α-/- MEFs. Thus, although the role of Rap-1 in 
the control of MMP2/9 activities is more complex, it is different from that of C3G, 
which indicate that Rap-1 is not the mediator of C3G actions on cell invasion. 
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Figure 55: C3G knock-down increases MMP2/9 activities through a mechanism dependent on 
p38 MAPK. MEFs (wt and p38-/-, with (shC3G) or without C3G knock-down, or expressing a 
dominant negative Rap-1 mutant (DNRap-1)) were maintained in absence of serum for 24h. Then, 
the conditioned media from the cells was used to perform zymographic analyses of MMP2/9 
activities. FBS was used as a positive control. A) Representative zymogram. B) Histograms show the 
mean values ± S.E.M. of the densitometric analyses of gelatinase areas expressed as fold increase of 
the control value (n=4). +++ p<0.001, ++ p<0.01, +p<0.05, versus wt; **p<0.01, compared as 
indicated. 
 
More studies will be necessary to fully characterize the precise 
mechanism by which C3G/p38 cascade is regulating cell migration and invasion.  
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1. p38 MAPK MEDIATES CELL SURVIVAL IN RESPONSE TO OXIDATIVE 
STRESS VIA INDUCTION OF ANTIOXIDANT GENES IN MEFs 
 
It is well established that ROS play important biological roles in cell 
homeostasis, but several studies have also reported that high intracellular ROS 
levels are usually associated with apoptosis (Dolado et al. 2007; Wang and Yi 
2008). 
Concerning the function of p38α in response to oxidative stress, there are 
data in favour of both, a pro-survival and a pro-apoptotic function that might 
depend on the stimuli, dose, cell type and other factors. Sustained activation of 
p38α by ROS has been implicated in apoptosis induction (Dolado et al. 2007; 
Tobiume et al. 2001; Wada and Penninger 2004). According to this, it has been 
demonstrated that oncogenic H-Ras-induced ROS activate p38α, leading to 
apoptosis, which contributes to inhibition of tumour initiation (Dolado et al. 
2007). In contrast, we have recently found a pro-survival effect of p38 in 
response to H2O2 in MEFs (Gutierrez-Uzquiza et al. 2010), which agrees with some 
data from other groups (Cai et al. 2011; Kurata 2000; Zhang et al. 2005). As the 
precise mechanism by which p38α MAPK protected cells from oxidative stress 
was poorly understood, we have further evaluated it.  
Here, we reveal a pro-survival function of p38, which is dependent on 
the regulation of the antioxidant response. In addition, we have found that 
although this response is associated with reduced Akt activity and enhanced 
mTOR/p70S6K signaling, these cascades are not immediately responsible for the 
p38-mediated survival effect, but instead, their modulation is a consequence of 
the ROS content in the cells.  
In agreement with the proposed role for p38 as a positive regulator of 
antioxidant enzymes expression, it was previously reported that p38 MAPK 
increased the basal expression and activation of SOD-2 (Qadri et al. 2004) and up-
regulated catalase (Aggeli et al. 2006; Sen et al. 2005) and heme oxygenase-1 
(Aggeli et al. 2006) mRNAs in response to H2O2. We have now characterized the 
precise role of p38 in the regulation of the expression and activity of different 
antioxidant enzymes, as well as the mechanisms involved. Our data reveal a novel 
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function for p38 controlling (i) H2O2-induced SOD-2 expression through direct 
regulation of transcription via ATF-2 activation and (ii) basal and H2O2-induced 
catalase expression through regulation of mRNA expression and/or stability and 
protein stability. Thus, p38α may negatively regulate ROS accumulation at 
different levels. In agreement with these results, we have more recently found 
that HGF acts through p38α MAPK to up-regulate SOD-2 and catalase expression 
and activity in cardiomyocytes (Arechederra et al. 2013). Other reports also 
indicates that p38 MAPK signaling negatively regulates ROS accumulation in 
cancer cells, but through the up-regulation of GPX5 and TXNDC2 genes, which 
encode a glutathione peroxidase and a thioredoxin, respectively (Pereira et al. 
2013). However, they found no evidence for the regulation of SOD-2 and catalase 
by p38 in their cells. This suggests that p38α signaling can probably regulate ROS 
accumulation by different mechanisms in different cell types.  
It is worth highlighting that we describe, for the first time, a p38-ATF-2 
dependent transcriptional regulation of SOD-2 in response to H2O2. Previously, it 
had been shown that low levels of H2O2 induced ATF-2 expression (Kurata 2000) 
or activation through p38 MAPK (Frippiat et al. 2002), leading to growth arrest. 
A role for JNKs/ATF-2 and p38 MAPK in the regulation of heme oxygenase-1 in 
response to oxidative stress was also demonstrated (Aggeli et al. 2006). However, 
we now show that the p38 MAPK/ATF-2 cascade also mediates SOD-2 up-
regulation and cell survival in response to low levels of oxidative stress.  
Regarding the regulation of mTORC1/p70S6K by H2O2, there are also 
conflicting data in the literature. In contrast to our results, demonstrating that 
mTORC1/p70S6K cascade is not responsible for the p38-mediated survival effect 
in response to H2O2, there are a number of data in the literature proposing that 
p38 MAPK activation and/or mTORC1 inhibition are required for H2O2-induced 
cell death in different cell types (Cao et al. 2008; Chen et al. 2010; Matsuzawa 
and Ichijo 2008; Tobiume et al. 2001). For example, some data indicate that 
mTORC1 can be inhibited by H2O2 treatment through different mechanisms such 
as up-regulation of REDD1 (Jin et al. 2009a) or inhibition of PDK1 and Akt, 
accompanied by AMPK activation (Chen et al. 2010). In addition, AMPK through 
p38-dependent and -independent mechanisms can decrease mTORC1 activation 
by H2O2 (Cao et al. 2008), mediating cell death (Cao et al. 2008; Chen et al. 2010). 
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However, our results indicate that p38 do not act as a negative regulator of 
mTORC1/p70S6K. This would be in agreement with previous data demonstrating 
a pro-survival role for p38 and a p38-dependent activation of mTORC1/p70S6K 
signaling in response to different types of stresses (Cully et al. 2010; Schewe and 
Aguirre-Ghiso 2008). Hence, consistent with Cully´s results (Cully et al. 2010), we 
also found that in cells treated with H2O2 at a low dose, mTORC1 activation is 
dependent on p38. We additionally found that p38 regulates mTORC1/p70S6K 
in an indirect way, which is dependent on ROS accumulation. So, in cells lacking 
p38, a high accumulation of ROS is produced, which leads to cell death and 
inactivation of the mTORC1/p70S6K pathway. However, in the presence of either 
catalase or N-acetyl-cysteine, which protects from a high ROS accumulation, 
mTORC1/p70S6K can be activated in p38 deficient cells treated with H2O2. 
Moreover, although we did not measure this process, autophagic cell death could 
contribute to the loss of cells observed in p38-deficient cells treated with H2O2, 
since autophagy is inhibited by mTOR (Noda and Ohsumi 1998;Ravikumar et al. 
2004). Nevertheless, the enhanced mTORC1/p70S6K signaling due to p38 
activation appears to favour cell size maintenance during stress (data not shown), 
a function recently identified in D. melanogaster cells (Cully et al. 2010). 
Based on our results, it is unclear whether Akt has any potential role in 
the response to H2O2 mediated by p38 in MEFs. The expression of SOD and 
catalase is higher in wt than in p38-/- cells under basal conditions, when Akt 
activation is quite similar in both cell lines. Upon H2O2 treatment, Akt activation is 
higher in p38α-/- cells and antioxidant enzymes are down-regulated, however, 
the Akt inhibitor does not affect survival. Hence, these findings do not support 
that Akt antagonizes the anti-oxidant response in these cells, as found in other 
systems (Nogueira et al. 2008).  
We conclude that p38 has a pro-survival function due to its ability to up-
regulate antioxidant genes expression, preventing from a high accumulation of 
ROS upon exposure to low or moderate doses of H2O2 (Fig. 56). In this way, in the 
presence of p38α, cell damage can be overcome, allowing cell survival and 
mTORC1/p70S6K pathway activation. In contrast, in the absence of p38, the 
antioxidant defense is not properly activated, leading to ROS accumulation and 
high cell damage. As a consequence, the mTORC1/p70S6K pathway is inactivated, 
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which might avoid protein synthesis and cell growth of damaged cells. In 
agreement with other studies (Jin et al. 2009b), we also found that 
mTORC1/p70S6K activation is dependent on p38 activation in an oxidative 
microenvironment. We believe this could be critical for other cellular responses 
such as autophagy that can also control cell size and to maintain cellular 
homeostasis and function.  
 
 
Figure 56: Proposed model showing the effect of p38α MAPK in response to oxidative stress. The 
up-regulation of antioxidant enzymes, SOD-1, SOD-2 and catalase, by p38α MAPK in response to 
H2O2 through different mechanisms, leads to the removal of ROS. As a consequence, ROS levels 
decrease, which allows cell survival and mTORC1/p70S6K activation.  
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2. p38 MAPK DOWN-REGULATES FIBULIN 3 EXPRESSION THROUGH 
HYPERMETHYLATION OF GENE REGULATORY SEQUENCES 
PROMOTING MIGRATION AND INVASION 
 
p38 can play a dual role in cancer acting either as a tumour suppressor 
or promoter depending on the type of cancer and the tumour stage (Wagner and 
Nebreda 2009). In some tumours, p38α inhibits tumour initiation (Dolado et al. 
2007), but at later stages, it can promote survival (Aguirre-Ghiso 2007; Schewe 
and Aguirre-Ghiso 2008), migration and invasion leading to metastasis (del Barco 
Barrantes and Nebreda 2012; Wagner and Nebreda 2009). Moreover, p38 also 
promotes migration in non-tumour cells (Rousseau et al. 2006), which might be 
relevant for different physio-pathological process such the migration processes 
occurring during embryonic development or tissue regeneration.  
The function of p38 and p38 in cancer has not been well characterized, 
although it has been recently shown that they can play a role. Using MEFs lacking 
p38 or p38, it was demonstrated that both isoforms inhibit cell migration and 
MMP2 secretion. In addition, in K-Ras-transformed MEFs, p38 suppresses 
tumour growth in vitro and in vivo (Cerezo-Guisado et al. 2011). In contrast, 
recent data also suggest that p38 and p38 might promote tumour 
development. p38 promotes the malignant phenotype of squamous cell 
carcinoma (Junttila et al. 2007) and p38γ is involved in Ras-increased invasion of 
breast cancer cells (Qi et al. 2006). 
Our data uncover Fibulin 3 as a new target of p38 MAPK, which 
participates in the regulation of migration and invasion in MEFs. p38, p38 and 
p38 regulate fibulin 3 expression. However, the effect of p38 is more 
significant, so, we have characterized it. We described for the first time that p38 
down-regulates fibulin 3 expression through hyper-methylation of fibulin 3 gene 
regulatory sequences. Moreover, p38 might do so through modulation of 
DNMT3A protein levels, as they are highly decreased when p38 is not present. 
This might be a consequence of a p38-mediated post-transcriptional regulation 
of DNMT3A. As previously mentioned, it is known that DNMT3B mRNA, highly 
homologous to DNMT3A mRNA, is stabilized by the binding of HuR protein to its 
3´UTR (Lopez de Silanes et al. 2009). Therefore, it can be hypothesized that 
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DNMT3A mRNA could be regulated in a similar way. Moreover, it is likely that 
p38 might stabilize it through HuR phosphorylation, as it happens with p21 
mRNA (Lafarga et al. 2009). In that case, p38 MAPK phosphorylates HuR, leading 
to cytoplasmic accumulation of HuR and enhancement of its binding to the 3´UTR 
of the mRNA. In agreement with this hypothesis, p38 MAPK mediated 
cytoplasmic accumulation of HuR stabilizes survival motor neuron mRNA (Farooq 
et al. 2009). Similarly, but involving the participation of additional proteins, p38 
MAPK via MK2 regulates the stability of other mRNAs such as TNF mRNA through 
regulation of HuR and tristetraprolin (TTP) (Tiedje et al. 2012). MK2 
phosphorylates TTP, decreasing its affinity to the AU-rich element and its ability 
to replace HuR, which allows HuR-mediated initiation of TNF mRNA translation. 
Hyperphosphorylation of TTP via p38 MAPK is also involved in the up-regulation 
of IL-8 and VEGF in malignant gliomas (Suswam et al. 2008).  
It is important to highlight the relevance of fibulin 3 gene silencing 
induced by the hypermethylation of its regulatory sequences in cancer (Kim et al. 
2012a; Tong et al. 2011). This down-regulation of fibulin 3 is associated with poor 
prognosis in some tumours, such as non-small cell lung cancinoma (Kim et al. 
2012a; Kim et al. 2014). However, the mechanisms controlling fibulin 3 gene 
hypermethylation remain unknown. Therefore, the finding of p38 MAPK as a 
novel regulator of this process opens new possibilities to fully characterize how 
fibulin 3 expression is controlled under physiological conditions and in cancer. 
Our findings also show that Fibulin 3 inhibits cell migration and invasion 
in MEFs. Data from the literature describe opposite effects of Fibulin 3 in the 
control of these processes in cancer models, which might depend on the type of 
tumour and/or its context (Obaya et al. 2012). For example, in glioma and 
pancreatic adenocarcinoma, Fibulin 3 is overexpressed, promoting migration and 
invasion (Camaj et al. 2009; Hu et al. 2009). In contrast, Fibulin 3 is a negative 
regulator of invasiveness in non-small cell lung cancer (Kim et al. 2012a) or in 
nasopharyngeal carcinomas (Hwang et al. 2010). 
It is interesting the finding of Fibulin 3 as a target of p38α in MEFs and its 
role inhibiting cell migration and invasion. As they are embryonic mesenchymal 
cells, it is likely that p38α-mediated regulation of Fibulin 3 might play a role 
during development. Moreover, it would be of great interest to know whether 
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this p38α/Fibulin 3 cascade might play a similar role in cancer cells with 
mesenchymal characteristics, acquired after an EMT process. 
During cell migration and invasion, MMPs are relevant for extracellular 
matrix degradation (Kessenbrock et al. 2011).  In agreement with data from the 
literature showing that p38 MAPK is a positive regulator of MMPs (Hou et al. 
2009; Kessenbrock et al. 2011; Loesch et al. 2010; Ren et al. 2013; Xu et al. 2006), 
we have found that MMP2/9 activities were lower in p38α-/- cells than in wt 
MEFs. Furthermore, the enhanced invasion induced by fibulin 3 knock-down in 
p38α-/-cells correlates with an increase in MMP2/9 activities. However, in the 
presence of p38α, MMP2/9 activities do not explain the higher invasiveness.  The 
fact that inhibition of MMPs with a broad spectrum MMP inhibitor (marimastat) 
blocks invasion, suggests that other MMPs might be also involved, although other 
proteases might also play a role.   
Curiously, Fibulin 3 also regulates p38α and/or p38β activity. Fibulin 3 
down-regulates p38α activation and most likely that of p38β, which would limit 
migration and invasion. So, fibulin 3 knock-down enhances p38α activation in wt 
cells and potentially, p38β in p38α-/- MEFs and this activation of p38α/β is 
required for migration and invasion as demonstrated by the effects of SB203580 
(10 μM) abolishing these processes. 
Finally, fibulin 3 knock-down not only increases the migratory and 
invasive capacity of MEFs, but it also contributes to deregulation of contact 
inhibition and foci formation in anchorage-dependent growth assays. However, 
results from soft agar (data not shown) and xenograft assays showed that these 
cells are not tumourigenic. This suggests that fibulin 3 knock-down is not 
sufficient to induce cell transformation. However, fibulin 3 might collaborate with 
other genes to induce cell transformation as it happens in lung carcinoma (Kim et 
al. 2012a;Kim et al. 2014).   
In summary (Fig. 57), working with MEFs, we have described for the first 
time that p38α down-regulates fibulin 3 expression through hypermethylation of 
regulatory sequences of the gene. p38α might do so through the up-regulation of 
DNMT3A. Moreover, Fibulin 3 acts as a negative regulator of cell migration and 
invasion, through mechanisms involving inhibition of MMPs and p38α/β MAPKs.  
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Figure 57: p38 MAPK down-regulates fibulin 3 expression regulating cell migration and invasion in 
MEFs. Model showing that p38α, γ and δ decrease fibulin 3 transcription, leading to low levels of 
secreted fibulin 3. p38α-mediated DNMT3A up-regulation might be responsible for 
hypermethylation of regulatory sequences of fibulin 3 gene and its silencing. Fibulin 3 negatively 
regulates migration and invasion through p38α/β inhibition. 
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3. C3G INHIBITS CELL MIGRATION AND INVASION THROUGH DOWN-
REGULATION OF p38α MAPK ACTIVITY 
 
Our group has previously described, using different cell models deficient 
in p38α and/or with C3G knock-down, a new functional relationship between C3G 
and p38α MAPK in the regulation of apoptosis, where C3G down-regulates p38α 
MAPK activity (Gutierrez-Uzquiza et al. 2010;Maia et al. 2009). However, 
depending on the cell type, Rap-1 is a mediator of C3G (Maia et al. 2009) or plays 
an opposite role (Gutiérrez-Uzquiza et al., 2010). Moreover, both proteins 
participate in the same signaling pathway regulating cell adhesion in CML (Maia 
et al. 2013). In the present work, we have explored whether C3G and p38α could 
also act in a common pathway regulating cell migration and invasion.  
We have found, in agreement with previous data from the literature, that 
p38α MAPK plays a role in different aspects of cell migration and invasion (del 
Barco Barrantes and Nebreda 2012; Rousseau et al. 2006; Wagner and Nebreda 
2009). However, although it is clear that C3G plays a relevant role in cell 
migration, its precise function has not been yet well characterized. Thus, whereas 
C3G deficiency in MEFs enhances migration (Ohba et al. 2001), its overexpression 
results in opposite outcomes in different cell types: increased migration in 
glomerulonephritis (Rufanova et al. 2009) and decreased migration in highly 
invasive breast carcinoma cells (Dayma and Radha 2011).  
The present work shows that C3G inhibits cell migration and invasion in 
MEFs, so that C3G silencing promotes these processes. This agrees with the 
increased migration observed in C3G-/- MEFs (Ohba et al. 2001) and with the 
reduced migration of highly invasive breast carcinoma cells upon C3G 
overexpression (Dayma and Radha 2011). However, there are other studies 
showing an opposite role for C3G in the regulation of cell migration. C3G is 
required for a correct migration of cortical (Voss et al. 2008) and sympathetic 
preganglionic neurons (Voss et al. 2008;Yip et al. 2012). Similarly, C3G-Rap1 
activation also promotes migration in MCF-7 cells in response to IGF-1 (Guvakova 
et al. 2014). Therefore, all these data indicate that C3G can play opposite 
functions in the control of cell motility, which might be dependent on the cell 
type, stimulus and/or other factors.   
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Our data show that C3G controls migration and invasion through the 
regulation of p38 MAPK activity. Thus, C3G knock-down was only capable to 
enhance migration/invasion in cells expressing p38. Therefore, the previously 
identified C3G/p38 cascade not only regulates cell death (Gutierrez-Uzquiza et 
al. 2010; Maia et al. 2009), but also cell migration and invasion.  
On the other hand, we have found that C3G and Rap-1 exert opposite 
effects on cell migration/invasion in MEFs. Thus, contrary to C3G knock-down, 
the expression of a Rap-1 dominant negative impaired cell migration in wt MEFs, 
while a slightly faster wound closure was observed in p38α-/- cells.  Therefore, 
Rap-1 would not be the mediator of C3G actions on these processes. This is in 
agreement with our previous results on cell death showing that C3G acting 
through p38, but through a Rap-1 independent mechanism regulated cell death 
in MEFs (Gutierrez-Uzquiza et al. 2010). In contrast, in K562, Rap1 is a component 
of the C3G/p38 cascade controlling cell death in CML cells (Maia et al. 2009).  
There are different potential reasons that can explain why Rap-1 does not 
always mediate the effect of C3G. On one side, C3G effects are not always 
dependent on its GEF activity (Guerrero et al. 1998; Guerrero et al. 2004; 
Gutierrez-Uzquiza et al. 2010; Martin-Encabo et al. 2007; Shivakrupa et al. 2003), 
but on protein-protein interactions. In addition, there are several Rap-1 GEFs, 
different from C3G, able to activate Rap-1 (Hattori and Minato 2003; Pannekoek 
et al. 2009; Schultess et al. 2005; Stork and Dillon 2005). Hence, depending on the 
cell type and the stimulus, specific GEFs are activated leading to Rap-1 activation. 
This might explain the different roles played by these two proteins in some 
contexts.  
Our findings suggest that Rap-1 in wt MEFs promotes cell migration and 
invasion through p38α activation. Although these results should be further 
confirmed by additional experiments, Rap-1 is known to activate p38 in MEFs in 
response to different stresses (Gutierrez-Uzquiza et al. 2010), so it is likely that it 
could do so in the context of migration. There are data in the literature 
supporting our hypothesis. On one hand, Rap-1 contributes to cell migration and 
invasion in a number of cells. For example, Rap-1 regulates the migration, 
invasiveness and in vivo dissemination of B-cell lymphomas (Lin et al. 2010), 
invasion of renal carcinoma cells (Kim et al. 2012b), migration of breast cancer 
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cells (McSherry et al. 2011) and promotes cell movement of MCF-7 cells in 
response to IGF-1 (Guvakova et al. 2014). According to this, optimal cell migration 
has been associated with cycles of Rap-1 activation (Takahashi et al. 2013). On 
the other hand, although Rap-1 can regulate p38 MAPK, there are contradictory 
results about it. While Rap-1 has an inhibitory effect on p38 MAPK activation 
upon IL-1 stimulation (Palsson et al. 2000; McDermott and O’Neill 2002), it is a 
positive regulator of p38α activity in response to oxidative and osmotic stress in 
MEFs (Gutierrez-Uzquiza et al. 2010) or to FGF-2 in endothelial cells (Yan et al. 
2008). However, it acts in parallel to p38 MAPK to induce chemotaxis in 
monocytes in response to LPS (lipopolysaccharide) (Yi et al. 2012).  
Several studies show a direct correlation between MMP2 and/or MMP9 
level and/or activity and an increase in cell motility and invasiveness 
(Kessenbrock et al. 2011). We have shown in results section 2 that p38α is a 
positive regulator of MMP2/9 activities, which agrees with several studies (Hou et 
al. 2009; Kessenbrock et al. 2011; Loesch et al. 2010; Ren et al. 2013; Xu et al. 
2006).  Our results also suggest that C3G acting through p38α regulates MMP2/9 
activities, which correlates with its effect on cell migration and invasion in wt 
MEFs. In contrast, the role of Rap-1 in the control of MMP2/9 activities is 
different from that of C3G, which indicate that Rap-1 is not the mediator of C3G 
actions on cell invasion. Moreover, our results suggest that Rap-1 in the presence 
of p38α increases MMP2/9 activation, which agrees with other data showing that 
Rap-1 promotes invasion via induction of MMP9 secretion in head and neck 
squamous cell carcinoma (Mitra et al. 2008). In contrast, in p38α-/- MEFs, Rap-1 
inhibits MMP9 activation, suggesting that the role of Rap-1 in the regulation of 
MMP2/9 activities is more complex.  
In summary (Fig. 58), results presented here indicate that C3G would be a 
suppressor of migration and invasion through its inhibitory effects on p38α MAPK 
activity in a Rap-1-independent pathway. 
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Figure 58: Model showing the regulation of p38α by C3G and Rap-1 in MEFs and their effects on 
cell migration and invasion. C3G through the negative regulation of p38α MAPK inhibits cell 
migration, invasion and MMP2/9 activation in a Rap-1 independent mechanism. In contrast, 
activation of Rap-1 by other GEFs would lead to p38α activation promoting these processes.  
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GENERAL DISCUSSION 
 
In the present study we have revealed a pro-survival role for p38 MAPK, 
in response to a level of oxidative stress able to generate damage, but not 
massive toxicity, which is dependent on the enhancement of the antioxidant 
response. This result is in agreement with other data from the literature, which 
proposed a role for p38α as a positive regulator of SOD-2 (Qadri et al. 2004), 
catalase (Sen et al. 2005) and heme-oxigenase-1 (Aggeli et al. 2006). However, we 
describe here, for the first time, a p38α-ATF-2 dependent transcriptional 
regulation of SOD-2 in response to H2O2. In addition, although this p38 
mediated response is associated with an enhanced mTORC1/p70S6K signaling, 
this cascade is not immediately responsible for the p38-mediated survival 
effect, but instead, their modulation is a consequence of the cellular ROS content.  
In the second part of our study, a new target of p38, Fibulin 3, has been 
identified. It is described for the first time that p38 down-regulates fibulin 3 
expression through hyper-methylation of fibulin 3 gene regulatory sequences in 
MEFs, which favours migration and invasion. Fibulin 3 acts as a negative regulator 
of cell migration and invasion, through mechanisms involving a p38α/β negative 
feedback loop. In some tumours, fibulin 3 is also down-regulated through 
promoter methylation (Kim et al. 2012a; Tong et al. 2011), although it can play a 
dual role in the control of  migration/invasion and tumour growth (Obaya et al. 
2012).  Therefore, our findings open new possibilities in order to understand how 
fibulin 3 expression can be controlled in cancer. 
Finally, the present work shows that C3G inhibits cell migration and 
invasion in MEFs. This agrees with the increased migration observed in C3G-/- 
MEFs (Ohba et al. 2001) and with the reduced migration of breast carcinoma cells 
upon C3G overexpression (Dayma and Radha 2011). However, we described here 
that C3G controls migration and invasion through the regulation of p38α MAPK 
activity. Therefore, the previously identified C3G/p38 cascade not only regulates 
cell death (Gutierrez-Uzquiza et al. 2010; Maia et al. 2009), but also cell migration 
and invasion. Moreover, we have found that C3G and Rap-1 exert opposite 
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effects on cell migration/invasion in MEFs, suggesting that C3G would be a 
suppressor of migration and invasion through its inhibitory effects on p38α MAPK 
activity via a Rap-1-independent pathway. 
Therefore, we have identified new mediators and regulators of p38α 
MAPK actions on cell survival, migration and invasion in MEFs. Moreover, our 
studies uncover a new function of p38 as a regulator of DNA methylation, which 
might have a wide impact, as other genes might be controlled in this way (Fig.59). 
Therefore, all these results open new perspectives for future studies in tumour 
cells in order to establish the potential relevance of these pathways during 
tumour progression and to find new targets for novel cancer therapies.   
 
 
Figure 59: Model showing new mediators and regulators of p38α actions on cell survival, 
migration and invasión in MEFs: (i) p38α through the up-regulation of antioxidant enzymes (SOD-1, 
SOD-2 and catalase) promotes cell survival in response to oxidative stress (ii) p38 MAPK down-
regulates fibulin 3 expression regulating cell migration and invasion in MEFs and (iii) C3G through 
the negative regulation of p38α MAPK inhibits cell migration, invasion and MMP2/9 activation in a 
Rap-1 independent mechanism 
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1. p38α MAPK plays a pro-survival role in MEFs exposed to low or moderate 
doses of H2O2 , preventing from a high accumulation of ROS .   
2. p38 mediates H2O2-induced SOD-2 expression through a direct regulation of 
transcription mediated by ATF-2.  
3. p3 positively regulatesH2O2-induced catalase expression through 
regulation of protein stability and mRNA expression and/or stabilization. 
4. p38-dependent antioxidant response allows wt cells to maintain an efficient 
activation of the mTORC1/p70S6K pathway. However, this activation is not 
responsible for survival in this context.  
5. Fibulin 3 is a new target of p38 MAPKs. p38α, p38γ and p38δ are all capable 
to down-regulate fibulin 3 expression, although p38α elicits the strongest 
effect. 
6. p38α down-regulates fibulin 3 expression through hypermethylation of 
regulatory sequences of the gene. 
7.  p38 up-regulates DNMT3A protein levels.  
8. p38-induced Fibulin 3 down-regulation contributes to p38α pro-
migratory/invasive effect. 
9. Fibulin 3 knock-down is not sufficient to induce cell transformation, but it 
might do it in collaboration with other genes.  
10. C3G acts through p38α MAPK in a common regulatory pathway to regulate 
cell migration and invasion of MEFs. Thus, C3G through down-regulation of 
p38α activity would inhibit these processes. 
11. Rap-1 is not a mediator of C3G inhibitory effects on MEFs migration/invasion. 
In contrast, it plays an opposite role. 
12. p38 up-regulates MMP2/9 activities, while C3G down-regulates them 
through its effect on p38.  
 
 
Conclusions 
136 
 
 
 
 
 
 
CONCLUDING REMARKS 
p38α MAPK plays a pro-survival role in response to a level of oxidative 
stress able to generate damage, but not massive toxicity. This involves the up-
regulation of the antioxidant defenses. Additionally, p38α promotes cell 
migration and invasion through mechanisms involving fibulin 3 down-regulation 
through hypermethylation of regulatory sequences. On the other hand, C3G 
limits cell migration/invasion through the negative regulation of p38α activity.  
Moving to a tumour model, these pathways would contribute to the 
control of tumour progression and they might represent potential targets for 
novel cancer therapies.   
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NEW MEDIATORS OF p38ALPHA MAPK ACTIONS ON CELL SURVIVAL 
AND MIGRATION/INVASION. CROSS-TALK WITH C3G 
INTRODUCTION 
p38 MAPKs (p38, p38, p38 and p38) are activated by several 
stimuli, leading to the regulation of different cellular functions (Nebreda 
and Porras 2000;Wagner and Nebreda 2009). p38 MAPK is ubiquitously 
expressed and is the most abundant isoform (Cuenda and Rousseau 2007). 
p38 MAPKs play an important role in the coordination of cellular responses 
to ROS (reactive oxygen species) (Dolado et al. 2007;Tobiume et al. 2001). 
Hence, although p38α MAPK can induce apoptosis in response to oxidative 
stress (Bragado et al. 2007;Dolado et al. 2007), it has been recently 
revealed that it can also promote cell survival (Gutierrez-Uzquiza et al. 
2010;Thornton and Rincon 2009). Moreover, p38 MAPKs regulate cell 
migration, invasion and metastasis at different levels (del Barco Barrantes 
and Nebreda 2012). 
C3G is a Crk-binding protein with guanine nucleotide exchange 
(GEF) activity against two proteins of the Ras family: Rap1 and R-Ras. It also 
regulates different cellular functions such as apoptosis, adhesion and 
migration (Radha et al. 2011) . Recently, our team in collaboration with Dr. 
Guerrero´s group has identified a new functional interaction between C3G 
and p38α MAPK involved in the regulation of cell death (Gutierrez-Uzquiza 
et al. 2010;Maia et al. 2009) and cell adhesion (Maia et al. 2013).  
Fibulins family is a newly recognized family of extracellular matrix 
proteins with at least seven members (de Vega et al. 2009). Fibulins 
expression can be deregulated in some human cancers, which correlates 
with tumour progression (Obaya et al. 2012). In particular, Fibulin 3 is 
known to regulate cell migration and invasion, playing both (i) antitumour, 
in lung cancer (Kim et al. 2012a) or nasopharyngeal carcinomas (Hwang et 
al. 2010),  and (ii) oncogenic activities, in glioma (Hu et al. 2009) or 
pancreatic adenocarcinomas (Camaj et al. 2009).  
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OBJECTIVES/AIMS 
1. To characterize the pro-survival function of p38α MAPK in response to 
oxidative stress and the potential implication of the 
Akt/mTORC1/p70S6K pathway. 
 
2. To identify the mechanisms involved in the regulation of fibulin 3 
expression by p38α MAPK and a potential role for fibulin 3 as a 
mediator of p38 effects on cell migration and invasion.  
 
3. To investigate whether C3G and p38α MAPK act in a common pathway 
to regulate cell migration and invasion.  
 
RESULTS 
1. p38 MAPK mediates cell survival in response to oxidative stress via 
induction of antioxidant genes in MEFs 
Loss of p38α sensitizes cells to H2O2-induced cell death and impaired 
mTORC1/p70S6K activation  
Our group had previously reported that wt MEFs exhibited a higher 
resistance to moderate oxidative stress than p38α-/- cells (Gutierrez-
Uzquiza et al. 2010). We validated this result, demonstrating that p38α 
protects from low levels of H2O2-induced cell death.  
In addition, we found that p38α MAPK positively regulated 
mTORC1/p70S6K activation in response to H2O2 through an AKt 
independent mechanism. However, this pathway did not mediate p38α-
dependent survival. 
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p38α increases basal and H2O2-induced expression of antioxidant enzymes: 
SOD-1, SOD-2 and Catalase 
Based on these results, we decided to explore alternative 
mechanisms by which p38α might protect cells from ROS damage, allowing 
cell survival in response to oxidative stress. Our data indicated that upon 
treatment with H2O2, p38α-/- cells were unable to efficiently scavange ROS, 
which led to an accumulation of ROS. 
The presence of p38α increased basal and H2O2-induced expression 
of the antioxidant enzymes: SOD-1, SOD-2 and catalase through different 
mechanisms, which protected from ROS accumulation and prevented cell 
death. p38α was found to regulate (i) H2O2-induced SOD-2 expression 
through a direct regulation of transcription mediated by ATF-2 (activating 
transcription factor-2) and (ii) H2O2-induced catalase expression through 
regulation of protein stability and mRNA expression and/or stabilization. As 
a consequence, SOD and catalase activities were higher in wt MEFs.  
 
2. p38 MAPK down-regulates fibulin 3 expression through 
hypermethylation of gene regulatory sequences, promoting migration 
and invasion 
p38 MAPK down-regulates fibulin 3 expression  
Based on our data derived from Affymetrix microarrays showing 
that fibulin 3 was down-regulated by p38α, we have characterized the role 
played by p38α in the regulation of Fibulin 3. We have also analyzed if other 
p38 MAPKs regulated Fibulin 3 expression.  Hence, fibulin 3 mRNA levels 
have been quantified by RT-qPRC in MEFs wt, p38α-/-, p38γ-/-, p38δ-/- and 
p38γ/δ-/-. In addition, the effect of the selective p38α/β inhibitor, 
SB203580, has been also evaluated to confirm p38 effect on Fibulin 3 
expression.   
Our data indicate that p38α, p38γ and p38δ are all capable to 
down-regulate fibulin 3 expression, although p38α elicits the strongest 
effect.  
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p38α MAPK induces the  hyper-methylation of regulatory sequences of 
fibulin 3 gene  
Data from the literature indicated that fibulin 3 expression was 
mainly regulated at the transcriptional level (Blackburn et al. 2003;Kim et 
al. 2012a). Thus, we next explored whether p38 might down-regulate 
Fibulin 3 expression through promoter methylation. Treatment with 5-aza-
2´-deoxicytidine (5A2dC) and pyrosequencing analyses strongly indicate 
that p38α represses fibulin 3 expression through hypermethylation of 5’UTR 
regulatory sequences.  Moreover, this might be mediated by the DNA 
methylase, DNMT3A, which is up-regulated by p38α MAPK.  
 
Fibulin 3 knock-down promotes migration and invasion of MEFs 
To study the function of the p38α/Fibulin 3 circuit in the regulation 
of cell migration and invasion, we permanently knocked-down Fibulin 3 in 
wt and p38α-/- MEFs.  
According to other data from the literature, our results support a 
role for p38 as a mediator of cell migration and invasion. Moreover, we 
have found that Fibulin 3 inhibits migration and invasion in MEFs through 
mechanisms dependent on p38α/β inhibition. Hence, the p38α pro-
migratory/invasive effect might be, at least in part, mediated by fibulin 3 
down-regulation in MEFs.  
Our data also suggest that MMPs might be involved in the 
regulation of cell invasion by Fibulin 3. 
 
3. C3G inhibits cell migration and invasion through down-regulation of 
p38α MAPK  
We have previously described that C3G through down-regulation of 
p38α MAPK activity was able to control apoptosis. Here, we show that the 
C3G/p38α pathway also modulates cell migration and invasion. Our data 
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are in favour of a model where C3G would inhibit cell migration and 
invasion through the negative regulation of p38α activation by a Rap-1 
independent mechanism.  
We have also seen by zymography that C3G decreases MMP2/9 
activities through down-regulation of p38α activity. In contrast, in the 
absence of p38α, C3G would be a positive regulator of MMP2 activity and 
Rap-1 would be a negative regulator of MMP9. 
 
DISCUSSION 
In the present study we have revealed a pro-survival function of 
p38, which is dependent on the enhancement of the antioxidant 
response. This result is in agreement with other data from the literature, 
which proposed a role for p38α as a positive regulator of SOD-2 (Qadri et al. 
2004), catalase (Sen et al. 2005) and heme-oxigenase-1 (Aggeli et al. 2006). 
However, we describe here, for the first time, a p38α-ATF-2 dependent 
transcriptional regulation of SOD-2 in response to H2O2. In addition, we 
have found that although this response is associated with a reduced Akt 
activity and enhanced mTORC1/p70S6K signaling, these cascades are not 
immediately responsible for the p38-mediated survival effect, but instead, 
their modulation is a consequence of the ROS content in the cells.  
The second part of our study describes for the first time that p38 
down-regulates fibulin 3 expression through hyper-methylation of fibulin 3 
gene regulatory sequences in MEFs. This would favour migration and 
invasion. Therefore, Fibulin 3 is a target of p38α in MEFs that acts as a 
negative regulator of cell migration and invasion, through mechanisms 
involving a p38α/β negative feedback loop. In several tumours, fibulin 3 is 
also down-regulated through promoter methylation (Kim et al. 2012a;Tong 
et al. 2011). However, it can play a dual role in the control of  migration and 
invasion of cancer cells (Obaya et al. 2012). Thus, depending on the type of 
tumour, Fibulin 3 can either promote or inhibit migration, invasion and/or 
tumour growth. 
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Finally, the present work shows that C3G inhibits cell migration and 
invasion in MEFs. This agrees with the increased migration observed in C3G-
/- MEFs (Ohba et al. 2001) and with the reduced migration of breast 
carcinoma cells upon C3G overexpression (Dayma and Radha 2011). 
However, we described here, that C3G controls migration and invasion 
through the regulation of p38α MAPK activity. Therefore, the previously 
identified C3G/p38 cascade not only regulates cell death (Gutierrez-
Uzquiza et al. 2010;Maia et al. 2009), but also cell migration and invasion. 
Moreover, we have found that C3G and Rap-1 exert opposite effects on cell 
migration/invasion in MEFs. Rap-1 promotes cell migration and invasion in 
wt MEFs, according with other publications (Kim et al. 2012b;Lin et al. 2010; 
McSherry et al. 2011). Additionally, we have found that it does so through 
p38α activation.  
 
MAIN CONCLUSION 
p38α MAPK plays a pro-survival role in response to a level of 
oxidative stress able to generate damage, but not massive toxicity. This 
involves the up-regulation of the antioxidant defenses. Additionally, p38α 
promotes cell migration and invasion through mechanisms involving fibulin 
3 down-regulation through hypermethylation of regulatory sequences. On 
the other hand, C3G limits cell migration/invasion through the negative 
regulation of p38α activity.  
Moving to a tumour model, these pathways would contribute to 
the control of tumour progression and they might represent potential 
targets for novel cancer therapies.  
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NUEVOS MEDIADORES DE LAS ACCIONES DE p38ALFA EN LA 
SUPERVIVENCIA Y MIGRACIÓN/INVASIÓN CELULAR. INTERACCIÓN CON 
C3G.  
INTRODUCCIÓN 
Las p38 MAPKs (p38, p38, p38 y p38) son activadas en respuesta a 
una gran variedad de estímulos, regulando numerosas funciones celulares 
(Nebreda and Porras 2000;Wagner and Nebreda 2009). p38α es la isoforma más 
ubicua y de mayor expresión (Cuenda and Rousseau 2007). Las p38 MAPKs 
desempeñan un papel importante en la coordinación de la respuesta frente a las 
especies reactivas de oxígeno (ROS) (Dolado et al. 2007;Tobiume et al. 2001). A 
pesar de que p38α MAPK media apoptosis en respuesta al estrés oxidativo 
(Bragado et al. 2007;Dolado et al. 2007), recientemente se ha descrito que 
también puede promover la supervivencia celular (Gutierrez-Uzquiza et al. 
2010;Thornton and Rincon 2009). Además, las p38 MAPKs regulan los procesos 
de migración e invasión celular, así como la metástasis (del Barco Barrantes and 
Nebreda 2012). 
C3G es una proteína activadora del intercambio de nucleótidos de 
guanina (GEF) de dos miembros de la familia de proteínas Ras: Rap-1 y R-Ras. 
Regula diferentes funciones celulares entre las que se encuentran la apoptosis, la 
adhesión y la migración celular (Radha et al. 2011). Recientemente, nuestro 
grupo, en colaboración con el de la Dra. Guerrero,  ha identificado una nueva 
interacción funcional entre C3G y p38α MAPK en la regulación de la apoptosis 
(Gutierrez-Uzquiza et al. 2010;Maia et al. 2009) y la adhesión celular (Maia et al. 
2013). 
Las fibulinas son una familia de proteínas de la matrix extracelular 
recientemente descubiertas (de Vega et al. 2009). Datos en la bibliografía indican 
que la expresión de las fibulinas se encuentra alterada en varios tipos de cáncer, 
relacionándose con la progresión tumoral  (Obaya et al. 2012). En concreto, se 
sabe que Fibulina 3 desempeña un papel relevante en la migración e invasión 
celular. No obstante, su papel en cáncer es dual y  dependiente del tipo de 
tumour: (i) anti-tumoral en cáncer de pulmón (Kim et al. 2012a) o carcinoma 
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nasofaríngeo (Hwang et al. 2010), y (ii) pro-tumoral en glioma (Hu et al. 2009) o 
adenocarcinoma pancreático (Camaj et al. 2009).  
 
OBJETIVOS 
1. Caracterización del papel de p38α MAPK en la regulación de la 
supervivencia celular en respuesta al estrés oxidativo y la posible 
implicación de la ruta Akt/mTORC1/p70S6K. 
 
2. Identificación de los mecanismos implicados en la regulación  de la 
expresión de fibulina 3 por p38α y de su papel como mediador de las 
acciones de p38α MAPK en la migración e invasión celular.  
 
3. Estudio del papel que juega la ruta C3G/p38α en la regulación de la 
migración e invasión celular.  
 
RESULTADOS 
1. p38 MAPK media supervivencia celular en respuesta al estrés oxidativo a 
través de la inducción de enzimas antioxidantes en fibroblastos 
embrionarios de ratón (MEFs). 
La ausencia de p38α  sensibiliza a las células a la muerte inducida por H2O2 e 
impide la activación de la ruta mTORC1/p70S6K.  
Previamente nuestro grupo había demostrado que los fibroblastos que 
expresaban p38α presentaban una mayor resistencia a la muerte inducida por 
niveles moderados de estrés oxidativo (Gutierrez-Uzquiza et al. 2010). Validamos 
dichos resultados, demostrando que p38α protege frente a la muerte inducida 
por H2O2.  
Además, nuestros resultados demuestran que p38α MAPK regula 
positivamente la activación de la ruta mTORC1/p70S6K en respuesta a H2O2 por 
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un mecanismo independiente de Akt. Sin embargo, dicha ruta no es la 
responsable de la mayor supervivencia observada en los fibroblastos p38α+/+.  
 
p38α protege frente a la muerte inducida por H2O2 mediante la expresión de 
enzimas antioxidantes: SOD-1, SOD-2 y catalasa 
Quisimos analizar otros posibles mecanismos que pudieran ser 
responsables del efecto protector de p38α frente al daño causado por el exceso 
de ROS, y, por lo tanto, de la supervivencia de las células. Nuestros datos 
indicaban que tras el tratamiento con H2O2, las células deficientes en p38α no 
eran capaces de eliminar eficazmente los ROS, acumulándose en su interior y 
causando la muerte celular. Por tanto, podía haber un déficit en los sistemas 
antioxidantes. 
Nuestros resultados demuestran que p38α incrementa la expresión de 
enzimas antioxidantes (SOD-1, SOD-2 y catalasa), tanto a nivel basal como tras el 
tratamiento con H2O2 a través de diversos mecanismos, lo que  evita la 
acumulación de ROS y la muerte celular. Por tanto, p38α induce: (i) la expresión 
de SOD-2 tras la estimulación con H2O2, facilitando  la unión del factor de 
transcripción ATF-2 al promotor y (ii) la expresión de catalasa inducida por el H2O2 
a través de un incremento en la estabilidad y/o expresión de su RNAm y en la 
estabilidad de la proteína.  
 
2. p38 MAPK inhibe la expressión de fibulina 3 a través de la hipermetilación 
de secuencias reguladoras, promoviendo la migración e invasión celular.  
p38 MAPK inhibe la expressión de fibulin 3  
A partir de los datos obtenidos mediante análisis de microarrays que 
indicaban que p38α regulaba negativamente la expresión de fibulina 3, quisimos 
caracterizar el mecanismo implicado en la regulación de la expresión de fibuina 3 
por p38α y si otras isoformas de la subfamilia de las p38 MAPKs podrían también 
regularla. Por ello, validamos y cuantificamos por RT-PCR cuantitativa los niveles 
Resumen 
176 
 
del RNAm de fibulina 3  en fibroblastos wt y deficientes en las isoformas p38α, 
p38γ, p38δ y p38γ/δ. Además, evaluamos el efecto del SB203580 (inhibidor de las 
isoformas α y β). Nuestros datos indican que tanto p38α como p38γ y p38δ 
regulan negativamente la expresión de fibulina 3, pero p38α presenta un efecto 
mucho mayor.  
 
p38α MAPK favorece la metilación de secuencias reguladoras en el gen de 
fibulina 3  
Datos de la literatura indicaban que la expresión de fibulina 3 se regulaba 
principalmente a nivel transcripcional a través de un mecanismo dependiente de 
la metilación de su promotor (Blackburn et al. 2003;Kim et al. 2012a). Por ello, 
analizamos si p38 podría estar inhibiendo a fibulina 3 a través de un incremento 
en la metilación de secuencias reguladoras del gen. Los resultados obtenidos tras 
el tratamiento con la 5-aza-2-deoxicitidina y el análisis del grado de metilación de 
secuencias reguladoras confirman que p38α inhibe la expresión de fibulina 3 a 
través de la metilación de dichas secuencias reguladoras. Además, dicha 
metilación se correlaciona con un aumento en los niveles de la metilasa DNMT3A, 
que es regulada positivamente por p38α. 
 
El silenciamiento de Fibulin 3 promueve la migración e invasión celular en MEFs 
Para estudiar el papel de la ruta p38α/Fibulin 3 en la regulación de la 
migración e invasión celular, se hizo un silenciamiento estable de Fibulina 3 en 
MEFs wt y deficientes en p38α.  
De acuerdo con los datos de la literatura, nuestros resultados 
demuestran que p38α es un mediador de dichos procesos. Además, la Fibulina 3 
inhibe ambos procesos a través de un mecanismo dependiente de la inhibición de 
p38α/β. Por lo tanto, el efecto positivo de p38α sobre los procesos de migración e 
invasión, podría estar mediado, en parte, por su inhibición de fibulina 3.  
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Nuestros datos también sugieren que las MMPs podrían estar 
desempeñado un papel relevante en la regulación que Fibulina 3 ejerce sobre la 
invasión celular.  
 
 
3. C3G regula negativamente la migración e invasión celular a través de la 
inhibición de la actividad de p38α MAPK  
Previamente habíamos descrito que C3G, a través de la regulación 
negativa de p38α, mediaba procesos de muerte celular/supervivencia  (Gutierrez-
Uzquiza et al. 2010; Maia et al. 2009). Por ello, quisimos analizar si ambas 
proteínas participaban también en una ruta común regulando los procesos de 
migración e invasión celular. Nuestros resultados indican que, de nuevo, C3G 
estaría inhibiendo la migración e invasión celular a través de la regulación 
negativa de la actividad de p38α, por un mecanismo independiente de Rap-1.  
Analizamos también si C3G modulaba la actividad de las MMPs durante 
estos procesos. C3G disminuye la actividad de MMP2 y MMP9 a través de la 
inhibición de p38α. Sin embargo, en ausencia de p38α, C3G parece ser un 
regulador positivo de la actividad de MMP2, mientras que Rap-1 sería un 
regulador negativo de MMP9.   
 
DISCUSIÓN  
Nuestros resultados demuestran que p38α desempeña una función 
importante en la regulación de la supervivencia celular en respuesta a niveles 
moderados de estrés oxidativo, que es dependiente del aumento en la respuesta 
antioxidante. Estos resultados están de acuerdo con datos de la literatura  que 
proponen a p38α como un regulador positivo de la expresión de SOD-2 (Qadri et 
al. 2004), catalasa (Sen et al. 2005) y hemo-oxigenasa-1 (Aggeli et al. 2006). Sin 
embargo, en este trabajo se describe, por primera vez, que p38α, por un 
mecanismo dependiente de la activación de ATF-2, regula positivamente la 
transcripción de SOD-2 tras un tratamiento con H2O2. Además, aunque en esta 
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situación de moderado nivel de estrés oxidativo, encontramos disminuida la 
activación de Akt y aumentada la p70S6K, dichas rutas no son responsables de la 
mayor supervivencia que presentan las células con p38α. La diferente activación 
de la ruta  mTORC1/p70S6K es consecuencia del contenido intracelular de ROS, 
de forma que unos elevados niveles de ROS bloquean la activación de dicha ruta.  
En la segunda parte de esta Tesis hemos descrito por primera vez que 
p38α regula negativamente la expresión de fibulina 3 a través del aumento en la 
metilación de secuencias reguladores del gen de fibulina 3 en MEFs. Además, la 
menor expresión de fibulina 3 estaría promoviendo los procesos de migración e 
invasión celular. Por tanto, la Fibulina 3, sería un nuevo mediador de p38α, 
actuando como un regulador negativo de la migración e invasión celular, a través 
de un mecanismo que implica la regulación negativa de  p38α/β. Ha sido descrito 
que la expresión de fibulina 3 puede estar desregulada en distintos tipos de 
tumores (Obaya et al. 2012), desempeñando un papel dual. Dependiendo del tipo 
de tumor, Fibulina 3 favorece o inhibe la migración, invasión y el crecimiento 
tumoral. Además, de acuerdo con nuestros resultados, en ciertos tumores el 
silenciamiento de fibulina 3 se correlaciona con un aumento en la metilación de 
su promotor (Kim et al. 2012a;Tong et al. 2011).  
Por último, nuestros resultados demuestran que C3G inhibe la migración 
e invasión celular en MEFs. Datos de la literatura coinciden con nuestros 
resultados, observándose un incremento en la migración en los fibroblastos 
deficientes en C3G (Ohba et al. 2001) o una disminución en dicho proceso al 
sobreexpresar C3G en células de cáncer de mama  (Dayma and Radha 2011). Sin 
embargo, nuestros resultados demuestran que C3G controla el proceso de 
migración a través de la regulación negativa de la actividad de p38α. Por ello, la 
ruta C3G/p38α no solo actúa modulando la muerte celular como previamente 
habíamos descrito(Gutierrez-Uzquiza et al. 2010; Maia et al. 2009), sino que 
también regula la migración e invasión celular en MEFs. Además, en este modelo 
C3G y Rap-1 presentan efectos opuestos. Rap-1 en presencia de p38α promueve 
la migración e invasión celular, lo que está de acuerdo con resultados de otros 
grupos (Kim et al. 2012b;Lin et al. 2010;McSherry et al. 2011). 
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CONCLUSIÓN FINAL  
p38α MAPK protege de la muerte inducida por niveles moderados de 
estrés oxidativo a través de la regulación positiva de la respuesta antioxidante. 
Además, p38α favorece  la migración e invasión celular por un mecanismo que 
implica la regulación negativa de fibulina 3, a través de metilación de secuencias 
reguladoras de su gen. Por último,  C3G inhibe la migración e invasión celular a 
través de la regulación negativa de la actividad de p38α. 
En el caso de un modelo tumoral, estas rutas  podrían contribuir al 
control de la progresión tumoral y representarían dianas potenciales para el 
desarrollo de nuevas terapias anti-tumorales.   
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p38Mediates Cell Survival in Response to Oxidative Stress
via Induction of Antioxidant Genes
EFFECT ON THE p70S6K PATHWAY*□S
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Background: p38MAPK is activated by stress stimuli, which can regulate cell death.
Results: In response to H2O2, p38 MAPK increases SOD and catalase levels, impairs ROS accumulation, and leads to cell
survival.
Conclusion: p38MAPK signals survival under moderate oxidative stress through up-regulation of antioxidant defenses.
Significance: To know how p38 regulates ROS levels is important for cell homeostasis.
We reveal a novel pro-survival role for mammalian p38 in
response to H2O2, which involves an up-regulation of antioxi-
dant defenses. The presence of p38 increases basal and H2O2-
induced expression of the antioxidant enzymes: superoxide-dis-
mutase 1 (SOD-1), SOD-2, and catalase through different
mechanisms,whichprotects fromreactive oxygen species (ROS)
accumulation and prevents cell death. p38 was found to regu-
late (i) H2O2-induced SOD-2 expression through a direct regu-
lation of transcriptionmediated by activating transcription fac-
tor 2 (ATF-2) and (ii) H2O2-induced catalase expression
through regulation of protein stability and mRNA expression
and/or stabilization. As a consequence, SOD and catalase activ-
ities are higher in WTMEFs. We also found that this p38-de-
pendent antioxidant response allows WT cells to maintain an
efficient activation of the mTOR/p70S6K pathway. Accord-
ingly, the loss of p38 leads to ROS accumulation in response to
H2O2, which causes cell death and inactivation of mTOR/
p70S6K signaling. This can be rescued by either p38 re-expres-
sion or treatment with the antioxidants, N-acetyl cysteine, or
exogenously added catalase. Therefore, our results reveal a
novel homeostatic role for p38 in response to oxidative stress,
where ROS removal is favored by antioxidant enzymes up-reg-
ulation, allowing cell survival and mTOR/p70S6K activation.
The intracellular redox state is tightly regulated because it is
essential for the control of cell fate. High levels of ROS5 can lead
to molecular damage and cell death, whereas low ROS levels
can be essential second messengers (1). Pro-oxidant and anti-
oxidant systems are involved in this regulation, preventing an
excessive accumulation of ROS.
Different members of theMAPK family, such as ERKs, JNKs,
and p38, can be activated by ROS (1). This activation leads to a
great variety of biological responses, including cell death or
survival. Hence, although the stress MAP kinases can induce
apoptosis in response to oxidative stress (2, 3), differences in the
duration and magnitude of the oxidative stress might be
directly proportional to the state of activation of these kinases,
and this might determine cell death or survival.
p38MAPK plays an important role in the coordination of
cellular stress responses to signals such as ROS. In fact, it is well
known that p38MAPK plays an important role in mediating
apoptosis (4) and/or senescence induced by different stimuli,
includingROS (5, 6). For example, ROS generated by oncogenic
H-Ras induces apoptosis through p38 activation, inhibiting
tumor initiation (7). In contrast, low levels of oxidative stress
can also induce cell cycle arrest (8) or cell survival (9, 10)
through p38. Initially, stress signalingmechanisms are pro-sur-
vival systems because they tend to repair damage before com-
mitting cells to death or senescence. Interestingly, p38 can
mediate survival upon activation with H2O2 (10), and p38 and
 can have pro-survival roles (11–13) such as during quiescence
of dormant tumor cells (14). However, the precise mechanisms
by which p38 signaling achieves cell survival are poorly
understood.
We have previously demonstrated that Akt activity is nega-
tively regulated by p38 (15), and recent data fromNogueira et
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